{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Intel MKL WARNING: Support of Intel(R) Streaming SIMD Extensions 4.2 (Intel(R) SSE4.2) enabled only processors has been deprecated. Intel oneAPI Math Kernel Library 2025.0 will require Intel(R) Advanced Vector Extensions (Intel(R) AVX) instructions.\n",
      "Intel MKL WARNING: Support of Intel(R) Streaming SIMD Extensions 4.2 (Intel(R) SSE4.2) enabled only processors has been deprecated. Intel oneAPI Math Kernel Library 2025.0 will require Intel(R) Advanced Vector Extensions (Intel(R) AVX) instructions.\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "import requests\n",
    "import pycountry\n",
    "import re\n",
    "import geopandas as gpd\n",
    "import lxml"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "BINDING_DATASET = \"BindingDB_All.tsv\"\n",
    "bindingDB = pd.read_csv(BINDING_DATASET, sep='\\t', nrows = 1000000)\n",
    "bindingDB.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "usecols = [\n",
    "    # 'BindingDB Reactant_set_id',\n",
    "    # 'Ligand SMILES',\n",
    "    # 'Ligand InChI',\n",
    "    # 'Ligand InChI Key',\n",
    "    # 'BindingDB MonomerID',\n",
    "    \"BindingDB Ligand Name\",\n",
    "    \"Target Name\",\n",
    "    \"Target Source Organism According to Curator or DataSource\",\n",
    "    # 'Ki (nM)',\n",
    "    # 'IC50 (nM)',\n",
    "    # 'Kd (nM)',\n",
    "    # 'EC50 (nM)',\n",
    "    # 'kon (M-1-s-1)',\n",
    "    # 'koff (s-1)',\n",
    "    # 'pH',\n",
    "    # 'Temp (C)',\n",
    "    \"Curation/DataSource\",\n",
    "    # 'Article DOI',\n",
    "    # 'BindingDB Entry DOI',\n",
    "    # 'PMID',\n",
    "    # 'PubChem AID',\n",
    "    \"Patent Number\",\n",
    "    \"Authors\",\n",
    "    \"Institution\",\n",
    "    # 'Link to Ligand in BindingDB',\n",
    "    # 'Link to Target in BindingDB',\n",
    "    # 'Link to Ligand-Target Pair in BindingDB',\n",
    "    # 'Ligand HET ID in PDB',\n",
    "    # 'PDB ID(s) for Ligand-Target Complex',\n",
    "    # 'PubChem CID',\n",
    "    # 'PubChem SID',\n",
    "    # 'ChEBI ID of Ligand',\n",
    "    # 'ChEMBL ID of Ligand',\n",
    "    'DrugBank ID of Ligand',\n",
    "    # 'IUPHAR_GRAC ID of Ligand',\n",
    "    # 'KEGG ID of Ligand',\n",
    "    # 'ZINC ID of Ligand',\n",
    "    # 'Number of Protein Chains in Target (>1 implies a multichain complex)',\n",
    "    # 'BindingDB Target Chain Sequence',\n",
    "    # 'PDB ID(s) of Target Chain',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain',\n",
    "    # 'BindingDB Target Chain Sequence.1',\n",
    "    # 'PDB ID(s) of Target Chain.1',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.1',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.1',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.1',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.1',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.1',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.1',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.1',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.1',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.1',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.1',\n",
    "    # 'BindingDB Target Chain Sequence.2',\n",
    "    # 'PDB ID(s) of Target Chain.2',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.2',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.2',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.2',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.2',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.2',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.2',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.2',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.2',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.2',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.2',\n",
    "    # 'BindingDB Target Chain Sequence.3',\n",
    "    # 'PDB ID(s) of Target Chain.3',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.3',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.3',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.3',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.3',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.3',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.3',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.3',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.3',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.3',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.3',\n",
    "    # 'BindingDB Target Chain Sequence.4',\n",
    "    # 'PDB ID(s) of Target Chain.4',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.4',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.4',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.4',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.4',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.4',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.4',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.4',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.4',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.4',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.4',\n",
    "    # 'BindingDB Target Chain Sequence.5',\n",
    "    # 'PDB ID(s) of Target Chain.5',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.5',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.5',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.5',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.5',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.5',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.5',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.5',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.5',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.5',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.5',\n",
    "    # 'BindingDB Target Chain Sequence.6',\n",
    "    # 'PDB ID(s) of Target Chain.6',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.6',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.6',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.6',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.6',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.6',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.6',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.6',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.6',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.6',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.6',\n",
    "    # 'BindingDB Target Chain Sequence.7',\n",
    "    # 'PDB ID(s) of Target Chain.7',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.7',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.7',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.7',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.7',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.7',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.7',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.7',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.7',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.7',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.7',\n",
    "    # 'BindingDB Target Chain Sequence.8',\n",
    "    # 'PDB ID(s) of Target Chain.8',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.8',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.8',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.8',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.8',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.8',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.8',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.8',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.8',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.8',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.8',\n",
    "    # 'BindingDB Target Chain Sequence.9',\n",
    "    # 'PDB ID(s) of Target Chain.9',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.9',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.9',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.9',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.9',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.9',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.9',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.9',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.9',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.9',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.9',\n",
    "    # 'BindingDB Target Chain Sequence.10',\n",
    "    # 'PDB ID(s) of Target Chain.10',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.10',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.10',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.10',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.10',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.10',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.10',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.10',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.10',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.10',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.10',\n",
    "    # 'BindingDB Target Chain Sequence.11',\n",
    "    # 'PDB ID(s) of Target Chain.11',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.11',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.11',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.11',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.11',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.11',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.11',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.11',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.11',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.11',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.11',\n",
    "    # 'BindingDB Target Chain Sequence.12',\n",
    "    # 'PDB ID(s) of Target Chain.12',\n",
    "    # 'UniProt (SwissProt) Recommended Name of Target Chain.12',\n",
    "    # 'UniProt (SwissProt) Entry Name of Target Chain.12',\n",
    "    # 'UniProt (SwissProt) Primary ID of Target Chain.12',\n",
    "    # 'UniProt (SwissProt) Secondary ID(s) of Target Chain.12',\n",
    "    # 'UniProt (SwissProt) Alternative ID(s) of Target Chain.12',\n",
    "    # 'UniProt (TrEMBL) Submitted Name of Target Chain.12',\n",
    "    # 'UniProt (TrEMBL) Entry Name of Target Chain.12',\n",
    "    # 'UniProt (TrEMBL) Primary ID of Target Chain.12',\n",
    "    # 'UniProt (TrEMBL) Secondary ID(s) of Target Chain.12',\n",
    "    # 'UniProt (TrEMBL) Alternative ID(s) of Target Chain.12'\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/65/r52mz7k10_l6lkp_jfvvl2mr0000gn/T/ipykernel_9883/3604030247.py:1: DtypeWarning: Columns (21,22,23,33) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  bindingDB_all = pd.read_csv(BINDING_DATASET, sep='\\t', on_bad_lines='skip', usecols = usecols)\n"
     ]
    }
   ],
   "source": [
    "bindingDB_all = pd.read_csv(BINDING_DATASET, sep='\\t', on_bad_lines='skip', usecols = usecols)\n",
    "\n",
    "# bindingDB_HS = bindingDB_all[bindingDB_all['Target Source Organism According to Curator or DataSource']=='Homo sapiens']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Institution                            \n",
       "Merck Sharp & Dohme Corp                   39210\n",
       "Burnham Center for Chemical Genomics       38634\n",
       "Janssen Pharmaceutica NV                   37115\n",
       "Bristol-Myers Squibb Co.                   32372\n",
       "Novartis AG                                32190\n",
       "                                           ...  \n",
       "Chemocentryx                                   1\n",
       "Innovative Therapeutics Lab                    1\n",
       "Indian Institute of Chemical Technology        1\n",
       "Sanofi Oncology                                1\n",
       "University of Lisbon                           1\n",
       "Name: count, Length: 2507, dtype: int64"
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bindingDB[['Institution']].value_counts()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [],
   "source": [
    "# institutions = bindingDB['Institution'].unique().tolist()\n",
    "# df_institutions = pd.DataFrame(institutions, columns=['institution']).sample(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [],
   "source": [
    "# #!pip install pandas geopy\n",
    "# from geopy.geocoders import Nominatim\n",
    "# from geopy.extra.rate_limiter import RateLimiter\n",
    "# import time\n",
    "\n",
    "# geolocator = Nominatim(user_agent=\"geo_institution_locator\")\n",
    "# geocode = RateLimiter(geolocator.geocode, min_delay_seconds=1)\n",
    "# def get_place(institution):\n",
    "#     try:\n",
    "#         location = geocode(institution)\n",
    "#         if location:\n",
    "#             return location.address, location.latitude, location.longitude\n",
    "#         else:\n",
    "#             return None, None, None\n",
    "#     except Exception as e:\n",
    "#         print(f\"Error geocoding {institution}: {e}\")\n",
    "#         return None, None, None\n",
    "\n",
    "#df_institutions['address'], df_institutions['latitude'], df_institutions['longitude'] = zip(*df_institutions['institution'].apply(get_place))\n",
    "#df_institutions\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "bindingDB_sample = bindingDB.sample(100000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_location(doi):\n",
    "    \"\"\"\n",
    "    Get affiliated institution location based on a DOI\n",
    "\n",
    "    :doi: str, DOI of article\n",
    "\n",
    "    return: location (str)\n",
    "    \"\"\"\n",
    "    url = f\"https://api.crossref.org/works/{doi}\"\n",
    "    response = requests.get(url)\n",
    "    if response.status_code == 200:\n",
    "        data = response.json()\n",
    "        authors = data.get('message', {}).get('author', [])\n",
    "        if authors:\n",
    "            main_author = authors[-1]\n",
    "            affiliation_info = main_author.get('affiliation', [])\n",
    "            if affiliation_info:\n",
    "                location = affiliation_info[0].get('name', 'No location found')\n",
    "                return location\n",
    "            else:\n",
    "                return 'No affiliation found'\n",
    "        else:\n",
    "            return 'No authors found'\n",
    "    \n",
    "    else:\n",
    "        return f\"Error: {response.status_code}\"\n",
    "\n",
    "def add_location(df):\n",
    "    \"\"\"\n",
    "    Add affiliated institution location to dataframes\n",
    "\n",
    "    :df: dataframe containing a column of DOIs TITLED \"Article DOI\"\n",
    "\n",
    "    return: new Pandas.Dataframe with an additional \"Affiliated Location\" column\n",
    "    \"\"\"\n",
    "    #group all identical DOIs together and get their affiliated institution location\n",
    "    pub_counts = df[\"Article DOI\"].value_counts().to_frame().reset_index()\n",
    "    pub_counts[\"Affiliated Location\"] = pub_counts[\"Article DOI\"].apply(get_location)\n",
    "\n",
    "    #final dataframe with date of publications\n",
    "    return df.merge(pub_counts, on='Article DOI', how='left')\n",
    "\n",
    "#bindingDB_sample = add_location(bindingDB_sample)\n",
    "locations = []\n",
    "for doi in bindingDB_sample['Article DOI'].unique():\n",
    "    locations.append(get_location(doi))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.5605095541401274\n"
     ]
    }
   ],
   "source": [
    "n=0\n",
    "for i in locations:\n",
    "    if i == 'No affiliation found':\n",
    "        n = n+1\n",
    "print(n/len(locations))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "DF_locations = pd.DataFrame(locations, columns=[\"location\"])\n",
    "DF_locations['country'] = None\n",
    "\n",
    "us_states = {\n",
    "    'Alabama', 'Alaska', 'Arizona', 'Arkansas', 'California', 'Colorado', 'Connecticut', 'Delaware',\n",
    "    'Florida', 'Georgia', 'Hawaii', 'Idaho', 'Illinois', 'Indiana', 'Iowa', 'Kansas', 'Kentucky',\n",
    "    'Louisiana', 'Maine', 'Maryland', 'Massachusetts', 'Michigan', 'Minnesota', 'Mississippi', 'Missouri',\n",
    "    'Montana', 'Nebraska', 'Nevada', 'New Hampshire', 'New Jersey', 'New Mexico', 'New York', 'North Carolina',\n",
    "    'North Dakota', 'Ohio', 'Oklahoma', 'Oregon', 'Pennsylvania', 'Rhode Island', 'South Carolina',\n",
    "    'South Dakota', 'Tennessee', 'Texas', 'Utah', 'Vermont', 'Virginia', 'Washington', 'West Virginia',\n",
    "    'Wisconsin', 'Wyoming'\n",
    "}\n",
    "\n",
    "def fct_extract_country(affiliation):\n",
    "    if not isinstance(affiliation, str):\n",
    "        return None\n",
    "    cleaned_affiliation = re.sub(r'\\b[A-Z]{1,2}\\d{1,4}[A-Z]{0,2}\\b', '', affiliation)\n",
    "    for state in us_states: # checks if US state present and map it to USA (some addresses from USA only have the state and not the country)\n",
    "        if state in cleaned_affiliation:\n",
    "            return \"United States of America\"\n",
    "    # Matches countries in pyountry database (standardized country names in english):\n",
    "    countries = []\n",
    "    for country in pycountry.countries:\n",
    "        if country.name in cleaned_affiliation or (country.alpha_2 in cleaned_affiliation or country.alpha_3 in cleaned_affiliation):\n",
    "            countries.append(country.name)\n",
    "    if countries: # returns the first matching country or None if no match\n",
    "        return countries[0]\n",
    "    return None\n",
    "\n",
    "DF_locations.loc[DF_locations['location'] != \"No affiliation found\", 'country'] = DF_locations['location'].apply(fct_extract_country)\n",
    "\n",
    "m=0\n",
    "for j in DF_locations['country']:\n",
    "    if j == None:\n",
    "        m = m+1\n",
    "print(m/len(DF_locations['country']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "countries = DF_locations['country'].to_list()\n",
    "sorted_countries_DF = pd.DataFrame(countries, columns=['NAME'])\n",
    "country_counts_ = sorted_countries_DF['NAME'].value_counts()\n",
    "sorted_countries_DF['counts'] = sorted_countries_DF['NAME'].map(country_counts_)\n",
    "sorted_countries_DF = sorted_countries_DF.sort_values(by='counts', ascending = False).dropna()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x1000 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "world = gpd.read_file(\"ne_110m_admin_0_countries/ne_110m_admin_0_countries.shp\")\n",
    "\n",
    "world = world.merge(sorted_countries_DF[['NAME', 'counts']], on='NAME', how='left')\n",
    "world['counts'] = world['counts'].fillna(0)\n",
    "world['NAME'].to_list()\n",
    "\n",
    "fig, ax = plt.subplots(1, 1, figsize=(15, 10))\n",
    "world.boundary.plot(ax=ax, linewidth=0.8, color='#cccccc')  \n",
    "cmap = plt.get_cmap('viridis_r')\n",
    "cmap.set_under('white')\n",
    "world.plot(column='counts', ax=ax, legend=True, cmap=cmap, vmin=5.1, \n",
    "           legend_kwds={'label': \"Country Counts\",\n",
    "                        'orientation': \"horizontal\",\n",
    "                        'shrink': 0.5},\n",
    "           edgecolor='black', linewidth=0.5)\n",
    "\n",
    "world_unique = world.drop_duplicates(subset='NAME')\n",
    "top_countries = world_unique.nlargest(3, 'counts')\n",
    "\n",
    "for idx, row in top_countries.iterrows():\n",
    "    centroid = row['geometry'].centroid\n",
    "    ax.text(centroid.x, centroid.y, f\"{row['NAME']} ({int(row['counts'])})\", \n",
    "            fontsize=9, ha='center', color='black', \n",
    "            bbox=dict(facecolor='white', edgecolor='none', alpha=0.7))\n",
    "\n",
    "plt.title(\"Countries Contributions to BindingDB (random 100 000 rows of 1M first rows)\", fontsize=14)\n",
    "plt.tight_layout() \n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Diseases classification"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "drugbank = pd.read_xml(\"full database.xml\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Lepirudin is indicated for anticoagulation in adult patients with acute coronary syndromes (ACS) such as unstable angina and acute myocardial infarction without ST elevation. In patients with ACS, lepirudin is intended for use with [aspirin].[L41539] Lepirudin is also indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease in order to prevent further thromboembolic complications.[L41539]',\n",
       " 'Cetuximab indicated for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck in combination with radiation therapy. It is indicated for treating a recurrent locoregional disease or metastatic squamous cell carcinoma of the head and neck in combination with platinum-based therapy with fluorouracil. It is indicated for recurrent or metastatic squamous cell carcinoma of the head and neck progressing after platinum-based therapy.[L30448]\\r\\n\\r\\nCetuximab is also indicated for K-Ras wild-type, EGFR-expressing, metastatic colorectal cancer as determined by an FDA-approved test in combination with FOLFIRI, a chemotherapy combination that includes [leucovorin], [fluorouracil], and [irinotecan]; in combination with irinotecan in patients who are refractory to irinotecan-based chemotherapy; or as monotherapy in patients who have failed oxaliplatin- and irinotecan-based chemotherapy or who are intolerant to irinotecan.[L30448]\\r\\n\\r\\nAdditionally, cetuximab is also indicated for metastatic colorectal cancer that is BRAF V600E mutation-positive (as determined by an FDA-approved test) in combination with [encorafenib] but only after prior therapy.[L39045]\\r\\n\\r\\nCetuximab is not indicated for the treatment of Ras-mutant colorectal cancer or when the results of the Ras mutation tests are unknown.[L30448]',\n",
       " 'Used as adjunct therapy in the treatment of cystic fibrosis. ',\n",
       " 'For treatment of cutaneous T-cell lymphoma',\n",
       " 'Etanercept is indicated for the treatment of moderately to severely active rheumatoid arthritis in adults and in chronic moderate to severe plaque psoriasis in patients 4 years of age and older.[L14862,L45523] It is also used to manage signs and symptoms of polyarticular idiopathic arthritis and Juvenile Psoriatic Arthritis in those aged 2 years and older. Etanercept is also used to manage the symptoms of psoriatic arthritis and ankylosing spondylitis.[L48526] ',\n",
       " 'For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned.',\n",
       " 'Leuprolide is indicated for the treatment of advanced prostate cancer [L13781, L34415] and as palliative treatment of advanced prostate cancer.[L13790] \\r\\n\\r\\nIt is also used for the treatment of pediatric patients with central precocious puberty (CPP).[L13784, L13787] \\r\\n\\r\\nIn combination with oral [norethisterone] (also known as norethindrone), leuprolide is also indicated for the initial treatment of the symptoms of endometriosis.[L10310] Finally, in combination with iron supplementation, leuprolide is indicated for the preoperative hematological improvement of anemic patients with uterine leiomyomata (uterine fibroids).[L13814]',\n",
       " 'Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.\\r\\n\\r\\nPeginterferon alfa-2a is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation [FDA Label].',\n",
       " 'Alteplase is indicated for the treatment of acute ischemic stroke (AIS) and for use in acute myocardial infarction (AMI) for the reduction of mortality and incidence of heart failure. Alteplase is also indicated for the lysis of acute massive pulmonary embolism, defined as acute pulmonary emboli obstructing blood flow to a lobe or multiple lung segments, and acute pulmonary emboli accompanied by unstable hemodynamics.[L43125]',\n",
       " 'For the treatment of dwarfism, prevention of HIV-induced weight loss',\n",
       " 'For the treatment of venereal or genital warts caused by the Human Papiloma Virus.',\n",
       " 'For the treatment of anemia (from renal transplants or certain HIV treatment)',\n",
       " 'In Canada, urokinase is indicated for lysis of acute massive pulmonary emboli, acute thrombi obstructing coronary arteries, occlusive thromboemboli in peripheral arteries and grafts, and restoration of patency to intravenous catheters.[L12141]',\n",
       " 'Goserelin is indicated for:\\r\\n\\r\\n- Use in combination with flutamide for the management of locally confined carcinoma of the prostate\\r\\n- Palliative treatment of advanced carcinoma of the prostate\\r\\n- The management of endometriosis\\r\\n- Use as an endometrial-thinning agent prior to endometrial ablation for dysfunctional uterine bleeding\\r\\n- Use in the palliative treatment of advanced breast cancer in pre- and perimenopausal women',\n",
       " 'For lysis of acute pulmonary emboli, intracoronary emboli, and management of myocardial infarction.',\n",
       " 'Indicated in adult and paediatric patients for the: \\r\\n\\r\\n- treatment of anemia due to Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis.\\r\\n- treatment of anemia due to zidovudine in patients with HIV-infection. \\r\\n- treatment of anemia due to the effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.\\r\\n- reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery.',\n",
       " \"Used in the treatment of symptomatic Paget's disease for patients unresponsive to alternate treatments or intolerant to such treatments. In addition, it is used in emergency situations when serum calcium levels must be decreased quickly until the underlying condition is identified. It can also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or corticosteroids, or other agents. Calcitonin can be used in patients with azotemia and cases where intravenous fluids would be contraindicated due to limited cardiac reserves. Also for the treatment of post-menopausal osteoporosis in women more than 5 years post-menopause.  \",\n",
       " 'For the intralesional treatment of refractory or recurring external condylomata acuminata.',\n",
       " 'Pegfilgrastim is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non\\xad myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.[L44221]\\r\\n\\r\\nIt is also indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome).[L44221]',\n",
       " 'For the treatment of cancer and bone marrow transplant',\n",
       " 'Peginterferon alfa-2b is indicated for the treatment of HCV in combination with [DB00811] and a NS3/4A protease inhibitor for genotype 1 or without a NS3/4A protease inhibitor for genotypes 2-6 [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.\\r\\n\\r\\nIt is also indicated for the adjuvant treatment of melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection, including complete lymphadenectomy.[L45334]',\n",
       " 'Indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL).[L39809]',\n",
       " 'For detection of residueal or recurrent thyroid cancer',\n",
       " 'The human recombinant antihemophilic factor is indicated for use in adults and children with hemophilia A for the control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.[L41025, L36130]',\n",
       " 'Anakinra is an interleukin-1 receptor antagonist indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis (RA), in patients 18 years of age or older who have failed one or more disease-modifying antirheumatic drugs (DMARDs). Anakinra can be used alone or in combination with DMARDs other than Tumor Necrosis Factor (TNF) blocking agents.[L35415]\\r\\n\\r\\nAnakinra is also indicated for the treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID) and the treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA).[L35415] Anakinra is also used off-label for the treatment of several inflammatory diseases.[A247000]\\r\\n\\r\\nThe FDA has issued an emergency use authorization (EUA) for the emergency use of anakinra for the treatment of coronavirus disease 2019 (COVID-19) in hospitalized adults with positive results of direct SARS-CoV-2 viral testing with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure and likely to have an elevated plasma soluble urokinase plasminogen activator receptor (suPAR). Since anakinra is approved for this condition under EUA, the drug should only be used when there are no alternative treatment available.[L43927]',\n",
       " 'For treatment of skin lesions, surface wounds and eye infections.',\n",
       " 'Human immunoglobulin G is indicated for the following conditions:\\r\\n\\r\\n### Primary Immunodeficiency\\r\\n- for the treatment of primary immunodeficiency in adult and pediatric patients[L39920, L39930, L39935, L39940, L39945, L39950, L39955, L39960, L39965, L39975, L39980, L40029, L40034, L40044]\\r\\n- in combination with [hyaluronidase (human recombinant)] for the treatment of primary immunodeficiency in patients 2 years of age.[L42760]\\r\\n\\r\\n### Immune Thrombocytopenic Purpura (ITP)\\r\\n- for the treatment of acute or chronic immune thrombocytopenic purpura in adult and pediatric patients[L39940, L39950, L39960, L39965, L39970, L39975, L39980]\\r\\n\\r\\n### Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\\r\\n- for the treatment of CIDP in adult patients[L39955, L39965, L39975, L39980, L40034]\\r\\n- in combination with hyaluronidase (human recombinant) as a maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP)[L40039]\\r\\n\\r\\n### Multifocal Motor Neuropathy (MMN)\\r\\n- for maintenance therapy to improve muscle strength and disability in adult patients with MMN[L39955]\\r\\n\\r\\n### Prophylaxis of Bacterial Infection\\r\\n- for the prevention of bacterial infections in patients with hypogammaglobulinemia and/or B-cell chronic lymphocytic leukemia[L39960]\\r\\n\\r\\n### Coronary Artery Aneurysm Associated With Kawasaki Syndrome\\r\\n- for the prevention of coronary artery aneurysms in pediatric patients with Kawasaki syndrome[L39960]\\r\\n\\r\\n### Dermatomyositis\\r\\n- for the treatment of dermatomyositis in adult patients[L39970]\\r\\n',\n",
       " 'For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction',\n",
       " 'Human insulin is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.',\n",
       " 'For treatment of myocardial infarction and lysis of intracoronary emboli',\n",
       " 'For the treatment of female infertility',\n",
       " 'Interferon gamma-1b is used for the treatment of Chronic granulomatous disease and Osteopetrosis.',\n",
       " \"For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatment of oral warts arising from HIV infection.\",\n",
       " \"- Indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void (intranasal). \\r\\n\\r\\n- Indicated as antidiuretic replacement therapy in the management of central cranial diabetes insipidus and for management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region (intranasal/parenteral).\\r\\n\\r\\n- Indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5% or mild to moderate classic von Willebrand's Disease (Type I) with factor VIII levels greater than 5% during surgical procedures and postoperatively to maintain hemostasis (parenteral).\",\n",
       " 'For treatment of hemorrhagic complications in hemophilia A and B.',\n",
       " 'Indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia.[Label]',\n",
       " 'For treatment of oral mucositis associated with chemotherapy and radiation therapy.',\n",
       " 'Glucagon is indicated as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.[L7634,L7637,L7640,L7643,L8519]',\n",
       " 'For treatment of adults with metastatic renal cell carcinoma.',\n",
       " 'For the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.',\n",
       " 'This drug is an anti-IgE antibody indicated for:\\r\\n\\r\\n1. Moderate to severe persistent asthma in patients 6 years of age and older\\r\\nwith a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids [FDA label]\\r\\n\\r\\n2. Chronic idiopathic urticaria in adults and adolescents 12 years of age and older who remain symptomatic despite H1 antihistamine treatment [FDA label]',\n",
       " 'For treatment of infertility in women with hypothalamic or pituitary insufficiency (hypogonadotropic hypogonadism) and profound LH deficiency (LH <1.2 international units [IU]/L)',\n",
       " 'For prophylactic treatment of Lyme Disease',\n",
       " 'Insulin lispro is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.[L47616]',\n",
       " 'Insulin glargine is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.[L12474,L43532,L43587]',\n",
       " \"Collagenase clostridium histolyticum is indicated for the treatment of adults with Dupuytren's contracture with a palpable cord. Additionally, it is used to treat men with Peyronie's disease diagnosed with a penile curvature deformity of at least a 30-degree angle at the beginning of therapy in addition to palpable plaques.[L14882] Collagenase ointment is used for the tissue debridement of chronic dermal ulcers and severely burned tissues.[L14952]\\r\\nThe combination collagenase product, also known as Qwo, is used for the treatment of moderate to severe cellulite in the buttocks of adult women.[L14872]\",\n",
       " 'For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy)',\n",
       " 'For the inhibition of premature LH surges in women undergoing controlled ovarian stimulation',\n",
       " 'Adalimumab is indicated for the following conditions:[L49101]\\r\\n\\r\\n- Moderately to severely active Rheumatoid Arthritis (RA) in adults, as monotherapy or in combination with [methotrexate] or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).[L42290, L42495, L42935, L44953, L45643, L45818, L49101]\\r\\n- Moderately to severely active polyarticular Juvenile Idiopathic Arthritis (JIA) in patients two years of age and older, as monotherapy or in combination with [methotrexate].[L42290, L42495, L42935, L44953, L45643, L45818, L49101]\\r\\n- Psoriatic Arthritis (PsA) in adults.[L42290, L42495, L42935, L44953, L45643, L45818, L49101]\\r\\n- Ankylosing Spondylitis (AS) in adults.[L42290, L42495, L42935, L44953, L45643, L45818, L49101]\\r\\n- Moderately to severely active Crohns Disease (CD) in adults and pediatric patients six years of age and older.[L42290, L42495, L42935, L44953, L45643, L45818, L49101]\\r\\n- Moderately to severely active Ulcerative Colitis (UC) in adults. Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.[L42290, L42495, L42935, L44953, L45643, L45818, L49101]\\r\\n- Moderate to severe chronic plaque psoriasis in adult candidates for systemic therapy or phototherapy and when other systemic therapies are medically less appropriate.[L42290, L42495, L42935, L44953, L45643, L45818, L49101]\\r\\n- Moderate to severe Hidradenitis Suppurativa (HS) in adults.[L44953]\\r\\n- Non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients two years of age and older.[L35370]\\r\\n\\r\\nAdalimumab has also been used off-label to treat Pyoderma gangrenosum.[A40001,A40002]',\n",
       " 'Somatotropin is indicated for the treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone, short stature associated with Turner syndrome, Prader-Willi syndrome (PWS), idiopathic short stature (ISS), short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency, and short stature born small for gestational age (SGA).[L31513, L31518] It is indicated for the treatment of growth failure in children associated with chronic kidney disease up to the time of renal transplantation.[L31523]\\r\\n\\r\\nIt is also indicated for adults with adult-onset growth hormone deficiency, either alone or associated with multiple hormone deficiencies (hypopituitarism), as a result of pituitary disease, hypothalamic disease, surgery, radiation therapy, or trauma. It is also used to treat childhood-onset growth hormone deficiency in adults due to congenital, genetic, acquired, or idiopathic causes.[L31518]\\r\\n\\r\\nSomatotropin is indicated for the treatment of wasting or cachexia in patients with human immunodeficiency virus (HIV) who are receiving antiretroviral therapy to increase lean body mass and body weight and improve physical endurance.[L31498]\\r\\n\\r\\nSomatotropin is indicated for the treatment of short bowel syndrome in adult patients receiving specialized nutritional support.[L31493]',\n",
       " \"For the treatment of Gaucher's disease (deficiency in glucocerebrosidase)\",\n",
       " 'Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous coronary intervention and in patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours. Abciximab is intended for use with aspirin and heparin and has been studied only in that setting.',\n",
       " 'For reduction of mortality in patients with severe sepsis.',\n",
       " 'Indicated for the treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for other cytotoxic chemotherapy. Indicated for the treatment of patients aged 2 years and older with CD33-positive AML who have experienced a relapse or who have not responded to initial treatment (refractory). ',\n",
       " 'For diagnosis of extrahepatic malignant cancers',\n",
       " 'For chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema.',\n",
       " 'Pegaspargase is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of pediatric and adult patients with 1) first-line acute lymphoblastic leukemia or 2) acute lymphoblastic leukemia and hypersensitivity to asparaginase.[L44667]',\n",
       " 'For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum',\n",
       " 'For treatment of adenosine deaminase deficiency',\n",
       " 'Albuminex solution is indicated for adults and children for hypovolemia, ascites, hypoalbuminemia including from burns, acute nephrosis, acute respiratory distress syndrome and cardipulmonary bypass [F229].',\n",
       " 'For treatment of myocardial infarction and acute coronary syndrome.',\n",
       " '* Indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult or pediatric ( 6 years of age) patients with moderately to severely active **Crohns disease** who have had an inadequate response to conventional therapy\\r\\n* Indicated for reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients with fistulizing **Crohns disease**. \\r\\n* Indicated for reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in adult or pediatric ( 6 years of age) patients with moderately to severely active **ulcerative colitis** who have had an inadequate response to conventional therapy. \\r\\n* Indicated for, in combination with methotrexate, reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active **rheumatoid arthritis**. \\r\\n* Indicated for reducing signs and symptoms in patients with active **ankylosing spondylitis**. \\r\\n* Indicated for reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage, and improving physical function in patients with **psoriatic arthritis**. \\r\\n* Indicated for the treatment of adult patients with chronic severe (i.e., extensive and/or disabling) **plaque psoriasis** who are candidates for systemic therapy and when other systemic therapies are medically less appropriate.',\n",
       " 'In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).',\n",
       " 'Vasopressin is indicated to increase blood pressure in adults in vasodilatory shock refractory to the application of fluids and catecholamines.[L31413]',\n",
       " 'Interferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease as well as to decrease the frequency of attacks.',\n",
       " \"For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma\",\n",
       " 'For increase of absorption and distribution of other injected drugs and for rehydration.',\n",
       " 'For the treatment of type I and II diabetes mellitus.',\n",
       " 'For the adjuvant treatment of HER2-overexpressing breast cancer, trastuzumab is indicated in several clinical settings: as part of a treatment regimen consisting of doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel; as part of a treatment regimen with docetaxel and carboplatin; or as monotherapy following multi-modality anthracycline-based therapy.[L14015]\\r\\n\\r\\nTrastuzumab is indicated as a first-line treatment, in combination with paclitaxel, for metastatic HER2-overexpressing breast cancer, and as monotherapy in patients who have previously received one or more chemotherapy regimens in the metastatic setting.[L14015] In Europe, trastuzumab can also be used in combination with paclitaxel or docetaxel for the treatment of metastatic HER2-positive breast cancer in adult patients and with an aromatase inhibitor in postmenopausal patients.[L49324]\\r\\n\\r\\nFor HER2-positive early breast cancer, the EMA approved trastuzumab as monotherapy following surgery, chemotherapy (neoadjuvant or adjuvant), and radiation or following adjuvant chemotherapy with doxorubicin and cyclophosphamide in combination with paclitaxel or docetaxel. It can also be used in combination with adjuvant chemotherapy consisting of docetaxel and carboplatin or with neoadjuvant chemotherapy followed by adjuvant trastuzumab therapy for locally advanced (including inflammatory) disease or tumors > 2 cm in diameter.[L49324]\\r\\n\\r\\nTrastuzumab is also indicated, in combination with cisplatin and capecitabine or 5-fluorouracil, for the treatment of patients with HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma who have not received prior treatment for metastatic disease by the FDA and EMA.[L14015]\\r\\n\\r\\nTrastuzumab is indicated for subcutaneous administration - in combination with either [hyaluronidase][L14132] or both hyaluronidase and [pertuzumab][L14510] - for the treatment of adults with HER2-positive breast cancers.',\n",
       " 'Rituximab is indicated for the treatment of adult patients with relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkins Lymphoma (NHL) as a single agent. Also, it is indicated for the treatment of adult patients with previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to a rituximab product in combination with chemotherapy, as single-agent maintenance therapy.[L26641,L42025,L42030,L42035,L42040] Additionally, rituximab is indicated for the treatment of adult patients with non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL as a single agent after first-line cyclophosphamide, vincristine, and prednisone (CVP) chemotherapy; and previously untreated diffuse large B-cell, CD20-positive NHL in combination with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) or other anthracycline-based chemotherapy regimens.[L26641,L42025,L42030,L42035,L42040]\\r\\n\\r\\nRituximab, in combination with fludarabine and cyclophosphamide (FC), is indicated for the treatment of adult patients with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).[L26641,L42025,L42030,L42035,L42040] In combination with methotrexate, rituximab is indicated for the treatment of adult patients with moderately-to severely-active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.[L26641,L42025,L42030,L42035] Additionally, rituximab, in combination with glucocorticoids, is indicated for the treatment of adult and pediatric patients 2 years of age and older with Granulomatosis with Polyangiitis (GPA) (Wegeners Granulomatosis) and Microscopic Polyangiitis (MPA).[L26641,L42025,L42030,L42035]\\r\\n\\r\\nRITUXAN (rituximab injection for intravenous use) is indicated for the treatment of pediatric patients aged 6 months and older with previously untreated, advanced stage, CD20-positive diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma (BLL) or mature B-cell acute leukemia (B-AL) in combination with chemotherapy; as well as the treatment of adult patients with moderate to severe pemphigus vulgaris.[L26641] These indications for RITUXAN are not included in the labels of rituximab biosimilar products (rituximab-arrx, rituximab-abbs, rituximab-pvvr).[L42025,L42030,L42035] The combination product RITUXAN HYCELA (rituximab and hyaluronidase human injection, for subcutaneous use) is not indicated for the treatment of non-malignant conditions.[L42040]',\n",
       " 'For prophylactic treatment of kidney transplant rejection',\n",
       " 'For treatment of organ transplant recipients, prevention of organ rejection',\n",
       " 'For treatment of digitoxin overdose or digitalis glycoside toxicity.',\n",
       " \"For treatment of non-Hodgkin's lymphoma\",\n",
       " 'Daptomycin is indicated for the treatment of complicated skin and skin structure infections (cSSSI) in patients one year of age and older. It is also indicated for the treatment of _Staphylococcus aureus_ bloodstream infections (bacteremia) in patients one year of age and older, including in adult patients with right-sided infective endocarditis.[L32534]\\r\\n\\r\\nDaptomycin is not indicated for the treatment of pneumonia or left-sided infective endocarditis due to _S. aureus_. Use is not recommended in pediatric patients younger than one year of age due to the risk of potential effects on muscular, neuromuscular, and/or nervous systems (either peripheral and/or\\r\\ncentral).[L32534]\\r\\n\\r\\nAs with all antibacterial drugs, it is strongly suggested to perform sufficient testing before treatment initiation in order to confirm an infection caused by susceptible bacteria. Failure to do so may result in suboptimal treatment, treatment failure, and the development of drug-resistant bacteria.[L32534]',\n",
       " \"For treatment of non-Hodgkin's lymphoma (CD20 positive, follicular)\",\n",
       " 'Pegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly.',\n",
       " 'Botulinum toxin A is indicated for a variety of conditions, depending on the preparations. Cosmetically, it is used for the treatment of facial fine lines and wrinkles, specifically for upper facial rhytides, including forehead, lateral canthus, and glabellar lines.[L32559]\\r\\n\\r\\nIn addition to the above indications, botulinum toxin A is used for the following conditions: treatment of adults with symptomatic overactive bladder with or without incontinence,  treatment of incontinence in adult patients who are not candidates for anticholinergic therapy, treatment of Neurogenic Detrusor Overactivity (NDO) in patients over 5 years who cannot undergo anticholinergic therapy.  Botulinum toxin A is indicated for the prevention of chronic migraines, for the treatment of muscle spasms, cervical dystonia, axillary hyperhidrosis, strabismus,[L32494] and disorders of the 7th cranial nerve.[L32569]\\r\\n\\r\\nOff-label, botulinum toxin A is used for a variety of conditions such as temporomandibular joint (TMJ) disorders and myofascial pain[A231874], neurogenic thoracic outlet syndrome, epicondylitis, post-stroke pain, post-herpetic neuralgia, diabetic neuropathy, trigeminal neuralgia, neuropathic pain, spinal cord injury, and bladder pain.[A231879]',\n",
       " 'The use of pancrelipase amylase is part of the pancreatic enzyme replacement therapy. This therapy is indicated for the treatment of pancreatic insufficiency attributed to cystic fibrosis, chronic pancreatitis or any other medically defined pancreatic disease that might require it.[A32721, A32736] Pancreatic diseases are associated with the deterioration of pancreatic parenchyma and of the dual physiological functions of the pancreas. Once established, pancreatic insufficiency results in malnutrition, weight loss, and steatorrhea.[A32723]',\n",
       " 'For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae',\n",
       " 'LEMTRADA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive disease, in adults. Because of its safety profile, the use of LEMTRADA should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.[L43397] LEMTRADA contains the same active ingredient (alemtuzumab) found in CAMPATH, and CAMPATH is approved for the treatment of B-cell chronic lymphocytic leukemia (B-CLL), although generally administered at higher and more frequent doses (e.g., 30 mg) than recommended in the treatment of MS.[L43397]',\n",
       " 'Alglucerase is indicated for use as a long-term enzyme replacement therapy in patients with Type I Gaucher disease who exhibit signs and symptoms that are severe enough to result in moderate-to-severe anemia, thrombocytopenia, bone disease, or significant hepato- or splenomegaly.[L44266]',\n",
       " 'For diagnosis of prostate cancer and detection of intra-pelvic metastases.',\n",
       " 'For the treatment of mucopolysaccharidosis',\n",
       " 'Cyclosporine is approved for a variety of conditions. Firstly, it is approved for the prophylaxis of organ rejection in allogeneic kidney, liver, and heart transplants. It is also used to prevent bone marrow transplant rejection. For the above indications, cyclosporine can be used in conjunction with azathioprine and corticosteroids. Finally, cyclosporine can be used in patients who have chronic transplant rejection and have received previous immunosuppressive therapy[L3002] and to prevent or treat graft-versus-host disease (GVHD).[L11097]\\r\\n\\r\\nSecondly, cyclosporine is used for the treatment of patients with severe active rheumatoid arthritis (RA) when they no longer respond to methotrexate alone.[L3734] It can be used for the treatment of adult non-immunocompromised patients with severe, recalcitrant, plaque psoriasis that have failed to respond to at least one systemic therapy or when systemic therapies are not tolerated or contraindicated.[L3734] The ophthalmic solution of cyclosporine is indicated to increase tear production in patients suffering from keratoconjunctivitis sicca.[L11097] In addition, cyclosporine is approved for the treatment of steroid dependent and steroid-resistant nephrotic syndrome due to glomerular diseases which may include minimal change nephropathy, focal and segmental glomerulosclerosis or membranous glomerulonephritis.[L11097]\\r\\n\\r\\nA cyclosporine ophthalmic emulsion is indicated in the treatment of vernal keratoconjunctivitis in adults and children.[L34694]\\r\\n\\r\\nOff-label, cyclosporine is commonly used for the treatment of various autoimmune and inflammatory conditions such as atopic dermatitis, blistering disorders, ulcerative colitis, juvenile rheumatoid arthritis, uveitis, connective tissue diseases, as well as idiopathic thrombocytopenic purpura.[A139,A174085,A189393,A189396,A189399]',\n",
       " 'As an immunosuppressive drug, Alefacept can be used for treatment of moderate to severe chronic plaque psoriasis',\n",
       " 'For use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.',\n",
       " 'For treatment of female infertility',\n",
       " 'For the treatment of adult patients with moderate to severe chronic plaque psoriasis, who are candidates for phototherapy or systemic therapy.',\n",
       " 'For the treatment of female infertility',\n",
       " 'For prevention of renal transplant rejection',\n",
       " 'Filgrastim is indicated to decrease the incidence of infection as manifested by febrile neutropenia in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever.[L40714]\\r\\n\\r\\nFilgrastim is indicated for reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia.[L40714]\\r\\n\\r\\nFilgrastim is indicated to reduce the duration of neutropenia and neutropenia-related clinical sequelae e.g. febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation.[L40714]\\r\\n\\r\\nFilgrastim is indicated for the mobilization of autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis.[L40714]\\r\\n\\r\\nFilgrastim is indicated for chronic administration to reduce the incidence and duration of sequelae of neutropenia (e.g. fever infections oropharyngeal ulcers) in symptomatic patients with congenital neutropenia cyclic neutropenia or idiopathic neutropenia.[L40714]\\r\\n\\r\\nFilgrastim is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation.[L40714]',\n",
       " 'For treatment of hemophilia (Christmas disease).',\n",
       " 'For topical treatment of skin ulcers (from diabetes)',\n",
       " 'Agalsidase beta is indicated in the treatment of Fabry disease.[L16383]',\n",
       " 'Octreotide by injection is used for the treatment of acromegaly and the reduction of flushing and diarrhea symptoms related to carcinoid tumors and/or vasoactive intestinal peptide (VIPoma) tumors.[L14513] The delayed-release oral formulation is used for the long-term treatment of acromegaly in patients who tolerate and respond adequately to injectable octreotide and [lanreotide].[L14507,L45528]',\n",
       " \"For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma.\",\n",
       " 'For palliative treatment of advanced prostate cancer.',\n",
       " 'Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern.[L31433] For example, It may be used to induce labor in cases of Rh sensitization, maternal diabetes, preeclampsia at or near term, and when delivery is indicated due to prematurely ruptured membranes.[A229018,L31433] Importantly, oxytocin is not approved or indicated for elective induction of labor. Oxytocin may be used to reinforce labor in select cases of uterine inertia and as adjunctive therapy in the management of incomplete or inevitable abortion. In the postpartum period, oxytocin may be used to induced contractions in the 3rd stage of labor and to control postpartum bleeding or hemorrhage.[L31433]',\n",
       " 'Natalizumab is indicated as monotherapy for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.[L48031, L48036, L49096] \\r\\n\\r\\nIt is also indicated for inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohns disease with evidence of inflammation who have had an inadequate response to or are unable to tolerate, conventional therapies and inhibitors of TNF-. It is not to be used in combination with immunosuppressants or inhibitors of TNF-.[L48031, L48036] ',\n",
       " 'Enfuvirtide is an antiretroviral drug used in combination therapy for the treatment of HIV-1/AIDS.',\n",
       " 'For prophylaxis of respiratory diseases casued by respiratory syncytial virus.',\n",
       " 'Zenapax is a humanized monoclonal antibody used for prevention of renal transplant rejection',\n",
       " 'As a vascular endothelial growth factor (VEGF) inhibitor, bevacizumab is used in several chemotherapy regimens to treat metastatic colorectal cancer; metastatic, unresectable, locally advanced or recurrent non-squamous non-small cell lung cancer; metastatic renal cell carcinoma; metastatic, persistent, or recurrent cervical cancer; primary peritoneal cancer; epithelial ovarian cancer; fallopian tube cancer; breast cancer; and recurrent glioblastoma.[L12648,L39233,L41514,L43130,L43302,L49826]\\r\\n\\r\\nInterestingly, bevacizumab is currently under investigation for the treatment of COVID-19 complications including acute respiratory distress syndrome (ARDS) and acute lung injury (ALI).[L12699] ',\n",
       " 'For imaging colorectal tumors',\n",
       " 'For nutritional supplementation and for treating dietary shortage or imbalance.',\n",
       " '\\r\\n**Nasal spray**\\r\\n\\r\\nThe cyanocobalamin nasal spray is indicated for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with deficiency of this vitamin who have no nervous system involvement [FDA label].\\r\\n\\r\\nNote:  CaloMist [FDA label], the nasal spray form, has not been evaluated for the treatment of newly diagnosed vitamin B12 deficiency.\\r\\n\\r\\n**Injection forms (subcutaneous, intramuscular)**\\r\\n\\r\\nThese forms are indicated for vitamin B12 deficiencies due to various causes, with or without neurologic manifestations [F3736].  Vitamin B12 deficiency is frequently caused by malabsorption, which is often associated with the following conditions [L5545]:\\r\\n\\r\\nAddisonian (pernicious) anemia\\r\\n\\r\\nGastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacterial overgrowth, total or partial gastrectomy\\r\\n\\r\\nFish tapeworm infestation\\r\\n\\r\\nMalignancy of the pancreas or bowel\\r\\n\\r\\nFolic acid deficiency\\r\\n\\r\\n\\r\\n**Oral forms**\\r\\n\\r\\nVitamin B12 supplements are widely available and indicated in patients who require supplementation for various reasons.  Dose requirements for vitamin B12 which are higher than normal (caused by pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be achieved with oral supplementation [L5545].   Oral products of vitamin B12 are not recommended in patients with malabsorption, as these forms are primarily absorbed in the gastrointestinal tract [F3739]. ',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance.',\n",
       " 'The actions of supplemental L-histidine are entirely unclear. It may have some immunomodulatory as well as antioxidant activity. L-histidine may be indicated for use in some with rheumatoid arthritis. It is not indicated for treatment of anemia or uremia or for lowering serum cholesterol.',\n",
       " 'S-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as a dietary supplement for the support of bone and joint health, as well as mood and emotional well being.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " 'L-phenylalanine may be helpful in some with depression. It may also be useful in the treatment of vitiligo. There is some evidence that L-phenylalanine may exacerbate tardive dyskinesia in some schizophrenic patients and in some who have used neuroleptic drugs.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " 'Supplemental lysine has putative anti-herpes simplex virus activity. There is preliminary research suggesting that it may have some anti-osteoporotic activity.',\n",
       " 'Used for nutritional supplementation, also for treating dietary shortage or imbalance.',\n",
       " 'Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " 'There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.',\n",
       " 'Used for nutritional supplementation, also for treating dietary shortage or imbalance. It has been claimed that ornithine improves athletic performance, has anabolic effects, has wound-healing effects, and is immuno-enhancing.',\n",
       " 'Used for nutritional supplementation, also for treating dietary shortage or imbalance.\\r\\n\\r\\nUsed to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older [FDA Label].',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " 'For nutritional supplementation and for treating dietary shortage or imbalance.',\n",
       " 'Used as a natural moisturizing agent in some cosmetics and skin care products.',\n",
       " 'Used for protein synthesis including the formation of SAMe, L-homocysteine, L-cysteine, taurine, and sulfate.',\n",
       " 'Tyrosine is claimed to act as an effective antidepressant, however results are mixed. Tyrosine has also been claimed to reduce stress and combat narcolepsy and chronic fatigue, however these claims have been refuted by some studies.',\n",
       " 'Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.',\n",
       " 'Xanthophylls are taken for nutritional supplementation, and also for treating dietary shortage or imbalance.',\n",
       " 'It has been claimed that L-cysteine has anti-inflammatory properties, that it can protect against various toxins, and that it might be helpful in osteoarthritis and rheumatoid arthritis. More research will have to be done before L-cysteine can be indicated for any of these conditions. Research to date has mostly been in animal models.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " 'For the treatment of ariboflavinosis (vitamin B2 deficiency).',\n",
       " 'For the treatment and prevention of osteoarthritis, by itself or in combination with chondroitin sulfate.',\n",
       " 'Considered to be nature\\'s \"Brain food\" by improving mental capacities; helps speed the healing of ulcers; gives a \"lift\" from fatigue; helps control alcoholism, schizophrenia and the craving for sugar.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " \"Phosphatidylserine has demonstrated some usefulness in treating cognitive impairment, including Alzheimer's disease, age-associated memory impairment and some non-Alzheimer's dementias. More research is needed before phosphatidylserine can be indicated for immune enhancement or for reduction of exercise stress.\",\n",
       " 'Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.',\n",
       " 'Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.',\n",
       " 'Pyridoxal is one of the natural forms available of vitamin B6, therefore, it is used for nutritional supplementation and for treating dietary shortage or imbalances.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance.',\n",
       " 'Indicated to assist in the prevention of the breakdown of muscle proteins that sometimes occur after trauma or severe stress.',\n",
       " 'Tryptophan may be useful in increasing serotonin production, promoting healthy sleep, managing depression by enhancing mental and emotional well-being, managing pain tolerance, and managing weight.',\n",
       " 'For the prevention of liver damage and kidney damage associated with overdoses of acetaminophen',\n",
       " \"For the treatment of thiamine and niacin deficiency states, Korsakov's alcoholic psychosis, Wernicke-Korsakov syndrome, delirium, and peripheral neuritis.\",\n",
       " 'Ergocalciferol is indicated for the treatment of hypoparathyroidism, refractory rickets, and familial hypophosphatemia.[FDA label]\\r\\n\\r\\nHypoparathyroidism is the result of inadequate parathyroid hormone production that occurs due to the presence of damage or removal of the parathyroid glands. This condition produces decreased calcium and increased phosphorus levels.[L6082]\\r\\n\\r\\nRickets is a condition produced due to a deficiency in vitamin D, calcium or phosphorus. However, this condition can also be related to renal diseases. It is characterized to present weak or soft bones.[A177664]\\r\\n\\r\\nFamilial hypophosphatemia is characterized by the impaired transport of phosphate and an altered vitamin D metabolism in the kidneys. The presence of this condition can derive in the presence of osteomalacia, bone softening and rickets.[L6085]',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " 'Used for nutritional supplementation, also for treating dietary shortage or imbalance.',\n",
       " 'L-Threonine makes up collagen, elastin, and enamel protein. It aids proper fat metabolism in the liver, helps the digestive and intestinal tracts function more smoothly, and assists in metabolism and assimilation.',\n",
       " \"Some evidence suggests that NADH might be useful in treating Parkinson's disease, chronic fatigue syndrome, Alzheimer's disease and cardiovascular disease.\",\n",
       " 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.',\n",
       " 'EPA can be used for lowering elevated triglycerides in those who are hyperglyceridemic. In addition, EPA may play a therapeutic role in patients with cystic fibrosis by reducing disease severity and may play a similar role in type 2 diabetics in slowing the progression of diabetic nephropathy.',\n",
       " 'Used for protein synthesis.',\n",
       " 'Promotes mental vigor, muscle coordination, and calm emotions. May also be of use in a minority of patients with hepatic encephalopathy and in some with phenylketonuria.',\n",
       " 'For the treatment of vitamin A deficiency.',\n",
       " 'Vitamin E supplementation is indicated for treatment of vitamin E deficiency which can occur in cystic fibrosis, cholestasis and severe liver disease, abetalipoproteinemia or simply poor diet[A176104,L3063].',\n",
       " 'Pyridoxine is indicated for the treatment of vitamin B6 deficiency and for the prophylaxis of [DB00951]-induced peripheral neuropathy. It is also approved by Health Canada for the treatment of nausea and vomiting in pregnancy in a combination product with [DB00366] (as the commercially available product Diclectin).',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance.',\n",
       " 'The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.',\n",
       " 'Used as a diet supplement and sugar substitute.',\n",
       " 'Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia [F4027, F4042].\\r\\n\\r\\nConcurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others [A176041, A176044, F4051].',\n",
       " 'The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " 'L-Proline is extremely important for the proper functioning of joints and tendons and also helps maintain and strengthen heart muscles.',\n",
       " 'For nutritional supplementation, also for treating dietary shortage or imbalance',\n",
       " 'Used for nutritional supplementation, also for treating dietary shortage or imbalance.',\n",
       " 'Pravastatin is indicated for primary prevention of coronary events hypercholesterolemic patients without clinical evidence of coronary heart disease. Its use includes the reduction of risk on myocardial infarction, undergoing myocardial revascularization procedures and cardiovascular mortality.[T274]\\r\\n\\r\\nAs well, pravastatin can be used as a secondary prevention agent for cardiovascular events in patients with clinically evident coronary heart disease. This indication includes the reduction of risk of total mortality by reducing coronary death, myocardial infarction, undergoing myocardial revascularization procedures, stroke, and stroke/transient ischemic attack as well as to slow the progression of coronary atherosclerosis.[T274]\\r\\n\\r\\nThe term cardiovascular events correspond to all the incidents that can produce damage to the heart muscle including the interruption of blood flow.[L6028]\\r\\n\\r\\nAs adjunctive therapy to diet, pravastatin is used in:\\r\\n\\r\\n- Patients with primary hypercholesterolemia and mixed dyslipidemias including hyperlipidemia type IIa and IIb.\\r\\n- Patients with elevated serum triglycerides including type IV hyperlipidemia.\\r\\n- Patients with heterozygous familial hypercholesterolemia in patients over 8 years of age with low-density lipoprotein (LDL) cholesterol higher than 190 mg/dl after diet modifications or LDL levels higher than 160 mg/dl and familial history of premature cardiovascular diseases or at least two cardiovascular risk factors.[T274]\\r\\n\\r\\nIn patients that do not respond adequately to diet, pravastatin is used to treat patients with primary dysbetalipoproteinemia (type III hyperlipidemia).[T274] \\r\\n\\r\\nDyslipidemia is defined as an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis.[L6025]',\n",
       " 'Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD) [FDA Label]. Has also been used in the management of bulimia nervosa [A250].',\n",
       " 'Valsartan is indicated for the treatment of hypertension to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It is also indicated for the treatment of heart failure (NYHA class II-IV) and for left ventricular dysfunction or failure after myocardial infarction when the use of an angiotensin-converting enzyme inhibitor (ACEI) is not appropriate.[F4703, L11305]\\r\\n\\r\\nIt is also used in combination with [sacubitril].[L36445]',\n",
       " 'For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. [FDA Label] To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy. [T116] ',\n",
       " 'Used for the treatment of actinic keratoses (precancerous skin growths that can become malignant if left untreated).',\n",
       " 'For the maintenance treatment of asthma as a prophylactic therapy.',\n",
       " 'Oral baclofen is indicated for the treatment of spasticity resulting from multiple sclerosis and is particularly useful for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. It may also be used to treat patients with spinal cord injuries and other spinal cord diseases. Baclofen should not be used to treat skeletal muscle spasms resulting from rheumatic disorders.[L39434]\\r\\n\\r\\nIntrathecal baclofen is also indicated for the management of severe spasticity of the cerebral or spinal original in patients 4 years of age and older. It is reserved for patients unresponsive to oral baclofen therapy, or those who experience intolerable central nervous system side effects at effective doses. For use in spasticity due to traumatic brain injury, baclofen should be considered after at least one year of injury.[L39429]',\n",
       " 'Amphetamine is indicated for the treatment of attention-deficit/hyperactivity disorders (ADHD) as well as for the treatment of central nervous system disorders such as narcolepsy.[A18540] \\r\\n\\r\\nADHD is a complex disorder associated with the substantial heterogeneity in etiology, clinical presentation, and treatment outcome. ADHD comes from a complex interplay between interdependent genetic and non-genetic factors which cause complex mental disorders in children and teenagers.[A174271]\\r\\n\\r\\nOn the other hand, narcolepsy is a chronic sleep disorder typically resenting during adolescence and characterized by excessive daytime sleepiness.[A174274]\\r\\n\\r\\nAmphetamine is also being used nowadays off-label for the treatment of obesity, depression and chronic pain.[A174268, A174283]',\n",
       " 'Used as a diagnostic aid for evaluation of gastric acid secretory function',\n",
       " 'For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.',\n",
       " \"For the treatment of symptoms of dry mouth in patients with Sj&ouml;gren's Syndrome.\",\n",
       " 'Lorazepam is FDA-approved for the short-term relief of anxiety symptoms related to anxiety disorders and anxiety associated with depressive symptoms such as anxiety-associated insomnia. It is as well used as an anesthesia premedication in adults to relieve anxiety or to produce sedation/amnesia and for the treatment of status epilepticus.[T385]\\r\\n\\r\\nSome off-label indications of lorazepam include rapid tranquilization of an agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, muscle spasms, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting, and psychogenic catatonia.[T385]',\n",
       " 'For the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Also used in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention.',\n",
       " 'Bortezomib is indicated for the treatment of adults with multiple myeloma or mantle cell lymphoma.[L44341]',\n",
       " 'Used for short-term hypnotic therapy in the management of insomnia for periods of up to one week in duration; however, this medication generally has been replaced by other sedative-hypnotic agents.',\n",
       " 'Carbidopa is indicated with [levodopa] for the treatment of symptoms of idiopathic Parkinson disease, postencephalitic parkinsonism and symptomatic parkinsonism followed by carbon monoxide or manganese intoxication.[FDA label]\\r\\n\\r\\nThe combination therapy is administered for the reduction of [levodopa]-driven nausea and vomiting.[FDA label]\\r\\n\\r\\nThe product of carbidopa should be used in patients where the combination therapy of carbidopa/[levodopa] provide less than the adequate daily dosage.[FDA label]\\r\\n\\r\\nAs well carbidopa can be used in patients where the dosages of carbidopa and [levodopa] require individual titration.[FDA label]',\n",
       " 'Phentermine is indicated, alone or in combination with topiramate, as a short-term adjunct, not pass a few weeks, in a regimen of weight reduction based on exercise, behavioral modifications and caloric restriction in the management of exogenous obesity for patients with an initial body mass index (BMI) greater than 30 kg/m2 or greater than 27 kg/m2 in presence of other risk factors such as controller hypertension, diabetes or hyperlipidemia.[FDA label]\\r\\n\\r\\nExogenous obesity is considered when the overweight is caused by consuming more food than the person activity level warrants. This condition commonly causes an increase in fat storage. It is an epidemic condition in the United States where over two-thirds of adults are overweight or obese and one in three Americans is obese. In the world, the incidence of obesity has nearly doubled.[A174391]',\n",
       " 'For the treatment of life-threatening dysrhythmias and sustained ventricular tachycardia.',\n",
       " 'Tramadol is approved for the management of moderate to severe pain in adults.[L9257,F4679]\\r\\n\\r\\nTramadol is also used off-label in the treatment of premature ejaculation.[A173986]',\n",
       " 'For treatment of chickenpox - varicella, herpes zoster and herpes simplex',\n",
       " 'For the management of hypertension.',\n",
       " 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:\\r\\n\\r\\n 1) Vaginal yeast infections caused by Candida\\r\\n 2) Systemic Candida infections\\r\\n 3) Both esophageal and oropharyngeal candidiasis \\r\\n 4) Cryptococcal meningitis\\r\\n 5) UTI (urinary tract infection) by Candida\\r\\n 6) Peritonitis (inflammation of the peritoneum) caused by Candida\\r\\n\\r\\n**A note on fungal infection prophylaxis**\\r\\n\\r\\nPatients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]\\r\\n\\r\\n**A note on laboratory testing**\\r\\n\\r\\nObtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]\\r\\n',\n",
       " 'For the treatment of Type II diabetes mellitus. It is used alone or in combination with a sulfonylurea, metformin, or insulin as an adjunct to diet and exercise.',\n",
       " 'According to FDA prescribing information, oseltamivir is indicated for the treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours [F3094]. In particular, this agent is indicated in adults and children including full-term neonates who present with symptoms typical of influenza when influenza virus is circulating in the community. Efficacy has been demonstrated when treatment is initiated within two days of the first onset of symptoms.[F3097]\\r\\n\\r\\nOseltamivir is also indicated for the prophylaxis of influenza in patients one year and older [F3094]. Specifically, post-exposure prevention in individuals one year of age or older following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community qualifies for such prophylactic therapy. Oseltamivir would only be indicated for post-exposure prevention of influenza in infants less than 1 year of age during a pandemic influenza outbreak. [F3097]',\n",
       " '\\r\\nErythromycin is indicated in the treatment of infections caused by susceptible strains of various bacteria.[L7261] The indications for erythromycin have been summarized by body system below:\\r\\n\\r\\n**Respiratory infections**\\r\\n\\r\\nMild to moderate upper respiratory tract infections caused by Streptococcus pyogenes, Streptococcus pneumoniae, or Haemophilus influenzae (when used concomitantly with appropriate doses of sulfonamides) can be treated with erythromycin.[L7261] Mild to moderate lower-respiratory tract infections due to susceptible strains of Streptococcus pneumoniae or Streptococcus pyogenes may also be treated. Erythromycin treats listeriosis caused by Listeria monocytogenes may also be treated with erythromycin.[L7261]\\r\\nErythromycin is indicated to treat pertussis (whooping cough) caused by Bordetella pertussis. It is effective in eliminating the causative organism from the nasopharynx of infected individuals, rendering them noninfectious. Clinical studies suggest that erythromycin may aid in the prevention of pertussis infection for individuals who have been exposed to the bacteria.[L7261] Respiratory tract infections due to Mycoplasma pneumoniae may also be treated with erythromycin.[L7261]  Despite the fact that no controlled clinical efficacy studies have been conducted to this date, in vitro and certain preliminary clinical study results indicate that erythromycin may be an effective treatment in  Legionnaires Disease.[L7261] Finally, erythromycin is indicated to treat diphtheria and other infections due to Corynebacterium diphtheriae, as an adjunct to antitoxin, to prevent carrier status and to eradicate the organism in existing carriers.[L7261] In addition to the prevention of diphtheria, erythromycin can be used to prevent rheumatic fever in penicillin intolerant patients.[L7261]\\r\\n \\r\\n\\r\\n**Skin infections**\\r\\n\\r\\nMild to moderate skin or skin structure infections caused by Streptococcus pyogenes or Staphylococcus aureus may be treated with erythromycin, however, resistant staphylococcal organisms may emerge.[L7261] Erythromycin can also be used to treat erythrasma, an infectious condition caused by Corynebacterium minutissimum.[L7261]\\r\\n\\r\\n\\r\\n**Gastrointestinal infections**\\r\\n\\r\\nIntestinal amebiasis caused by Entamoeba histolytica can be treated with oral erythromycin. Extraenteric amebiasis warrants treatment with other antimicrobial drugs.[L7261]\\r\\n\\r\\n\\r\\n**Genital infections/STIs**\\r\\n\\r\\nErythromycin can be used as an alternative drug in treating acute pelvic inflammatory disease caused by N. gonorrheae in female patients who have demonstrated hypersensitivity or intolerance to penicillin.[L7261] Syphilis, caused by Treponema pallidum, can be treated with erythromycin.  It serves as an alternative treatment for primary syphilis in patients who have demonstrated penicillin hypersensitivity. Erythromycin can also be used in the primary stage of primary syphilis.[L7261] Another approved indication of erythromycin is to treat chlamydial infections that cause conjunctivitis of the newborn, pneumonia of infancy, and urogenital infections occurring in pregnancy. It is indicated as an alternative option to tetracyclines for the treatment of uncomplicated rectal, urethral and endocervical infections in adults caused by Chlamydia trachomatis.[L7261] Erythromycin can be used in nongonococcal urethritis can be used when tetracyclines cannot be administered. Finally, erythromycin is indicated to treat nongonococcal urethritis due to Ureaplasma urealyticum.[L7261]\\r\\n',\n",
       " 'For treatment of pernicious anemia and the prevention and treatment of vitamin B12 deficiency arising from alcoholism, malabsorption, tapeworm infestation, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, prolonged stress, vegan diets, macrobiotic diets or other restrictive diets. Also for the treatment of known or suspected cyanide poisoning.',\n",
       " 'Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth.[T716,L9851] In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs.[L9899] Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.[T716,L9854,L9872]',\n",
       " 'Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.[L9004]',\n",
       " 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:\\r\\n\\r\\n(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and\\r\\n\\r\\n(2) treatment of pulmonary hypertension, where:\\r\\na) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];\\r\\n\\r\\nb) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and\\r\\n\\r\\nc) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].',\n",
       " 'For the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm',\n",
       " 'For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamine',\n",
       " 'For the treatment of hypertension',\n",
       " 'Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin [FDA label].\\r\\n\\r\\nAzithromycin is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the microorganisms listed in the specific conditions below. Recommended dosages, duration of therapy and considerations for various patient populations may vary among these infections. Refer to the FDA label and \"Indications\" section of this drug entry for detailed information [FDA label]. \\r\\n\\r\\n**Adults**:\\r\\n\\r\\nAcute bacterial exacerbations of chronic obstructive pulmonary disease due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_\\r\\n\\r\\nAcute bacterial sinusitis due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_\\r\\n\\r\\nCommunity-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy\\r\\n\\r\\nPharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.\\r\\nUncomplicated skin and skin structure infections due to _Staphylococcus aureus_, _Streptococcus pyogenes_, or _Streptococcus agalactiae_. Abscesses usually require surgical drainage.\\r\\n\\r\\nUrethritis and cervicitis due to _Chlamydia trachomatis_ or _Neisseria gonorrhoeae_.\\r\\n\\r\\nGenital ulcer disease in men due to _Haemophilus ducreyi_ (chancroid). Due to the small number of women included in clinical trials, the efficacy of azithromycin in the treatment of chancroid in women has not been established.\\r\\n\\r\\n**Pediatric Patients**\\r\\n\\r\\nAcute otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_\\r\\n\\r\\nCommunity-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy.\\r\\n\\r\\nPharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.',\n",
       " 'Used in patients, who have had a stroke or stroke precursors and who cannot take aspirin or aspirin has not worked, to try to prevent another thrombotic stroke.\\r\\n',\n",
       " 'For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, detrusor instability and frequency of micturition.',\n",
       " 'Adapalene is indicated for the topical treatment of acne vulgaris in patients aged 12 and over.[L12873] It is also indicated for acne vulgaris in combination with [benzoyl peroxide][L12930] and in a triple combination therapy with benzoyl peroxide and [clindamycin].[L48666]',\n",
       " 'For the treatment of symptomatic orthostatic hypotension (OH).',\n",
       " 'For the treatment of hypertension and heart failure',\n",
       " '\\r\\n**Pantoprazole Injection**:\\r\\n\\r\\n**Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis**\\r\\n\\r\\nPantoprazole for injection is indicated for short-term treatment (7-10 days) of patients having gastroesophageal reflux disease (GERD) with a history of erosive esophagitis, as an alternative to oral medication in patients who are unable to continue taking pantoprazole delayed-release tablets. _Safety and efficacy of pantoprazole injection as the initial treatment of patients having GERD with a history of erosive esophagitis have not been demonstrated at this time_.[FDA label]\\r\\n\\r\\n**Pathological Hypersecretion Associated with Zollinger-Ellison Syndrome**\\r\\n\\r\\nPantoprazole for injection is indicated for the treatment of pathological hypersecretory conditions associated with Zollinger-Ellison Syndrome or other neoplastic conditions.[FDA label]\\r\\n\\r\\n**Pantoprazole delayed-release oral suspension**:\\r\\n\\r\\n**Short-Term Treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD)**\\r\\n\\r\\nIndicated in adults and pediatric patients five years of age and above for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been determined.[F3202]\\r\\n\\r\\n**Maintenance of healing of erosive esophagitis**\\r\\n\\r\\nIndicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD.[F3202]\\r\\n\\r\\n**Pathological hypersecretory conditions including Zollinger-Ellison syndrome**\\r\\n\\r\\nIndicated for the long-term treatment of the above conditions.[F3202]',\n",
       " 'Torasemide is indicated for the treatment of edema associated with congestive heart failure, renal or hepatic diseases. From this condition, it has been observed that torasemide is very effective in cases of kidney failure.[FDA label]\\r\\n\\r\\nAs well, torasemide is approved to be used as an antihypertensive agent either alone or in combination with other antihypertensives.[FDA label]',\n",
       " 'Citalopram is approved by the FDA for treating adults with major depressive disorder.[L47941] It has also been used off-label to treat various diseases, including but not limited to sexual dysfunction, ethanol abuse, psychiatric conditions such as obsessive-compulsive disorder (OCD), social anxiety disorder, panic disorder, and diabetic neuropathy.[L5224,A321,A322,A261296] ',\n",
       " 'For the acute treatment of migraine with or without aura in adults.',\n",
       " 'For the treatment of hypertension.',\n",
       " 'For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).',\n",
       " 'For the treatment of visceral spasms',\n",
       " 'Used in combination with other antiviral drugs in the treatment of HIV in both adults and children.[L36485]',\n",
       " 'For the treatment of asthma, wheezing, and chronic asthmatic bronchitis.',\n",
       " 'Glimepiride is indicated for the management of type 2 diabetes in adults as an adjunct to diet and exercise to improve glycemic control as monotherapy. \\r\\n\\r\\nIt may also be indicated for use in combination with metformin or insulin to lower blood glucose in patients with type 2 diabetes whose high blood sugar levels cannot be controlled by diet and exercise in conjunction with an oral hypoglycemic (a drug used to lower blood sugar levels) agent alone.[L10322]',\n",
       " 'For relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.',\n",
       " 'Indinavir is an antiretroviral drug for the treatment of HIV infection.',\n",
       " 'Gadodiamide is indicated for the visualization of lesions with abnormal vascularity in the brain (intracranial lesions), spine, and associated tissues and the body (including  the thoracic (noncardiac), abdominal, pelvic cavities, and retroperitoneal space) by the FDA and Health Canada.[L36873,L49881] Additionally, gadoliamide is approved by Health Canada to detect and localize tenosis in renal arteries and aorto-iliac arteries in magnetic resonance angiography (MRA).[L36873]\\r\\n',\n",
       " 'Used to treat and control hypertension.',\n",
       " 'Lovastatin is indicated to reduce the risk of myocardial infarction, unstable angina, and the need for coronary revascularization procedures in individuals without symptomatic cardiovascular disease, average to moderately elevated total-C and LDL-C, and below average HDL-C. It is indicated as an intervention alternative in individuals presenting dyslipidemia at risk of developing atherosclerotic vascular disease. The administration of this agent should be accompanied by the implementation of a fat and cholesterol-restricted diet.[F4661]\\r\\n\\r\\nTherapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Lovastatin is indicated as an adjunct to diet for the reduction of elevated total-C and LDL-C levels in patients with primary hypercholesterolemia (Types IIa and IIb2), when the response to diet restricted in saturated fat and cholesterol and to other nonpharmacological measures alone has been inadequate.[F4661,F4664]\\r\\n\\r\\nLovastatin is also indicated to slow the progression of coronary atherosclerosis in patients with coronary heart disease as part of a treatment strategy to lower total-C and LDL-C to target levels.[F4661]\\r\\n\\r\\nLovastatin is indicated as an adjunct to diet to reduce total-C, LDL-C and apolipoprotein B levels in adolescent boys and girls with Heterozygous Familial Hypercholesterolemia (HeFH) who are at least one year post-menarche, 10 to 17 years of age, with HeFH if after an adequate trial of diet therapy the following findings are present: LDL-C remains greater than 189 mg/dL or LDL-C remains greater than 160 mg/dL and there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the adolescent patient.\\r\\n\\r\\nBefore administering lovastatin, it is important to rule out the presence of secondary causes of hypercholesterolemia and a lipid profile should be performed.\\r\\n\\r\\nPrescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]',\n",
       " 'Enflurane may be used for both the induction and maintenance of general anesthesia. It can also be used to induce analgesia for vaginal delivery. Low concentrations of enflurane can also be used as an adjunct to general anesthetic drugs during delivery by Cesarean section.[L13646]',\n",
       " 'For treatment of severe infections caused by susceptible bacteria.',\n",
       " 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]',\n",
       " 'Temazepam is specifically indicated only for the short-term management of insomnia [FDA Label], [L5539]. Furthermore, such management is generally predominantly associated with the symptomatic relief of transient and short-term insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings and/or early morning awakenings [F3718]. In particular, the official prescribing information for temazepam typically specifies that the instructions issued for dispensed prescriptions of the medication should indicate specifically that patients are only expected to use the therapy for short periods of time - usually 7-10 days in general [FDA Label, F3718]. Subsequently, treatment with temazepam should usually not exceed 7 to 10 consecutive days and nor should it be prescribed in quantities exceeding a one-month supply [F3718].\\r\\n\\r\\nSome regional prescribing information also notes that temazepam may be used for premedication prior to minor surgery or other related procedures [L5539].',\n",
       " 'For use in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Also used as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.',\n",
       " 'For the treatment of tuberculosis',\n",
       " 'For the treatment of clinical depression.',\n",
       " 'Milrinone is indicated for the short-term (48 hours or less) treatment of patients with acute decompensated heart failure. Milrinone administration should occur together with close monitoring using appropriate electrocardiographic equipment and should occur in a facility equipped for the immediate treatment of potential cardiac events, including ventricular arrhythmias.[L31483]',\n",
       " 'For the treatment of polycythaemia vera and refractory chronic myeloid leukaemia.',\n",
       " 'Butabarbital is indicated for use as a sedative or hypnotic.[L13613] Butabarbital should not be used to treat insomnia for longer than 2 weeks.[L13613]',\n",
       " 'For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.',\n",
       " 'For treatment of dermal fungal infection.',\n",
       " 'For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.',\n",
       " 'Indicated for the management of the symptom complex of tension (or muscle contraction) headache, when other non-opioid analgesics and alternative treatments are inadequate, in various combinations with acetaminophen, aspirin, caffeine, and codeine .[L10370]',\n",
       " \"For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma.\",\n",
       " 'Ranolazine is indicated for the treatment of chronic angina. It can be used alone or in conjunction with nitrates, beta-blockers, angiotensin receptor blockers, anti-platelet drugs, calcium channel blockers, lipid-lowering drugs, and ACE inhibitors.[L3580]\\r\\n\\r\\nRanolazine has also been used off-label for the treatment of certain arrhythmias, including ventricular tachycardia, however, this use is not strongly  supported by scientific evidence.[A174940] Ranolazine has also been studied for the treatment of acute coronary syndrome, microvascular coronary dysfunction, arrhythmia, and glycemic control, which are not yet approved indications.[A174898,L3580]',\n",
       " \"Mesalazine is indicated for the treatment of mildly to moderately active ulcerative colitis in adults and patients 5 years or older.[L36280,L36275]. Mesalazine is also indicated for the maintenance of remission of ulcerative colitis in adults and maintenance of remission of Crohn's ileocolitis.[L44196,L5101]\\r\\n\",\n",
       " \"Benztropine is indicated to be used as an adjunct in the therapy of all forms of parkinsonism. It can also be used for the control of extrapyramidal disorders due to neuroleptic drugs.[T203]\\r\\n\\r\\nThe extrapyramidal symptoms are defined as drug-induced disorders that include symptoms of dystonia, akathisia, parkinsonism, bradykinesia, tremors, and dyskinesia.[A175120] \\r\\n\\r\\nParkinsonism is a general term that refers to the group of neurological disorders that produce symptoms similar to Parkinson's disease such as tremors, slow movement, and stiffness. The parkinsonism includes a large number of disorders and some of them have not been clearly defined.[L5509]\",\n",
       " 'In its oral form, ziprasidone is approved for the treatment of schizophrenia, as monotherapy for acute treatment of manic or mixed episodes related to bipolar I disorder, and as adjunctive therapy to lithium or valproate for maintenance treatment of bipolar I disorder.[L7342] The injectable formulation is approved only for treatment of acute agitation in schizophrenia.[L7342]',\n",
       " 'For the treatment of vascular headache',\n",
       " 'For the treatment of hyperprolactinemic disorders, either idiopathic or due to prolactinoma (prolactin-secreting adenomas). May also be used to manage symptoms of Parkinsonian Syndrome as monotherapy during initial symptomatic management or as an adjunct to levodopa therapy during advanced stages of disease. ',\n",
       " 'For use in keratoconjunctivitis and keratitis caused by herpes simplex virus.',\n",
       " 'For the treatment and management of leprosy and dermatitis herpetiformis.',\n",
       " 'For the treatment of candidiasis (a yeast-like fungal infection) of the vulva and vagina.',\n",
       " 'Phenytoin is indicated to treat grand mal seizures, complex partial seizures, and to prevent and treat seizures during or following neurosurgery.[L9362] Injectable phenytoin and [Fosphenytoin], which is the phosphate ester prodrug formulation of phenytoin[A188571], are indicated to treat tonic-clonic status epilepticus, and for the prevention and treatment of seizures occurring during neurosurgery.[L10740]',\n",
       " 'For the treatment of allergic conjunctivitis, vernal conjunctivitis, episcleritis, and epinephrine sensitivity.',\n",
       " 'Doxycycline is indicated for the treatment of various infections by gram-positive and gram-negative bacteria, aerobes and anaerobes, as well other types of bacteria, including:\\r\\n\\r\\n- Early Lyme disease (as evidenced by erythema migraines) due to _Borrelia burgdorferi_ in adults and pediatric patients 8 years of age and older weighing 45 kg and above [L42875]\\r\\n- Rickettsial infections,[L42870] such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers [L42880]\\r\\n- Sexually transmitted infections [L42870]\\r\\n- Respiratory tract infections [L42870] caused by _Mycoplasma pneumoniae_ and _Haemophilus influenzae_ [L42880]\\r\\n- Specific bacterial infections [L42870] after indicative bacteriologic testing. These include infections caused by _Escherichia coli_, _Enterobacter aerogenes_, _Shigella_ species, _Acinetobacter_ species, and _Klebsiella_ species [L42880]\\r\\n- Ophthalmic infections,[L42870] such as inclusion conjunctivitis caused by _Chlamydia trachomatis_ [L42880]\\r\\n- Anthrax, including inhalational anthrax (post-exposure) [L42870]\\r\\n- Alternative treatment for selected infections when [penicillin] is contraindicated [L42870]\\r\\n- Adjunctive therapy in acute intestinal amebiasis and severe acne [L42870, L42880]\\r\\n- Lymphogranuloma venereum caused by _Chlamydia trachomatis_ [L42880]\\r\\n- Psittacosis (ornithosis) caused by _Chlamydophila psittaci_ [L42880]\\r\\n- Trachoma caused by _Chlamydia trachomatis_, although the infectious agent is not always eliminated, as judged by immunofluorescence [L42880]\\r\\n- Uncomplicated urethral, endocervical, or rectal infections in adults caused by _Chlamydia trachomatis_ [L42880]\\r\\n- Nongonococcal urethritis caused by _Ureaplasma urealyticum_ [L42880]\\r\\n- Relapsing fever due to _Borrelia recurrentis_ [L42880]\\r\\n- Prophylaxis of malaria due to _Plasmodium falciparum_ in short-term travelers (<4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine resistant strains [L42870, L42880]\\r\\n\\r\\nIt is also used to treat infections caused by the following gram-negative microorganisms:\\r\\n\\r\\n- Chancroid caused by _Haemophilus ducreyi_ [L42880]\\r\\n- Plague due to _Yersinia pestis_ [L42880]\\r\\n- Tularemia due to _Francisella tularensis_ [L42880]\\r\\n- Cholera caused by _Vibrio cholerae_ [L42880]\\r\\n- Campylobacter fetus infections caused by _Campylobacter fetus_ [L42880]\\r\\n- Brucellosis due to _Brucella_ species (in conjunction with [streptomycin]) [L42880]\\r\\n- Bartonellosis due to _Bartonella bacilliformis_ [L42880]\\r\\n- Granuloma inguinale caused by _Klebsiella granulomatis_ [L42880]',\n",
       " 'Used in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery.',\n",
       " 'Lymecycline is used for the treatment of acne in addition to other susceptible infections; propionibacterium is often the cause of acne.[L13880]  Some of the infections that can be treated with lymecycline include upper respiratory tract infections, urinary tract infections, bronchitis, chlamydial infections, and rickettsial infections.[L13883]',\n",
       " '**Topical preparations**\\r\\n\\r\\nClotrimazole topical cream is indicated for the topical treatment of the following dermal infections [F3088], [F3121]:\\r\\n\\r\\nTinea pedis, tinea cruris, and tinea corporis due to _Trichophyton rubrum_, _Trichophyton mentagrophytes_, _Epidermophyton floccosum_\\r\\n\\r\\nCandidiasis due to _Candida albicans_\\r\\n\\r\\nTinea versicolor due to _Malassezia furfur_\\r\\n\\r\\nDiaper rash infected by _Candida albicans_\\r\\n\\r\\n\\r\\nIn some preparations, clotrimazole may be combined with betamethasone dipropionate, a corticosteroid [F3121]. \\r\\n\\r\\n**Oral preparations**\\r\\n\\r\\nThe oral troche preparation is indicated for the local treatment of oropharyngeal candidiasis [FDA label].  It is also indicated as a prophylactic drug to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions such as chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation [FDA label]. Troche preparations are not indicated for the treatment of any systemic mycoses [FDA label].',\n",
       " 'Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.',\n",
       " 'For the treatment of vulvovaginitis caused by <i>Candida albicans</i>.',\n",
       " 'Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB).',\n",
       " 'Anagrelide is indicated for the treatment of thrombocythemia, secondary to malignant neoplasms, to reduce platelet count and the associated risk of thrombosis. It is also beneficial in the amelioration of thrombocythemia symptoms including thrombo-hemorrhagic events.[L14153]',\n",
       " \"For the treatment of brain tumors, multiple myeloma, Hodgkin's disease and Non-Hodgkin's lymphomas.\",\n",
       " 'For the treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections.',\n",
       " 'Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension.[A175141,L36065,L45553]\\r\\n\\r\\nSome off-label uses of metoprolol include supraventricular tachycardia and thyroid storm.[A175141]\\r\\n\\r\\nAll the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.[L5533]',\n",
       " 'For eradication of scabies (<i>Sarcoptes scabiei</i>) and for symptomatic treatment of pruritic skin.',\n",
       " 'For decreasing blood clotting. Often used along with heparin for treatment of deep vein thrombosis.',\n",
       " 'Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria.',\n",
       " \"For the treatment of the signs and symptoms of Parkinson's disease and for the treatment of primary moderate-severe restless legs syndrome [FDA label].\",\n",
       " 'Used to treat symptoms of menopause, deficiencies in ovary function (including underdevelopment of female sexual characteristics and some types of infertility), and in rare cases, prostate cancer. Chlorotrianisene may also be used to prevent breast engorgement following childbirth.',\n",
       " 'For the management of mild to moderate essential hypertension. It may be used alone or concurrently with thiazide-type diuretics.',\n",
       " 'Used, alone or in combination, for a wide variety of diagnostic imaging methods, including angiography, urography, cholangiography, computed tomography, hysterosalpingography, and retrograde pyelography. It can be used for imaging the gastrointestinal tract in patients allergic to barium.',\n",
       " 'For use clinically to test gastric secretory function.',\n",
       " 'Topiramate is indicated  for the following conditions: 1)Monotherapy for partial onset or primary generalized tonic-clonic seizures for patients 2 years of age and above 2)Adjunctive therapy for partial onset seizures or primary generalized tonic-clonic seizures for both adult and pediatric patients above 2 years old 3)Adjunctive therapy for seizures associated with Lennox-Gastaut syndrome in patients above 2 years of age 4)Prophylaxis of migraine in children 12 years of age and older and adults.[L10544]\\r\\n\\r\\nTopiramate is also used off-label as an adjunct therapy for weight management[L10550] and for mood disorders.[A188312]',\n",
       " 'For the treatment of infections caused by susceptible organisms.',\n",
       " 'Olmesartan is indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents.[F4709,F4712,A173869] \\r\\n\\r\\nOlmesartan is also used off-label for the management Type 2 Diabetes-associated nephropathy, heart failure, and post-myocardial infarction, particularly in patients who are unable to tolerate ACE inhibitors.[A178153,A185912,A185915] ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.[A185906,A185909,A185912] ',\n",
       " 'For treatment of acute myeloid leukaemia.',\n",
       " 'For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.',\n",
       " 'Argatroban is indicated for prevention and treatment of thrombosis caused by heparin-induced thrombocytopenia (HIT). It is also indicated for use in patients with, or at risk for, HIT who are undergoing percutaneous coronary intervention.',\n",
       " 'Liothyronine is officially approved for the following indications:\\r\\n\\r\\n- Replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.\\r\\n\\r\\n- As an adjunct therapy to surgery and radioiodine in the management of thyroid cancer.\\r\\n\\r\\n- As a diagnostic agent in suppression tests for mild hyperthyroidism or thyroid gland autonomy.[FDA label]\\r\\n\\r\\nIn general terms, exogenous liothyronine is used to replace insufficient hormonal production and restore T3 plasma levels.[T457]\\r\\n\\r\\nThe lack of liothyronine can be presented as a pale and puffy face, coarse,  brittle hair, dry skin, croaky voice and constipation as well as irregular periods, drowsiness, and lethargy.[T457]\\r\\n\\r\\nLiothyronine should never be used in the suppression of benign nodules and nontoxic diffuse goiter in iodine-sufficient patients nor in the treatment of hyperthyroidism during the recovery phase of subacute thyroiditis.[FDA label]',\n",
       " 'For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias. It is a Class Ia antiarrhythmic drug.',\n",
       " 'Lidocaine is an anesthetic of the amide group indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks [F4349, L5930].',\n",
       " \"Pamidronate is indicated to treat moderate to severe hypercalcemia of malignancy, moderate to severe Paget's disease of bone, osteolytic bone metastases of breast cancer, and osteolytic lesions of multiple myeloma.[L13838]\",\n",
       " 'For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation. Also for the management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Used as self-medication for temporary relief of symptoms associated with the common cold.',\n",
       " 'Acarbose is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.[L31628]',\n",
       " 'Venlafaxine is indicated for the management of major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder.[L43030]',\n",
       " 'The conjugated estrogens are indicated for several different conditions including:\\r\\n\\r\\n- Treatment of moderate to severe vasomotor symptoms due to menopause.\\r\\n- Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.\\r\\n- Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure.\\r\\n- Palliative treatment of breast cancer in appropriately selected patients with metastatic disease.\\r\\n- Palliative treatment of androgen-dependent carcinoma of the prostate.\\r\\n- Preventive therapy of postmenopausal osteoporosis.[A38238] ',\n",
       " 'Travoprost is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.[L49434, L49429, L49515] It is also used in pediatric patients aged two months to less than 18 years.[L5146] ',\n",
       " 'For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.',\n",
       " 'Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults.',\n",
       " 'For palliative treatment in the management malignant neoplasm (trachea, bronchus, lung), squamous cell carcinoma, and lymphomas.',\n",
       " \"For treatment of chronic lymphatic (lymphocytic) leukemia,  childhood minimal-change nephrotic syndrome, and malignant lymphomas including lymphosarcoma, giant follicular lymphoma, Hodgkin's disease,  non-Hodgkin's lymphomas, and Waldenstrms Macroglobulinemia.\",\n",
       " 'Used in the induction of general anesthesia.',\n",
       " 'For the treatment of malignant neoplasm of colon and rectum',\n",
       " \"Etonogestrel is administered in subdermal implants as long-acting reversible contraception. It is known to be effective in postpartum insertion including breastfeeding women.[A175990]\\r\\n\\r\\nEtonogestrel is part of the long-acting contraceptive implants that prevent pregnancy. The implant's effect can remain for 5 years.[L5698]\",\n",
       " 'Morphine is used for the management of chronic, moderate to severe pain.[A176050]\\r\\n\\r\\nOpiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.[L5728]',\n",
       " 'Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.[L42140]',\n",
       " 'As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.[L41270]\\r\\n\\r\\nBupivacaine, in liposome suspension, is indicated in patients aged 6 years and older for single-dose infiltration to produce postsurgical local analgesia. In adults, it is also indicated as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia.[L40418]  \\r\\n\\r\\nBupivacaine, in combination with [meloxicam], is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.[L34100]\\r\\n\\r\\nBupivacaine, alone or in combination with [epinephrine], is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations are recommended for each type of block indicated to produce local or regional anesthesia or analgesia. Finally, its use is not indicated in all blocks given clinically significant risks associated with use.[L30533]  \\r\\n\\r\\n',\n",
       " 'Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.',\n",
       " 'Used to treat recurrent cold sores on the lips and face from various herpesvirus invections.',\n",
       " 'Tenofovir disoproxil is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients 2 years old and weighing 10 kg.[L12600] It is also indicated for the treatment of chronic hepatitis B in patients 2 years old and weighing 10 kg.[L12600]\\r\\n\\r\\nTenofovir disoproxil is also an ingredient in several combination products, all of which are indicated either alone or in combination with other antiretrovirals for the treatment of HIV-1 infection.[L9848,L4385,L9842,L41010,L9587,L41015,L9833]\\r\\n\\r\\nIn addition, tenofovir disoproxil is available in combination with [emtricitabine] (under the brand name Truvada) for use as pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents weighing  35kg to reduce the risk of sexually-acquired HIV-1 infection.[L9833]',\n",
       " 'Used to treat bacterial infection by susceptible microorganisms.',\n",
       " 'Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema,[L31883] cyclic heavy menstrual bleeding in premenopausal females,[L31858] and other instances of significant bleeding in the context of hyperfibrinolysis.[L31883] Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleeding following tooth extraction.[L31853]',\n",
       " 'Ertapenem is indicated to treat the following moderate to severe infections caused by susceptible bacteria in adult and pediatric patients (three months of age and older):[L14339,L44416]\\r\\n\\r\\n- Complicated intra-abdominal infections.[L14339,L44416]\\r\\n- Complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis.[L14339,L44416]\\r\\n- Community-acquired pneumonia.[L14339,L44416]\\r\\n- Complicated urinary tract infections, including pyelonephritis.[L14339]\\r\\n- Acute pelvic infections, including postpartum endomyometritis, septic abortion and post-surgical gynecologic infections.[L14339]\\r\\n- Acute gynecological infections.[L44416]\\r\\n\\r\\nErtapenem is also used in adults for the prophylaxis of surgical site infection following elective colorectal surgery.[L14339,L44416]',\n",
       " 'Oral desogestrel is used in combination with [ethinylestradiol] as a contraceptive agent for the prevention of pregnancy.[FDA label]\\r\\n\\r\\nDesogestrel is part of the combined oral contraceptives that contain a mix of estrogen and progestin which inhibit ovulation.[L5698]',\n",
       " 'For treatment of malignant neoplasm of lip, oral cavity, pharynx, digestive organs, peritoneum, female breast, and urinary bladder. Also used as an adjunct to ab externo glaucoma surgery. Mitomycin is also indicated as a pyelocalyceal solution for the treatment of adults with low-grade upper tract urothelial cancer (LG-UTUC).[L12867]',\n",
       " 'For use as a sedative and hypnotic.',\n",
       " 'Used orally for the treatment of skin manifestations of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to at least one prior systemic therapy. Also used topically for the treatment of skin lesions in early (stage IA and IB) CTCL in patients who experience refractory or persistent disease with the use of other therapies or are intolerant of other therapies.',\n",
       " 'Indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm.',\n",
       " \"For the treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia and acute panmyelosis\",\n",
       " 'Chlorthalidone is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension.\\r\\n\\r\\nChlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.\\r\\n\\r\\nChlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure.',\n",
       " 'For use in the treatment of duodenal ulcers, as a diuretic, and in the treatment of glaucoma, and may also be useful in the treatment of seizures associated with epilepsy.',\n",
       " 'For the short-term treatment of insomnia.',\n",
       " '**Indicated** for:[Label] \\r\\n\\r\\n1) Use as monotherapy or adjunctive therapy in the management of complex partial seizures and simple or complex absence seizures. \\r\\n\\r\\n2) Adjunctive therapy in the management of multiple seizure types that include absence seizures. \\r\\n\\r\\n3) Prophylaxis of migraine headaches.\\r\\n\\r\\n4) Acute management of mania associated with bipolar disorder.\\r\\n\\r\\n\\r\\n**Off-label** uses include:\\r\\n \\r\\n1) Maintenance therapy for bipolar disorder.[A177919]\\r\\n\\r\\n2) Treatment for acute bipolar depression.[A177928,A177931,A177934]\\r\\n\\r\\n3) Emergency treatment of status epilepticus.[A177955]',\n",
       " 'Used in the treatment of tuberculosis in combination with other drugs.',\n",
       " 'Zolmitriptan is indicated for the acute treatment of migraine with or without auras in patients aged 18 and over.[L12978]',\n",
       " 'In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever.[F4124] It is available over the counter in various forms, the most common being oral forms.\\r\\n\\r\\nAcetaminophen _injection_ is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.[Label]\\r\\n\\r\\nBecause of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics.[F4124] Specific dosing guidelines should be followed when administering acetaminophen to children.[L5780]',\n",
       " 'For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies.',\n",
       " 'Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form [FDA label] and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate [FDA label].\\r\\n\\r\\nThe solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above [L5521], [L5524]. ',\n",
       " 'For the treatment of polymicrobial infections.',\n",
       " 'Dihydroergotamine (DHE) in all formulations is indicated for the acute treatment of migraine with or without aura in adults.[L38459, L38464, L38469] As an injection, DHE is also indicated for the acute treatment of cluster headache episodes.[L38459]\\r\\n\\r\\nDHE is not indicated for migraine prevention or the management of hemiplegic or basilar migraine.[L38459, L38464, L38469]',\n",
       " 'This drug in indicated for the following conditions [FDA label]:\\r\\n\\r\\nMajor depressive disorder in adults [L46357]\\r\\n\\r\\nManagement of neuropathic pain in adults\\r\\n\\r\\nProphylactic treatment of chronic tension-type headache (CTTH) in adults\\r\\n\\r\\nProphylactic treatment of migraine in adults\\r\\n\\r\\nTreatment of nocturnal enuresis in children aged 6 years and above when organic pathology, including spina bifida and related disorders, have been excluded and no response has been achieved to all other non-drug and drug treatments, including antispasmodics and vasopressin-related products. This product should only be prescribed by a healthcare professional with expertise in the management of persistent enuresis [FDA label]\\r\\n\\r\\nOff-label uses: irritable bowel syndrome, sleep disorders, diabetic neuropathy, agitation, fibromyalgia, and insomnia ',\n",
       " 'For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. Also for the palliative management of liver cancer (usually administered by hepatic intra-arterial infusion).',\n",
       " \"Used as an adjunct to levodopa/carbidopa therapy for the symptomatic treatment of Parkinson's Disease. This drug is generally reserved for patients with parkinsonian syndrome receiving levodopa/carbidopa who are experiencing symptom fluctuations and are not responding adequately to or are not candidates for other adjunctive therapies.\",\n",
       " 'For the ophthalmic treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.',\n",
       " 'For immediate reduction of blood pressure of patients in hypertensive crises, reduce bleeding during surgery, and for the treatment of acute congestive heart failure',\n",
       " 'For treatment of mild hypocalcemia due to neonatal tetany, tetany due to parathyroid deficiency or vitamin D deficiency, and alkalosis, as prophylaxis of hypocalcemia during exchange transfusions, in the treatment of intestinal malabsorption, and to replenish electrolytes.',\n",
       " 'Hydromorphone is indicated for the management of moderate to severe acute pain and severe chronic pain. Due to its addictive potential and overdose risk, hydromorphone is only prescribed when other first-line treatments have failed.[A176468]\\r\\n\\r\\nThe WHO has proposed a three-step ladder for the management of pain in which it is suggested to start with a non-opioid medication followed by addition of weak opioids to the non-opioid treatment for moderate pain and finishing in the use of strong opioids such as hydromorphone along with the existing regimen for cases of severe pain.[A176471]\\r\\n\\r\\nOff-label, hydromorphone can be administered for the suppression of refractory cough.[A176468]',\n",
       " 'Oral indometacin is indicated for symptomatic management of moderate to severe rheumatoid arthritis including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.[A177871,L6778]\\r\\n \\r\\nIntravenous indometacin is indicated to induce closure of a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.[L10553]',\n",
       " 'Ethambutol is indicated in combination with other anti-tuberculosis drugs in the treatment of pulmonary tuberculosis.[L31663] Ethambutol is commonly used in combination with [isoniazid], [rifampin], and [pyrazinamide].[L31743]',\n",
       " '**Metformin immediate-release formulations**\\r\\n \\r\\nMetformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years old with type 2 diabetes mellitus.[L40243]\\r\\n\\r\\n**Metformin extended-release tablet (XR)**\\r\\n\\r\\nThe extended-release formulation of metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Safety in children has not been determined to this date.[L12207]\\r\\n\\r\\n**Metformin combination products**\\r\\n\\r\\nMetformin is a component of a variety of combination products with other anti-diabetic agents. It is indicated, along with diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus in combination with DPP-4 inhibitors ([sitagliptin], [linagliptin], [alogliptin], or [saxagliptin]),[L11479,L40248,L40253,L40258,L40263] in combination with SGLT2 inhibitors ([canagliflozin], [empagliflozin], [ertugliflozin], or [dapagliflozin]),[L11479,L30503,L1134,L13679,L38729] or in combination with [pioglitazone].[L11419]',\n",
       " 'Inhaled ipratropium is indicated in combination with inhaled beta-agonist systemic corticosteroids for the management of severe exacerbations of asthma flares requiring treatment.[A176939]\\r\\n\\r\\nAsthma exacerbations are characterized by a progressive increase in one or more of asthma symptoms accompanied by a decrease in expiratory flow.[L5900]\\r\\n\\r\\nAs a single agent, ipratropium was indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for patients 5 years or older. It does not alleviate nasal congestion nor sneezing.[FDA label]\\r\\n\\r\\nRhinorrhea refers to recurrent or chronic watery nasal discharge. This condition is debilitating and its pathogenesis and etiology is complex and not very well understood presenting very substantial cost burden.[L5903]\\r\\n\\r\\nAdditionally, ipratropium is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.[FDA label]\\r\\n\\r\\nThe chronic obstructive pulmonary disease includes a large number of conditions characterized by breathlessness. As this includes several conditions, the etiology, symptoms, and treatments are diverse.[L5906]\\r\\n\\r\\nIpratropium has also been studied to be used for the treatment of sialorrhea.[A176942]\\r\\n\\r\\nSialorrhea is a common symptom that accompanies different neurologic conditions and it is characterized by drooling or excessive salivation.[A176963]',\n",
       " \"Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.[F4688]\\r\\n\\r\\nMethadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services.[F4685,F4691]\",\n",
       " \"Olanzapine was initially used orally and intramuscularly for the chronic treatment of schizophrenia in patients over 13 years old and other psychiatric disorders such as bipolar I disorder including mixed or manic episodes.[A177014] \\r\\n\\r\\nOlanzapine is also indicated, in combination with lithium or valproate for the short-term treatment of acute manic or mixed episodes associated with bipolar I disorder in adults.[FDA label]\\r\\n\\r\\nAs well, olanzapine is indicated, in combination with fluoxetine for the treatment of episodes of depression associated with bipolar disorder type 1 and treatment-resistant depression in patients over 10 years old.[A177014]\\r\\n\\r\\nOlanzapine is also approved for the management of psychomotor agitation associated with schizophrenia and bipolar I mania.[FDA label]\\r\\n\\r\\nSchizophrenia is a complex biochemical brain disorder that affects the person's ability to differentiate reality. It is usually observed as the presence of delusions, hallucinations, social withdrawal and disturbed thinking.[L5936]\\r\\n\\r\\nBipolar disorder is a mental health condition defined by periods of extreme mood disturbances. It is categorized in different types from which type 1 is known to involve episodes of severe mania and often depression while type 2 presents less severe forms of mania.[L5939]\\r\\n\\r\\nOlanzapine is also indicated in combination with [samidorphan] for the treatment of bipolar I disorder, either as an adjunct to lithium or valproate or as monotherapy for the acute treatment of manic or mixed episodes or as maintenance therapy, and for the treatment of schizophrenia in adults.[L34359]\",\n",
       " '**Indicated** for:[label]\\r\\n\\r\\n1) Management of hypertension alone and in combination with other antihypertensives.\\r\\n\\r\\n2) Management of angina pectoris associated with coronary atherosclerosis.\\r\\n\\r\\n3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg.\\r\\n\\r\\n**Off-label** uses include:\\r\\n\\r\\n1) Secondary prevention of myocardial infarction.[A178156]\\r\\n\\r\\n2) Management of heart failure.[A178153]\\r\\n\\r\\n3) Management of atrial fibrillation.[A178141]\\r\\n\\r\\n4) Management of supraventricular tachycardia.[A178162]\\r\\n\\r\\n5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy.[A178168]\\r\\n\\r\\n6) Management of symptomatic thyrotoxicosis in combination with [methimazole].[A178147]\\r\\n\\r\\n7) Prophylaxis of migraine headaches.[A178171]\\r\\n\\r\\n8) Management of alcohol withdrawal.[A178174,A178177]',\n",
       " 'For the treatment of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.',\n",
       " 'For treatment of mild to moderate atopic dermatitis.',\n",
       " 'Omeprazole, according to the FDA label [FDA label] is a proton pump inhibitor (PPI) used for the following purposes:\\r\\n\\r\\n Treatment of active duodenal ulcer in adults \\r\\n\\r\\n Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer\\r\\nrecurrence in adults \\r\\n\\r\\n Treatment of active benign gastric ulcer in adults \\r\\n\\r\\n Reduction of risk of upper gastrointestinal (GI) bleeding in critically ill adult patients.\\r\\n\\r\\n Treatment of symptomatic gastroesophageal reflux disease (GERD) in\\r\\npatients 1 year of age and older \\r\\n\\r\\n Treatment of erosive esophagitis (EE) due to acid-mediated GERD in\\r\\npatients 1 month of age and older \\r\\n\\r\\n Maintenance of healing of EE due to acid-mediated GERD in patients 1\\r\\nyear of age and older \\r\\n\\r\\n Pathologic hypersecretory conditions in adults',\n",
       " 'For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.',\n",
       " 'Used for the symptomatic treatment of parkinsonism.',\n",
       " '**Seasonal Allergic Rhinitis**: Indicated for the relief of symptoms associated with seasonal allergic rhinitis caused by allergens such as ragweed, grass and tree pollens in adults and children 2 years of age and above. Symptoms treated effectively include sneezing, rhinorrhea, nasal pruritus, ocular pruritus, tearing, and redness of the eyes [FDA label]. \\r\\n\\r\\n**Perennial allergic rhinitis**: This drug is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens including dust mites, animal dander, and molds in adults and children 6 months of age and older. Symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing [FDA label]. \\r\\n\\r\\n**Chronic urticaria**: Cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. It markedly reduces the occurrence, severity, and duration of hives and significantly reduces pruritus [FDA label].',\n",
       " 'For the treatment of allergic rhinitis, hay fever, and allergic skin disorders.',\n",
       " \"**Oral**\\r\\n\\r\\nIndicated for the management of hypertension, to lower blood pressure, alone or in combination with other antihypertensive agents.[L10556]\\r\\n\\r\\nIndicated for use to improve exercise tolerance in patients with chronic stable angina.[L10556]\\r\\n\\r\\nIndicated for the management of variant angina (Prinzmetal's angina).[L6298]\\r\\n\\r\\n**Intravenous**\\r\\n\\r\\nIndicated for the short-term management of atrial fibrillation or atrial flutter for temporary control of rapid ventricular rate.[L6292]\\r\\n\\r\\nIndicated for the rapid conversion of paroxysmal supraventricular tachycardias (PSVT) to sinus rhythm. This includes AV nodal reentrant tachycardias and reciprocating tachycardias associated with an extranodal accessory pathway such as the WPW syndrome or short PR syndrome.[L6292]\\r\\n\\r\\n**Off-label**\\r\\n\\r\\nIndicated for off-label uses in anal fissures (as topical formulation), migraine prophylaxis, cramps in lower leg related to rest, pulmonary hypertension,[L6289] idiopathic dilated cardiomyopathy, and proteinuria associated with diabetic nephropathy.[L6298]\",\n",
       " 'For the treatment of depression. ',\n",
       " 'Used to measure effective renal plasma flow (ERPF) and to determine the functional capacity of the tubular excretory mechanism.',\n",
       " 'Alfuzosin is used to treat the signs and symptoms of benign prostatic hyperplasia (BPH).[L9251] ',\n",
       " 'Used in the control of absence (petit mal) seizures that are refractory to treatment with other medications.',\n",
       " 'Used as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1.',\n",
       " 'Clobazam is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.[L44888] ',\n",
       " 'For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia.',\n",
       " 'For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used for the palliative management of recurrent, inoperable, or metastatic breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.',\n",
       " 'For remission induction and remission consolidation treatment of acute nonlymphocytic leukemias.',\n",
       " 'For the prevention and control of excessive bleeding following vaginal childbirth',\n",
       " 'For prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness and vertigo (dizziness caused by other medical problems).',\n",
       " 'For the treatment of the following infections caused by susceptible gram-negative microorganisms: urinary tract infections, lower respiratory tract infections, septicemia, skin and skin-structure infections, intra-abdominal infections, and gynecologic infections.',\n",
       " 'For the relief of discomfort associated with acute painful musculoskeletal conditions.',\n",
       " \"For the suppression of adrenal function in selected patients with Cushing's syndrome, malignant neoplasm of the female breast, and carcinoma in situ of the breast.\",\n",
       " 'Mefloquine is indicated for the treatment of mild to moderate cases of malaria caused by Plasmodium falciparum and Plasmodium vivax.  It is effective against chloroquine-resistant forms of Plasmodium falciparum.  Mefloquine is also indicated for the prophylaxis of malaria caused by Plasmodium falciparum and Plasmodium vivax, including chloroquine-resistant forms of Plasmodium falciparum.[L8953] ',\n",
       " 'For the treatment of rheumatic fever and meningococcal meningitis',\n",
       " 'For the treatment of tetrahydrobiopterin (BH4) deficiency.',\n",
       " '\\r\\n Vinorelbine tartrate is indicated for adults in the treatment of advanced non-small cell lung cancer (NSCLC), as a single therapy or in combination with other chemotherapeutic drugs [L1998].\\r\\n\\r\\nUsed in relapsed or refractory Hodgkin lymphoma, in combination with other chemotherapy agents [L2011].\\r\\n \\r\\nFor the treatment of desmoid tumor or aggressive fibromatosis, in combination with methotrexate [L2011].\\r\\n\\r\\nFor the treatment of recurrent or metastatic squamous cell head and neck cancer [L2011].\\r\\n\\r\\nFor the treatment of recurrent ovarian cancer [L2011].\\r\\n\\r\\nFor the treatment of metastatic breast cancer, in patients previously treated with anthracyline and/or taxane therapy [L2011].\\r\\n\\r\\nFor the treatment of HER2-positive, trastuzumab-resistant, advanced breast cancer in patients previously treated with a taxane, in combination with trastuzumab and everolimus [L2011].\\r\\n',\n",
       " 'For use in the treatment of the following fungal infections: Candidemia and other forms of <i>Candida</i> infections (intra-abdominal abscess, and peritonitis), Aspergillus infections, and esophageal candidiasis. Also considered an alternative treatment for oropharyngeal canaidiasis.',\n",
       " 'Clozapine is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. Because of the risks of severe neutropenia and of seizure associated with its use, Clozapine should be used only in patients who have failed to respond adequately to standard antipsychotic treatment.[L905]\\r\\n\\r\\nClozapine is also indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for death.[L905]',\n",
       " 'The sucralfate suspension [FDA label] and tablet [F4534] are used for the treatment of active duodenal ulcer for up to 8 weeks.  The tablet form may be used at a lower dose for healed duodenal ulcers, for the purpose of maintaining healing and preventing recurrence [F4519, F4534]. \\r\\n\\r\\nSucralfate is also used in the prevention and/or treatment of gastro-esophageal reflux disease (GERD), gastritis, peptic ulcer disease, stress ulcer, in addition to dyspepsia [A177655, F4519].',\n",
       " 'For treatment of adults with mild to moderate infections caused by susceptible strains of <i>Haemophilus influenzae</i>, <i>Streptococcus pneumoniae</i>, or <i>Moraxella catarrhalis</i>.',\n",
       " 'Used alone as a short-term sleep aid, in combination with other drugs as a night-time cold and allergy relief drug. Also used in combination with Vitamin B6 (pyridoxine) to prevent morning sickness in pregnant women.',\n",
       " '**Emergency contraception**\\r\\n\\r\\nLevonorgestrel, in the single-agent emergency contraceptive form, is indicated for the prevention of pregnancy after the confirmed or suspected failure of contraception methods or following unprotected intercourse. It is distributed by prescription for patients under 17, and over the counter for those above this age.[L7760] This levonorgestrel-only form of contraception is not indicated for regular contraception and must be taken as soon as possible within 72 hours after intercourse.[A181976,L7760] It has shown a lower efficacy when it is used off label within 96 hours.[T659]\\r\\n\\r\\n**Long-term contraception or nonemergency contraception**\\r\\n\\r\\nIn addition to the above indication in emergency contraception, levonorgestrel is combined with other contraceptives in contraceptive formulations designed for regular use, for example with ethinyl estradiol.[L7766] It is used in various hormone-releasing intrauterine devices for long-term contraception ranging for a duration of 3-5 years.[L7778,L7781,L7787] Product labeling for Mirena specifically mentions that it is recommended in women who have had at least 1 child and can be indicated for the prevention of pregnancy for up to 8 years.[L7778,L42950] A subdermal implant is also available for the prevention of pregnancy for up to 5 years.[L7823]\\r\\n\\r\\n**Hormone therapy and off-label uses**\\r\\n\\r\\nLevonorgestrel is prescribed in combination with estradiol as hormone therapy during menopause to manage vasomotor symptoms and to prevent osteoporosis.[L7805]Off-label, levonorgestrel may be used to treat menorrhagia, endometrial hyperplasia, and endometriosis.[T659]',\n",
       " 'Mainly used to treat patients in vasodilatory shock states such as septic shock and neurogenic shock and has shown a survival benefit over dopamine. Also used as a vasopressor medication for patients with critical hypotension.',\n",
       " 'For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)',\n",
       " 'This drug is indicated for the treatment of major depressive disorder and its associated symptoms.[FDA label]\\r\\n\\r\\nMirtazapine has been used off-label for a variety of conditions including panic disorder, generalized anxiety disorder, dysthymia, tension headaches, hot flushes, post-traumatic stress disorder (PTSD), sleep disorders, substance abuse disorders, and sexual disorders, among others.[A177811,A177946]',\n",
       " 'For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.',\n",
       " 'For the treatment or relief of nausea and vomiting.',\n",
       " ' Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure.[L6724,L6727] In certain cases, timolol is used in the prevention of migraine headaches.[A179530,L6742] ',\n",
       " 'The FDA has indicated treprostinil for the treatment of pulmonary arterial hypertension[L41855,L41860,L41865] and pulmonary hypertension associated with interstitial lung disease[L41855] to improve exercise ability. It is also used to treat pulmonary arterial hypertension in patients requiring transition from epoprostenol.[L41860] The Health Canada label specifies that treprostinil is indicated for the long-term treatment of pulmonary arterial hypertension in NYHA Class III and IV patients who did not respond adequately to conventional therapy.[L24244]\\r\\n\\r\\nL24244',\n",
       " \"Colestipol is indicated as adjunctive therapy to diet for the reduction of elevated serum total and low-density lipoprotein cholesterol (LDL-C) in patients with primary hypercholesterolemia (a condition that features elevated LDL-C) who do not respond adequately to dietary changes .[FDA Label,L6115,F4555]\\r\\n\\r\\nTherapy with lipid-altering agents like colestipol should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia [FDA Label, L6115, F4555]. Treatment should begin and continue with dietary therapy [FDA Label, L6115, F4555]. In general, a minimum of six months of intensive dietary therapy and counseling should be carried out prior to initiation of drug therapy such as that with colestipol [FDA Label, F4555]. Shorter periods may be considered in patients with severe elevations of LDL-C or with definite coronary heart disease [FDA Label, F4555].\\r\\n\\r\\nAlthough colestipol is effective in all types of hypercholesterolemia, some regional prescribing information note in particular that it is medically most appropriate in patients with Fredrickson's type II hyperlipoproteinemia [L6115]. Nevertheless, in patients with combined hypercholesterolemia and hypertriglyceridemia, although colestipol may be helpful in reducing elevated cholesterol, it is not formally indicated where hypertriglyceridemia is the abnormality of greatest concern [F4567].\",\n",
       " 'Tihexyphenidyl is indicated as an adjunct in the treatment of parkinsonism, an adjuvant in the treatment of parkinsonism with levodopa, and in the control of extrapyramidal disorders caused by central nervous system drugs.[L31773,L31778]',\n",
       " 'For the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy, as well as prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy. Also used for the prevention of postoperative nausea and vomiting for up to 24 hours post operation.',\n",
       " 'Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.',\n",
       " 'For the treatment of ventricular tachycardia and symptomatic premature ventricular beats, and prevention of ventricular fibrillation.',\n",
       " 'For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg/m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines.',\n",
       " 'Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions [FDA label]:\\r\\n\\r\\n Hypertension \\r\\n\\r\\n Coronary artery disease\\r\\n\\r\\n Chronic stable angina\\r\\n\\r\\n Vasospastic angina (Prinzmetals or Variant angina) \\r\\n\\r\\n Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%',\n",
       " \"For the palliative treatment of mild to moderate dementia of the Alzheimer's type.\",\n",
       " 'For the treatment of peptic ulcer disease and the relief of smooth muscle spasms in gastrointestinal disorders.',\n",
       " 'Triamterene is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and the nephrotic syndrome; also in steroid-induced edema, idiopathic edema, and edema due to secondary hyperaldosteronism.[L6166]\\r\\n\\r\\nTriamterene in combination with hydrochlorothiazide is indicated for the managment of hypertension or treatment of edema in patients who develop hypokalemia following hydrochlorothiazide monotherapy, and in patients who require thiazide diuretic and in whom the development of hypokalemia cannot be risked.[L6169] Triamterene allows the maintenance of potassium balance when given in combination with loop diuretics and thiazides.[T28]',\n",
       " 'For the treatment of cancer of the bladder.',\n",
       " \"For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents.\",\n",
       " 'Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia.[L9416, L9410] The ophthalmic formulation is indicated to induce mydriasis [L9413, L46332] and conjunctival vasoconstriction.[A187370] The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids.[A187370] Off-label uses include priapism and induction of local vasoconstriction.[A187370]',\n",
       " 'For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy.',\n",
       " 'Digoxin is indicated in the following conditions: 1) For the treatment of mild to moderate heart failure in adult patients.[L9143] 2) To increase myocardial contraction in children diagnosed with heart failure.[L9143] 3) To maintain control ventricular rate in adult patients diagnosed with chronic atrial fibrillation.[L9143]\\r\\n\\r\\nIn adults with heart failure, when it is clinically possible, digoxin should be administered in conjunction with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor for optimum effects.[L9143]\\r\\n\\r\\n',\n",
       " 'Sulpiride is indicated for the treatment of acute and chronic schizophrenia.[L31933]',\n",
       " \"Profenamine is indicated in the symptomatic treatment of drug-induced extrapyramidal reactions and of the manifestations (rigidity, akinesia, sialorrhea, oculogyric crisis, tremor, etc.) of Parkinson's disease of encephalitic, arteriosclerotic or idiopathic origin.[L46812] It is also used to control severe reactions to certain medicines such as reserpine.\",\n",
       " 'For use as an adjunct to improve neurologic outcome following subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms by reducing the incidence and severity of ischemic deficits.',\n",
       " 'Indicated for oral inhalation use in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. The aerosol form of beclomethasone diproprionate is not indicated for the relief of acute bronchospasm.[L6871]\\r\\n\\r\\nIndicated for intranasal use to relieve the symptoms of seasonal or perennial allergic and nonallergic (vasomotor) rhinitis and prevent the recurrence of nasal polyps following surgical removal.[L6880]\\r\\n\\r\\nIndicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age and older.[L10782] Corticosteroid-responsive dermatoses include psoriasis, contact dermatitis (dermatitis venenata), atopic dermatitis (infantile eczema, allergic dermatitis), neurodermatitis (lichen simplex chronicus, lichen planus, eczema, eczematous dermatitis), intertrigo, dyshidroses (pompholyx), seborrheic dermatitis, exfoliative dermatitis, solar dermatitis, stasis dermatitis, and anogenital and senile pruritus.[L6886]',\n",
       " 'Carisoprodol is indicated for the relief of discomfort related to acute, painful musculoskeletal conditions [FDA label].\\r\\n\\r\\n\\r\\n**Important limitations of use** [FDA label]:\\r\\n\\r\\n Should only be used for acute treatment periods up to two or three weeks \\r\\n\\r\\n Adequate evidence of effectiveness for more prolonged use has not been established \\r\\n\\r\\n Not recommended in pediatric patients less than 16 years of age',\n",
       " '**Gelatinized capsules**\\r\\n\\r\\nThe gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea [FDA label]. \\r\\n\\r\\n**Vaginal gel**\\r\\n\\r\\nProgesterone gel (8%) is indicated as progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency.  The lower concentration progesterone gel (4%) is used in the treatment of secondary amenorrhea, with the use of the 8% concentration if there is no therapeutic response to the 4% gel [F3898].\\r\\n\\r\\n**Vaginal insert**\\r\\n\\r\\nThis form is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women [F3901].\\r\\n\\r\\n**Injection (intramuscular)**\\r\\n\\r\\nThis drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer [F3907]. \\r\\n\\r\\n**Tablets, contraceptive**\\r\\n\\r\\nThe tablet form of progesterone in contraceptive formulations is indicated for the prevention of pregnancy [F3904]. ',\n",
       " 'For the treatment of nasal congestion, control of urinary incontinence, priapism and obesity.',\n",
       " 'Sorafenib is indicated for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma.[L9341,L44577]\\r\\n\\r\\nIn the US, it is also indicated for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma that is refractory to radioactive iodine treatment.[L9341]',\n",
       " \"Zoledronic acid is indicated to treat hypercalcemia of malignancy, multiple myeloma, bone metastases from solid tumors, osteoporosis in men and postmenopausal women, glucocorticoid induced osteoporosis, and Paget's disease of bone in men and women.[L13712,L13715,L13721] Zoledronic acid is also indicated for the prevention of osteoporosis in post menopausal women and glucocorticoid induced osteoporosis.[L13712,L13715,L13721]\",\n",
       " 'For the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, cradle cap or other conditions caused by <i>Trichophyton</i> or <i>Microsporum</i> fungi.',\n",
       " 'For the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.',\n",
       " 'Eszopiclone is indicated for the treatment of insomnia.[L6769]',\n",
       " 'Caerulein is used in the treatment of paralytic ileus and as diagnostic aid in pancreatic malfunction.',\n",
       " 'Alprazolam is indicated for the acute treatment of generalized anxiety disorder in adults.[L34783] Alprazolam is also indicated, either as a standard or extended-release formulation, for the treatment of panic disorder with or without agoraphobia in adults.[L34783, L34788]\\r\\n\\r\\nAlprazolam may also be prescribed off-label for insomnia, premenstrual syndrome, and depression.[A177973]',\n",
       " 'For treatment and relief of symptoms of allergies, hay fever, and colds',\n",
       " \"For the treatment of bacterial and fungal infections inside the mouth (thrush) and skin, also for the prevention of transmission of Chagas' disease (as a blood additive).\",\n",
       " 'For prevention of deep vein thrombosis, which may result in pulmonary embolism, following knee surgery.',\n",
       " 'For the management of the manifestations of psychotic disorders such as schizophrenia',\n",
       " 'Remoxipride is an atypical antipsychotic once used for the treatment of schizophrenia.[A215532]',\n",
       " 'Indicated for the treatment of impetigo and secondary skin infections, leading to traumatic skin lesions, due to _Staphylococcus aureus_ and _Streptococcus pyogenes_.[L10580] ',\n",
       " 'Carbamoylcholine is indicated to induce miosis for surgery and to reduce intraocular pressure elevations in the first 24 hours after cataract surgery.[L30245]',\n",
       " 'Rosiglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ',\n",
       " 'This drug is indicated for the symptomatic treatment of Parkinsons disease [FDA label].  This drug can be administered as monotherapy or in conjunction with levodopa. It is also indicated for symptomatic treatment of moderate to severe primary Restless Legs Syndrome (RLS) [FDA label].  ',\n",
       " 'Used in the management of diabetes mellitus type 2 (adult-onset).',\n",
       " 'For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc',\n",
       " 'For use as an anesthesia adjunct to induce skeletal muscle relaxation and to reduce the intensity of muscle contractions in convulsive therapy.',\n",
       " 'Indicated for the treatment of mild to moderately severe infections due to penicillin G\\xad-sensitive microorganisms, with the use of bacteriological studies (including sensitivity tests) and clinical response.[label] \\r\\n\\r\\nPhenoxymethylpenicillin may be used for the treatment of: \\r\\n\\r\\n- mild to moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas caused by Streptococcus without bacteremia\\r\\n- mild to moderately severe infections of the respiratory tract caused by Pneumococcus\\r\\n- mild infections of the skin and soft tissues caused by penicillin G-sensitive Staphylococcus\\r\\n- mild to moderately severe infections of the oropharynx caused by Fusospirochetosis, including Vincents gingivitis and pharyngitis, usually respond to oral penicillin therapy\\r\\n\\r\\n**Off-label**\\r\\n\\r\\nIndicated for use as prophylaxis against bacterial endocarditis in patients with congenital heart disease or rheumatic or other acquired valvular heart disease when they undergo dental procedures and surgical procedures of the upper respiratory tract.[label]',\n",
       " 'For the Short-term treatment of intractable insomnia for patients habituated to barbiturates',\n",
       " \"For the treatment of adult patients with mild to moderate type 1 (nonneuropathic) Gaucher's disease for whom enzyme replacement therapy is not a therapeutic option (e.g. due to constraints such as allergy, hypersensitivity, or poor venous access). Now approved in some countries for the treatment of progressive neurological symptoms in adult and pediatric patients with Niemann-Pick disease type C (NP-C). \",\n",
       " 'Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.',\n",
       " 'Spironolactone is indicated for the treatment of the following conditions:\\r\\n\\r\\n- NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. Spironolactone is usually administered in conjunction with other heart failure therapies.[L44602]\\r\\n- Hypertension, as add-on therapy, in patients not adequately controlled by other agents.[L44602, L47810]\\r\\n- Edema associated with hepatic cirrhosis when edema is not responsive to fluid and sodium restriction.[L44602, L47810]\\r\\n- Edema associated with nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.[L44602]\\r\\n- Refractory edema associated with congestive cardiac failure, malignant ascites, hepatic cirrhosis with ascites, and essential hypertension.[L47810]\\r\\n- Short-term preoperative treatment of patients with primary hyperaldosteronism.[L44602, L47810]\\r\\n- Diagnosis of primary aldosteronism.[L47810]\\r\\n- Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery.[L44602]\\r\\n- Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).[L44602]\\r\\n\\r\\nAs spironolactone has antiandrogenic activity, its off-label uses include the treatment of hirsutism, female pattern hair loss, and adult acne vulgaris.[A178135, A261025]',\n",
       " 'Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.',\n",
       " 'Methocarbamol tablets and intramuscular injections are indicated in the United States as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions.[Label,L6268] Oral methocarbamol in America may be given up to 1500mg 4 times daily for 2-3 days.[A31312]\\r\\n\\r\\nIn Canada, methocarbamol containing oral formulations are sold over the counter for pain associated with muscle spasm.[L6295] However, if these combination formulations include codeine, they are prescription only.[L6295]',\n",
       " 'As a drug that is not FDA approved, hyscyamine has no official indications.[L31548,L31553] Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic.[L31548] Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation.[L31548] Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.[L31553]',\n",
       " 'This drug is indicated for the short-term treatment of insomnia in adults characterized by difficulties with sleep initiation [FDA label]. ',\n",
       " 'For the treatment of acute herpes zoster (shingles). Also for the treatment or suppression of recurrent genital herpes in immunocompetent patients and treatment of recurrent mucocutaneous herpes simplex infections in HIV infected patients.',\n",
       " 'For the symptomatic relief of seasonal or perennial allergic rhinitis or nonallergic rhinitis; allergic conjunctivitis; and mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Also used in combination with other agents for the symptomatic relief of symptoms associated with the common cold.',\n",
       " 'For the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma).',\n",
       " 'For aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and in the following conditions related to second trimester abortion: 1. Failure of expulsion of the fetus during the course of treatment by another method; 2. Premature rupture of membranes in intrauterine methods with loss of drug and insufficient or absent uterine activity; 3. Requirement of a repeat intrauterine instillation of drug for expulsion of the fetus; 4. Inadvertent or spontaneous rupture of membranes in the presence of a previable fetus and absence of adequate activity for expulsion. Also for the treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management.',\n",
       " 'For treatment of severe infections caused by susceptible bacteria such as P. aeruginosa.',\n",
       " 'For the treatment of patients infested with Sarcoptes scabiei or pediculosis capitis who have either failed to respond to adequate doses, or are intolerant of other approved therapies.',\n",
       " 'As a standalone product, trifluridine is used for the ophthalmic treatment of primay keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2.[L47671] \\r\\n\\r\\nTrifluridine is also available as a combination product with [tipiracil], which is indicated either alone or in combination with [bevacizumab] for the treatment of adult patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.[L47676] This combination product is also used for adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma and were previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy.[L47676]',\n",
       " 'Indicated for the symptomatic treatment of severe nausea and vomiting.[label]\\r\\n\\r\\nIndicated for the management of manifestations of psychotic disorders, such as schizophrenia and generalized non-psychotic anxiety. The use of prochlorperazine for the management of generalized non-psychotic anxiety is typically not a first-line therapy and should be limited to doses of less than 20 mg per day or for shorter than 12 weeks.[label,L6634]\\r\\n\\r\\nOff-label uses include use in emergency settings for adult and pediatric migraines. The American Headache Society recommends the use of prochlorperazine as the first-line medication in this setting. In pediatric migraines, a non-steroidal anti-inflammatory agent is often used in combination with dopamine antagonist.[L6637]',\n",
       " 'In the US, prescription cyproheptadine is indicated for the treatment of various allergic symptomatologies - including dermatographia, rhinitis, conjunctivitis, and urticaria - as well as adjunctive therapy in the management of anaphylaxis following treatment with epinephrine.[L32474] In Canada, cyproheptadine is available over-the-counter and is indicated for the treatment of pruritus and for appetite stimulation.[L32519] In Australia, cyproheptadine is additionally indicated for the treatment vascular headaches.[L32479]\\r\\n\\r\\nCyproheptadine is also used off-label for the treatment of serotonin syndrome.[A231274]',\n",
       " 'For the treatment of term and near-term (&gt;34 weeks) neonates with hypoxic respiratory failure',\n",
       " 'For the treatment of high blood pressure and management of edema related to heart failure.',\n",
       " 'Allopurinol is indicated in [FDA label]:\\r\\n\\r\\n1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy).\\r\\n\\r\\n2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present.\\r\\n\\r\\n3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.',\n",
       " 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]\\r\\n\\r\\nCeftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]\\r\\n\\r\\nIn all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]',\n",
       " 'Used as an adjunct to diet for the reduction of elevated total and LDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson Types IIa and IIb) when the response to dietary restriction of saturated fat and cholesterol and other non-pharmacological measures alone has been inadequate.',\n",
       " \"As a monotherapy, trimethoprim is indicated for the treatment of acute episodes of uncomplicated urinary tract infections caused by susceptible bacteria, including _E. coli._, _K. pneumoniae_, _Enterobacter spp._, _P. mirabilis_, and coagulase-negative _Staphylococcus_ species.[L11893,L11890] In various formulations in combination with [sulfamethoxazole], trimethoprim is indicated for the following infections caused by bacteria with documented susceptibility: urinary tract infections, acute otitis media in pediatric patients (when clinically indicated), acute exacerbations of chronic bronchitis in adults, enteritis caused by susceptible _Shigella_, prophylaxis and treatment of _Pneumocystis jiroveci_ pneumonia, and travelers' diarrhea caused by enterotoxigenic _E. coli_.[L11830,L11863]\\r\\n\\r\\nTrimethoprim is available as an ophthalmic solution in combination with [polymyxin B] for the treatment of acute bacterial conjunctivitis, blepharitis, and blepharoconjunctivitis caused by susceptible bacteria.[L11887]\",\n",
       " 'Gemcitabine is a chemotherapeutic agent used as monotherapy or in combination with other anticancer agents. \\r\\n\\r\\nIn combination with [carboplatin], it is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.[L32950]\\r\\n\\r\\nGemcitabine in combination with [paclitaxel] is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.[L32950]\\r\\n\\r\\nIn combination with [cisplatin], gemcitabine is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer (NSCLC).[L32950] Dual therapy with cisplatin is also used to treat patients with Stage IV (locally advanced or metastatic) transitional cell carcinoma (TCC) of the bladder.[L32955]\\r\\n\\r\\nGemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine is indicated for patients previously treated with [fluorouracil].[L32950]',\n",
       " 'For the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.',\n",
       " 'As a member of the corticosteroid family, betamethasone is indicated for the treatment of several inflammatory conditions. As topical monotherapy, betamethasone is indicated to relieve pruritic and inflammatory symptoms of corticosteroid-responsive-dermatoses.[L11991,L10782,L11997] Betamethasone can be used topically in combination with a vitamin D analog such as calcipotriene to treat plaque psoriasis.[L12000] The corticosteroid is also available as an injectable suspension and can be used to manage a range of inflammatory conditions including endocrine disorders, gastrointestinal disorders, and rheumatic disorders among other conditions.[L11994]\\r\\n',\n",
       " 'Teniposide is used for the treatment of refractory acute lymphoblastic leukaemia',\n",
       " 'For use as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.',\n",
       " 'Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.',\n",
       " 'Used to treat upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by <i>E. coli</i>, <i>S. pyogenes</i>, <i>S. aureus</i>, <i>S. saprphyticus</i>, <i>S. penumoniae</i>, <i>H. influenzae</i> and <i>M. catarrhalis</i>.',\n",
       " 'Lansoprazole is used to reduce gastric acid secretion and is approved for short term treatment of active gastric ulcers, active duodenal ulcers, erosive reflux oesophagitis, symptomatic gastroesophageal reflux disease, and non-steroidal anti-inflammatory drug (NSAID) induced gastric and duodenal ulcers. [A4892][A177065][FDA Label]  It may be used in the maintenance and healing of several gastric conditions including duodenal ulcers, NSAID related gastric ulcers, and erosive esophagitis.[FDA Label] Lansoprazole prevents recurrence of gastric ulcers in patients who have a documented history of gastric ulcers who also use NSAIDs chronically. [FDA Label]  Predictably, it is also useful in the management of hypersecretory conditions including Zollinger-Ellison syndrome. [FDA Label]  Lansoprazole is effective at eradicating H. pylori when used in conjunction with amoxicillin and clarithromycin (triple therapy) or with amoxicillin alone (dual therapy). [FDA Label]',\n",
       " 'Dipivefrin is a prodrug which is used as initial therapy for the control of intraocular pressure in chronic open-angle glaucoma.',\n",
       " 'Droperidol is used to produce tranquilization and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures.',\n",
       " 'Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. It is also indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.',\n",
       " 'For the treatment of bacterial blepharitis, bacterial bonjunctivitis, corneal injuries, corneal ulcers and meibomianitis. For the prophylaxis of ocular infections following foreign body removal',\n",
       " 'For the treatment and management of Brucellosis, mycoplasma infection, acne vulgaris, chlamydial infection;Chronic bronchitis',\n",
       " 'Used to control moderate to severe pain.',\n",
       " 'Loratadine is a 2nd generation antihistamine and is used to manage symptoms of allergic rhinitis, wheal formation, urticaria, and other allergic dermatologic conditions.[A176435][A176438][L8486] ',\n",
       " 'Used to prevent infection during surgery and to treat many kinds of infections of the blood, bone or joints, respiratory tract, skin, and urinary tract.',\n",
       " 'This drug is indicated for the treatment of hypertension (high blood pressure). Prazosin can be given alone or given with other blood pressure-lowering drugs, including diuretics or beta-adrenergic blocking agents [FDA label].\\r\\n\\r\\nPrazosin does not negatively impact lung function, and therefore may be used to manage hypertension in patients who are asthmatic or patients with chronic obstructive lung disease (COPD)[A176630].',\n",
       " 'For the relief of symptoms of depression and as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older [FDA Label]. \\r\\n\\r\\nMay also be used off-label to manage panic disorders with or without agoraphobia, as a second line agent for ADHD in children and adolescents, to manage bulimia nervosa, for short-term management of acute depressive episodes in bipolar disorder and schizophrenia, for the treatment of acute stress disorder and posttraumatic stress disorder, and for symptomatic treatment of postherpetic neuralgia and painful diabetic neuropathy [L1349,L1348,A31900,L1351,L1352,L1353,A31904]. ',\n",
       " 'For the treatment of severe psoriasis in adults.',\n",
       " 'For the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis syndrome. Verteporfin can also be used to destroy tumors.',\n",
       " '**Indicated** for:[label]\\r\\n\\r\\n1) Symptomatic relief in rheumatoid arthritis.\\r\\n\\r\\n2) Symptomatic relief in osteoarthritis.',\n",
       " 'Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.',\n",
       " 'Metharbital is used for the treatment of epilepsy.',\n",
       " 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.',\n",
       " 'Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and has antipyretic, analgesic and anti-inflammatory properties.[A176131]  It is indicated for short term management of acute pain that requires the calibre of pain management offered by opioids.[L3674]  Clinicians may choose to initiate ketorolac to manage post-operative pain, spinal and soft tissue pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders and headaches among other ailments.[L6520] Regardless of the etiology of pain, patients should use the lowest possible dose, and avoid using ketorolac for an extended period of time (ideally  5 days).[L3674] A benefit of choosing ketorolac over other analgesics with similar potency is that that there does not appear to be a risk of dependence or tolerance with ketorolac use.[A176131]     ',\n",
       " 'Used internally for relieving respiratory distress. Also for use as an antidote in poisoning by CNS depressants, especially barbiturates.',\n",
       " 'For the treatment of adults (&ge;18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to <i>Neisseria gonorrhoeae</i>, (2) uncomplicated urinary tract infections (cystitis) due to <i>Escherichia coli</i>, <i>Staphylococcus epidermidis</i>, or <i>Staphylococcus saprophyticus</i>, and (3) complicated urinary tract infections due to <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Proteus mirabilis</i>, <i>Pseudomonas aeruginosa</i>, <i>Staphylococcus epidermidis</i>, or <i>Enterobacter cloacae</i>.',\n",
       " 'For the treatment of malaria and leg cramps',\n",
       " 'For the treatment of rheumatoid arthritis, osteoarthritis, backache, and pain.',\n",
       " 'Dronabinol is indicated for the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.[L43438]',\n",
       " \"Montelukast is indicated for:\\r\\n\\r\\n(a) the prophylaxis and chronic treatment of asthma in adults and pediatric patients who are 12 months of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307] and also include indications for preventing day and night-time symptoms, and the treatment of acetylsalicylic acid-sensitive asthma[L6304];\\r\\n\\r\\n(b) the prevention of exercise-induced bronchoconstriction (EIB) in patients who are 6 years of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307]; and\\r\\n\\r\\n(c) the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older[L6301], although other regional health authorities specifically note the relief of seasonal allergic rhinitis symptoms for adults and adolescents who are 15 years and older[L6304,L6307].\\r\\n\\r\\nFurthermore, some formulations like chewable montelukast tablets may also be specifically indicated by particular regulatory bodies for the prophylaxis and chronic treatment of asthma, including the prevention of day and night-time symptoms, the treatment of acetylsalicylic acid based asthma, and the prevention of exercise-induced bronchoconstriction in adult and pediatric patients aged 2 and older[L6328], between the ages 2 and 5[L6325], or between the ages of 6 and 14 years.[L6331]\\r\\n\\r\\nMoreover, when employed for such indications montelukast is considered effective as monotherapy or when combined with other medications indicated for the maintenance treatment of chronic asthma.[L6304,L6328] For instance, montelukast and inhaled corticosteroids can be used concomitantly to demonstrate additive effects to control asthma or to decrease the necessary inhaled corticosteroid dose while still maintaining clinical stability.[L6304,L6328]\\r\\n\\r\\nAdditionally, in patients who continue to experience asthma symptoms, montelukast can also be combined with an 'as required' short-acting beta-agonist, an inhaled corticosteroid, or inhaled corticosteroid paired with a long-acting beta-agonist.[L6304,L6328]\",\n",
       " 'Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present.[L7664] Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar I Disorder, and treatment resistant depression.[L7664] Fluoxetine is additionally indicated for the treatment of female patients with premenstrual dysphoric disorder (PMDD).[L40833]',\n",
       " 'Used as a local anesthetic for surface application, infiltration or nerve block',\n",
       " 'Methohexital is indicated for use as an intravenous anaesthetic. It has also been commonly used to induce deep sedation.',\n",
       " 'Chlordiazepoxide is indicated for the management of anxiety disorders or for the short-term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety.[L37934] \\r\\n\\r\\nIn combination with amitriptyline, chlordiazepoxide is indicated for the treatment of moderate to severe depression.[L44898] In combination with clidinium, chlordiazepoxide is indicated to control emotional and somatic factors in gastrointestinal disorders, and is used as adjunctive therapy in the treatment of peptic ulcer, irritable bowel syndrome and acute enterocolitis.[L44893]',\n",
       " '**Indicated** for:\\r\\n\\r\\n1) Management of Major Depressive Disorder.[label]\\r\\n\\r\\n2) Management of Generalized Anxiety Disorder.[label]\\r\\n\\r\\n3) Management of diabetic peripheral neuropathy.[label]\\r\\n\\r\\n4) Management of fibromyalgia.[label]\\r\\n\\r\\n5) Management of chronic musculoskeletal pain.[label]\\r\\n\\r\\n6) Management of osteoarthritis of the knee in adults.[L6364]\\r\\n\\r\\n7) Management of chronic lower back pain in adults.[L6364]\\r\\n\\r\\n8) Management of stress urinary incontinence in adult women.[L6367]\\r\\n\\r\\n**Off-label** uses include:\\r\\n\\r\\n1) Management of chemotherapy-induced peripheral neuropathy.[A178603]\\r\\n\\r\\n2) Management of stress urinary incontinence in adult men after prostatectomy until recovery is complete.[L6370]',\n",
       " 'For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance.',\n",
       " 'For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults.',\n",
       " 'The amikacin sulfate injection is indicated in the short-term treatment of serious bacterial infections due to susceptible strains of gram-negative bacteria, including Pseudomonas species, Escherichia coli, species of indole-positive and indole-negative Proteus, Providencia species, Klebsiella-Enterobacter-Serratia species, as well as Acinetobacter (Mima-Herellea) species.[F1954]\\r\\n\\r\\nClinical studies have shown amikacin sulfate injection to be effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis) and skin and soft tissue; intra-abdominal infections (including peritonitis); and in burns and postoperative infections (including post-vascular surgery).[F1954]\\r\\n\\r\\nClinical studies have shown amikacin also to be effective in serious, complicated, and recurrent urinary tract infections due to the above organisms. Aminoglycosides, including amikacin, are not indicated in uncomplicated first-time episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics which are less toxic.[F1954]\\r\\n\\r\\nIn September 2018, a new indication with a new dosage route was approved for this drug. Amikacin liposome inhalation suspension was approved for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment (refractory disease).[L4673] This indication is approved under accelerated approval based on achieving sputum culture conversion (defined as 3 consecutive negative monthly sputum cultures) by Month 6 of treatment. Clinical benefit has not yet been established.[Label]\\r\\n\\r\\n**Important notes regarding Staphylococcus and Sensitivity testing:**\\r\\n\\r\\nStaphylococcus aureus, including methicillin-resistant strains, is the principal Gram-positive organism sensitive to amikacin.\\r\\nThe use of amikacin in the treatment of staphylococcal infections should be restricted only to second-line therapy, and should be limited to only those patients suffering from severe infections caused by susceptible strains of staphylococcus species who have failed to show sensitivity to other available antibiotics.[F1949]\\r\\n\\r\\nBacteriologic studies should be performed to identify causative organisms and their susceptibilities to amikacin. Amikacin may be used as initial therapy in suspected gram-negative infections and therapy may be initiated before obtaining the results of susceptibility testing.[Label,F1949,F1954]',\n",
       " 'Lenalidomide is indicated for the treatment of adult patients with multiple myeloma (MM) in combination with dexamethasone. It is also indicated as maintenance therapy in multiple myeloma following autologous hematopoietic stem cell transplantation (auto-HSCT).\\r\\n\\r\\nIt is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.\\r\\n\\r\\nLenalidomide is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.\\r\\n\\r\\nIn combination with a rituximab product, lenalidomide is indicated for the treatment of adult patients with previously treated follicular lymphoma (FL) or previously treated marginal zone lymphoma (MZL).[L16028]',\n",
       " 'Indicated for the prevention and treatment of osteoporosis in postmenopausal women, as well as prevention and treatment of corticosteroid-induced bone loss.[label]\\r\\n\\r\\nIndicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis or postmenopausal women with a high risk for invasive breast cancer.[label]',\n",
       " 'Celecoxib is indicated for symptomatic treatment of adult osteoarthritis (OA) and adult rheumatoid arthritis (RA).[L7646] Celecoxib is not a substitute for aspirin for cardiovascular event prophylaxis.[L7646] \\r\\n\\r\\nIt may be also be used to treat acute pain from various sources, juvenile rheumatoid arthritis in children over 2, ankylosing spondylitis, and primary dysmenorrhea.[L7646]\\r\\n\\r\\nCelecoxib, in combination with [tramadol], is indicated for the management of acute pain in adults severe enough to require an opioid analgesic and in whom alternative treatments are inadequate.[L38949]',\n",
       " 'For use as adjuncts to anesthesia to induce skeletal muscle relaxation and to facilitate the management of patients undergoing mechanical ventilation',\n",
       " '**Opthalmic**\\r\\n\\r\\nIndicated for lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension [label] as monotherapy or combination product with [brinzolamide].\\r\\n\\r\\n**Topical**\\r\\n\\r\\nIndicated for the treatment of persistent (non-transient) facial erythema of rosacea in adults 18 years of age or older.[L6535]',\n",
       " 'Used to treat infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.',\n",
       " 'Nabilone is indicated for the treatment of the nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. This restriction is required because a substantial proportion of any group of patients treated with Nabilone can be expected to experience disturbing psychotomimetic reactions not observed with other antiemetic agents.',\n",
       " 'For the treatment of uncomplicated gonococcal urethritis in males and for gram-negative-bacterial infections in the gastrointestinal system and the genitourinary tract.',\n",
       " 'For use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination.',\n",
       " 'Sotalol is indicated to treat life threatening ventricular arrhytmias and maintain normal sinus rhythm in patients with atrial fibrillation or flutter.[Label] There are also oral solutions and intravenous injections indicated for patients requiring sotalol, but for whom a tablet would not be appropriate.[Label,L6373,L6376]',\n",
       " 'Indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.[L4478]',\n",
       " 'For use as an adjunct to diet to improve glycemic control in patients with non-insulin-dependent diabetes mellitus (NIDDM) whose hyperglycemia cannot be managed with diet alone.',\n",
       " 'For treating mild to moderate hypertension, use as an adjunct in treating congestive heart failure, and may be used to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. ',\n",
       " 'Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.',\n",
       " 'Used as an adjunct to levodopa / carbidopa in the symptomatic treatment of patients with idiopathic Parkinson\\'s Disease who experience the signs and symptoms of end-of-dose \"wearing-off\".',\n",
       " 'Used in combination with other antiretroviral agents for the treatment of human immunovirus (HIV) infections.',\n",
       " 'For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.',\n",
       " 'Oxycodone is indicated for the treatment of moderate to severe pain.[Label] There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label]',\n",
       " 'For the treatment of pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, mural thrombosis, and thrombophili. Also used for anticoagulant prophylaxis.',\n",
       " 'For the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate',\n",
       " 'For the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, including the treatment of acute flares long-term management. Also for treatment of juvenile rheumatoid arthritis.',\n",
       " 'Cimetidine is indicated to reduce gastric acid secretion and to treat the following disease states: duodenal ulcers, non-malignant gastric ulcers, gastroesophageal reflux disease, and pathological hypersecretion associated with Zollinger-Ellison Syndrome, systemic mastocytosis, and multiple endocrine adenomas.[L30280] It is indicated for prophylaxis of recurrent gastric or duodenal ulcers, as adjunctive therapy in the management of cystic fibrosis in children, and to treat NSAID induced lesions and gastrointestinal symptoms.[L30280]',\n",
       " 'Haloperidol is indicated for a number of conditions including for the treatment of schizophrenia, for the manifestations of psychotic disorders, for the control of tics and vocal utterances of Tourettes Disorder in children and adults, for treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). Haloperidol is also indicated in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. Haloperidol should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics.[F4645]',\n",
       " 'Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.[L3513, L12357, L11163, L13443]\\r\\n\\r\\nIn the US, Europe, and Canada, ritonavir, in combination with [nirmatrelvir], is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.[L46586, L39840] In Europe, this therapeutic indication is approved under conditional marketing authorization.[L40089]',\n",
       " 'For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids.',\n",
       " 'Used as an adjunct in the treatment of peptic ulcer disease and in Acquired nystagmus',\n",
       " 'For the treatment of diarrhea in adults and children caused by the protozoa <i>Giardia lamblia</i>,  and for the treatment of diarrhea in children caused by the protozoan,  <i>Cryptosporidium parvum</i> [FDA label].\\r\\n\\r\\nNitazoxanide has not been shown to be superior to placebo medication for the management of diarrhea caused by Cryptosporidium parvum in patients with HIV/immunodeficiency [FDA label, A31973, A31976]. ',\n",
       " 'Used mainly in the management of psychoses. Also used to control nausea and vomiting.',\n",
       " 'Used to lower high cholesterol levels in the blood.',\n",
       " 'Used for fast digitalization in congestive heart failure.',\n",
       " 'Administered intravenously, vancomycin is indicated in adult and pediatric patients for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections.[L41529] Administered orally, vancomycin is indicated in adult and pediatric patients for the treatment of _Clostridium difficile_-associated diarrhea and for enterocolitis caused by _Staphylococcus aureus_ (including methicillin-resistant strains).[L41534]',\n",
       " 'For use in the treatment of excessive postoperative bleeding.',\n",
       " 'Dextromethorphan is indicated in combination with [brompheniramine] and [pseudoephedrine] in the treatment of coughs and upper respiratory symptoms associated with allergies or the common cold.[L14366] Dextromethorphan is also used in combination with [guaifenesin] as an over-the-counter product to relieve a cough.[L14369] Dextromethorphan in combination with [quinidine] is indicated in the treatment of pseudobulbar affect.[L14363]',\n",
       " 'For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.',\n",
       " 'Used to prevent or reduce the severity of allergic contact dermatitis due to urushiol, the allergenic resin of poison ivy, poison oak, and poison sumac.',\n",
       " 'For use in conjunction with antacids or histamine H<sub>2</sub>-receptor antagonists in the treatment of peptic ulcer, to reduce further gastric acid secretion and delay gastric emptying.',\n",
       " 'For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, <i>Taenia solium</i> and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, <i>Echinococcus granulosus</i>.',\n",
       " 'For the treatment of mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure (CHF), to improve survival following myocardial infarction (MI) in individuals who are hemodynamically stable and demonstrate symptoms of left ventricular systolic dysfunction or signs of CHF within a few days following acute MI, and to slow progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy. ',\n",
       " 'For the treatment of esophageal candidiasis and invasive aspergillosis in patients who are refractory to or intolerant of other therapies.',\n",
       " 'For the treatment of intraocular hypertension and chronic open-angle glaucoma',\n",
       " 'Indicated as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy.',\n",
       " \"For topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.\",\n",
       " 'For the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class.',\n",
       " \"Tolnaftate topical is used to treat skin infections such as athlete's foot, jock itch, and ringworm infections. Tolnaftate is also used, along with other antifungals, to treat infections of the nails, scalp, palms, and soles of the feet. The powder and powder aerosol may be used to prevent athlete's foot.\",\n",
       " 'Oxaliplatin, in combination with infusional fluorouracil and leucovorin, is indicated for the treatment of advanced colorectal cancer and adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.[L47206]',\n",
       " 'For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.',\n",
       " \"For the treatment of Hypertension, management of angina pectoris and Raynaud's syndrome\",\n",
       " 'For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients.',\n",
       " 'Erlotinib is indicated for:\\r\\n\\r\\n- The treatment of metastatic non-small cell lung cancer (NSCLC) with tumors showing epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations [FDA label]. \\r\\n\\r\\n- In combination with first-line treatment for patients diagnosed with locally advanced, unresectable or metastatic pancreatic cancer [FDA label].\\r\\n\\r\\nThe safety and efficacy of erlotinib have not been established for patients with NSCLC whose tumors show other EGFR mutations. Additionally it is not recommended for use in combination with platinum-based chemotherapy. [FDA label]',\n",
       " 'Cyclophosphamide is indicated for the treatment of malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides (advanced disease), neuroblastoma (disseminated disease), adenocarcinoma of the ovary, retinoblastoma, and carcinoma of the breast. It is also indicated for the treatment of biopsy-proven minimal change nephrotic syndrome in pediatric patients. ',\n",
       " 'For the treatment of refractory partial epilepsy.',\n",
       " 'For the treatment of osteoarthritis, rheumatoid arthritis, acute pain in adults, and primary dysmenorrhea, as well as acute treatment of migraine attacks with or without auras.',\n",
       " 'Previously used as a diuretic. The radiolabeled form has been used as a diagnostic and research tool.',\n",
       " 'Cefdinir is indicated to treat acute bacterial otitis media, acute maxillary sinusitis, community-acquired (CA) pneumonia, acute bacterial exacerbations of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections in children and adults.[L7330,A180739]\\r\\n\\r\\nThe organisms susceptible to cefdinir have been listed below in addition to their associated clinical condition that may be treated with cefdinir.[L7330] Various beta-lactamase producing organisms may be treated, as indicated in certain sections below.\\r\\n\\r\\n**Respiratory**\\r\\nAcute bacterial exacerbations of chronic bronchitis caused by Haemophilus influenzae, Haemophilus parainfluenzae, Streptococcus pneumoniae (penicillin-susceptible only), and Moraxella catarrhalis\\r\\n\\r\\nCommunity-acquired pneumonia caused by Haemophilus influenzae, Haemophilus parainfluenzae, Streptococcus pneumoniae (penicillin-susceptible only), and Moraxella catarrhalis\\r\\n\\r\\n**Ear, nose, and throat** \\r\\nAcute bacterial otitis media caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae (penicillin-susceptible only)\\r\\n\\r\\nTonsillitis caused by Streptococcus pyogenes\\r\\n\\r\\nPharyngitis caused by Streptococcus pyogenes\\r\\n\\r\\nAcute maxillary sinusitis caused by Haemophilus pneumoniae and Streptococcus pneumoniae (penicillin-susceptible only), and Moraxella catarrhalis\\r\\n\\r\\n**Skin and skin structure infections**\\r\\n\\r\\nUncomplicated skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes',\n",
       " 'For the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of Eaton-Lambert. It is not indicated for treating myasthenia gravis.',\n",
       " 'Ciprofloxacin is only indicated in infections caused by susceptible bacteria.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493]\\r\\n\\r\\nCiprofloxacin immediate release tablets, oral suspensions, and intravenous injections are indicated for the treatment of skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, nosocomial pneumonia, febrile neutropenia, adults who have inhaled anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections including acute exacerbations of chronic bronchitis, urinary tract infections, complicated urinary tract infections in pediatrics, complicated pyelonephritis in pediatrics, and acute sinusitis.[L6481,L6478]\\r\\n\\r\\nA ciprofloxacin otic solution and otic suspension with hydrocortisone are indicated for acute otitis externa.[L6469,L6484] Ciprofloxacin suspension with dexamethasone is indicated for acute otitis media in pediatric patients with tympanostomy tubes or acute otitis externa.[L6490] A ciprofloxacin intratympanic injection is indicated for pediatric patients with bilateral otitis media with effusion who are having tympanostomy tubes placed or pediatric patients 6 months or older with acute otitis externa.[L6493]\\r\\n\\r\\nA ciprofloxacin eye drop is indicated for bacterial corneal ulcers and conjunctivitis.[L6472] A ciprofloxacin eye ointment is indicated for bacterial conjunctivitis.[L6475]\\r\\n\\r\\nA ciprofloxacin extended release tablet is indicated for uncomplicated urinary tract infections, complicated urinary tract infections, and acute uncomplicated pyelonephritis.[L6487]',\n",
       " 'Gadoversetamide is an MRI contrast agent used for MRI diagnostic procedures to provide increased enhancement and visualization of lesions of the brain, spine and liver, including tumors.',\n",
       " 'For the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive or receptor-unknown tumors. Toremifene is currently under investigation as a preventative agent for prostate cancer in men with high-grade prostatic intraepithelial neoplasia and no evidence of prostate cancer.',\n",
       " 'Nortriptyline is indicated for the relief of the symptoms of major depressive disorder (MDD).[L11878] Some off-label uses for this drug include treatment of chronic pain, myofascial pain, neuralgia, and irritable bowel syndrome.[A191083,L11878]',\n",
       " \"Treatment of acute lymphocytic leukemia (ALL), Hodgkin lymphoma, non-Hodgkin lymphomas, Wilms' tumor, neuroblastoma, rhabdomyosarcoma. Liposomal vincristine is indicated for the treatment of relapsed Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL). \",\n",
       " 'Benazepril is indicated for the treatment of hypertension[A840]. It may be used alone or in combination with thiazide diuretics[FDA Label].',\n",
       " 'For the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions. May also be used to treat depression accompanied by anxiety or agitation.',\n",
       " 'For the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in the palliative management of some types of cancer, including colon, esophageal, gastric, rectum, breast, biliary tract, stomach, head and neck, cervical, pancreas, renal cell, and carcinoid.',\n",
       " 'Pyridostigmine is indicated for the treatment of myasthenia gravis.[L32408] When administered intravenously, it is indicated for the reversal or antagonism of the neuromuscular blocking effects of nondepolarizing muscle relaxants.[L32413]\\r\\n\\r\\nPyridostigmine has also been used as a prophylactic agent against irreversible organophosphorus acetylcholinesterase inhibitors, primarily in a military capacity.[L32418]',\n",
       " 'For the treatment of anxiety and status epilepticus.',\n",
       " 'For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.',\n",
       " 'For the topical treatment of mild-to-moderate inflammatory acne vulgaris.',\n",
       " 'For the prophylaxis and chronic treatment of asthma.',\n",
       " \"Used to manage hyperthyroidism which is due to an overactive thyroid gland (Grave's disease).\",\n",
       " 'Used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections.',\n",
       " 'For the treatment of hairy cell leukaemia refractory to alpha interferon.',\n",
       " 'For the treatment of psoriasis and vitiligo',\n",
       " 'For treatment of osteoarthritis and rheumatoid arthritis.',\n",
       " 'Lamotrigine is indicated as adjunctive therapy for the following seizure types in patients 2 years of age: partial seizures, primary generalized tonic-clonic seizures, and generalized seizures due to Lennox-Gastaut syndrome.[L9404]\\r\\n\\r\\nIt is also indicated for the process of conversion to drug monotherapy for those at least 16 years of age or older with partial seizures and currently are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED).[L9404]\\r\\n\\r\\nIn addition to the above, lamotrigine is also indicated for the maintenance treatment of bipolar I disorder, delaying the time to mood episodes (which may include mania, hypomania, depression, mixed episodes) in adults at least 18 years or older, who have been treated for acute mood symptoms with standard therapy.[L9404]\\r\\n\\r\\nLimitations of use\\r\\n\\r\\nIt is important to note that lamotirigine should not be used in the treatment of acute mood episodes, as efficacy has not been established in this context.[L9404]',\n",
       " 'Used as an ultrasound contrast imaging in cardiology and radiology.',\n",
       " 'Hydroxyzine is indicated for the symptomatic relief of anxiety and tension associated with psychoneuroses, and as an adjunct in organic disease states in which anxiety is manifested.[L9677] It is also indicated in the treatment of histamine-mediated pruritus and pruritus due to allergic conditions such as chronic urticaria.[L9677]\\r\\n\\r\\nCanadian labeling states that hydroxyzine is also indicated in adults and children as a premedication prior to medical procedures, such as dental surgery.[L9680] It is also used in the control of nausea and vomiting, excluding nausea and vomiting of pregnancy.[L9680]',\n",
       " 'For the prevention and treatment of influenza A and B.',\n",
       " 'Used in the treatment of pulmonary arterial hypertension (PAH), to improve exercise ability and to decrease the rate of clinical worsening (in patients with WHO Class III or IV symptoms).',\n",
       " 'For the treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: Complicated skin and skin structure infections caused by <i>Escherichia coli</i>, <i>Enterococcus faecalis</i> (vancomycin-susceptible isolates only), <i>Staphylococcus aureus</i> (methicillin-susceptible and -resistant isolates), <i>Streptococcus agalactiae</i>, <i>Streptococcus anginosus</i> grp. (includes <i>S. anginosus</i>, <i>S. intermedius</i>, and <i>S. constellatus</i>), <i>Streptococcus pyogenes</i> and <i>Bacteroides fragilis</i>. Complicated intra-abdominal infections caused by <i>Citrobacter freundii</i>, <i>Enterobacter cloacae</i>, <i>Escherichia coli</i>, <i>Klebsiella oxytoca</i>, <i>Klebsiella pneumoniae</i>, <i>Enterococcus faecalis</i> (vancomycin-susceptible isolates only), <i>Staphylococcus aureus</i> (methicillin-susceptible isolates only), <i>Streptococcus anginosus</i> grp. (includes <i>S. anginosus</i>, <i>S. intermedius</i>, and <i>S. constellatus</i>), <i>Bacteroides fragilis</i>, <i>Bacteroides thetaiotaomicron</i>, <i>Bacteroides uniformis</i>, <i>Bacteroides vulgatus</i>, <i>Clostridium perfringens</i>, and <i>Peptostreptococcus micros</i>.',\n",
       " 'For use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.',\n",
       " 'For the treatment of high blood pressure and management of edema.',\n",
       " \"Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis.[L7144] Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis.[L7147,L7150,L10457] It has also been approved by the EMA for the treatment of adult patients requiring systemic therapy for moderate-to-severe plaque psoriasis.[L48796]\\r\\n\\r\\nOther formulations are indicated to treat gestational choriocarcinoma, chorioadenoma destruens, hydatiform mole, breast cancer, epidermoid cancer of the head and neck, advanced mycosis fungoides, lung cancer, and advanced non-Hodgkin's lymphoma.[L7180] It is also used in the maintenance of acute lymphocytic leukemia.[L7180] Methotrexate is also given before treatment with leucovorin to prolong relapse-free survival following surgical removal of a tumour in non-metastatic osteosarcoma.[L7180]\",\n",
       " 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]',\n",
       " 'Cisatracurium is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and pediatric patients 1 month to 12 years of age. Cisatracurium is also indicated to provide skeletal muscle relaxation during surgery in adults and pediatric patients 2 to 12 years of age as a bolus or infusion maintenance and for mechanical ventilation in the ICU in adults.[L43577]',\n",
       " 'For the treatment of lead poisoning in pediatric patients with blood lead levels above 45 &micro;g/dL. May also be used to treat mercury or arsenic poisoning.',\n",
       " 'Cephalexin is indicated for the treatment of certain infections caused by susceptible bacteria.[Label,L6550,L6553] These infections include respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections.[Label,L6550,L6553]',\n",
       " \"For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.\",\n",
       " 'Approved for: (1) prophylaxis of VTE for up to one month post surgery in patients undergoing orthopedic surgery of the lower limbs such as hip fracture, hip replacement and knee surgery; (2) prophylaxis of VTE patients undergoing abdominal surgery who are at high risk of thromboembolic complications (e.g. patients undergoing abdominal cancer surgery); (3) treatment of acute DVT and PE; (4) management of UA and NSTEMI for the prevention of death and subsequent myocardial infarction (MI); and (5) management of STEMI for the prevention of death and myocardial reinfarction in patients who are managed with thrombolytics or who are initially to receive no form of reperfusion therapy. Fondaparinux should not be used as the sole anticoagulant during percutaneous coronary intervention (PCI) due to an increased risk of guiding catheter thrombosis. ',\n",
       " \"For treatment of breast cancer, testicular cancer, lymphomas, neuroblastoma, Hodgkin's and non-Hodgkin's lymphomas, mycosis fungoides, histiocytosis, and Kaposi's sarcoma.\",\n",
       " 'Propranolol is indicated to treat hypertension.[L6907,L6904] Propranolol is also indicated to treat angina pectoris due to coronary atherosclerosis, atrial fibrillation, myocardial infarction, migraine, essential tremor, hypertrophic subaortic stenosis, pheochromocytoma, and proliferating infantile hemangioma.[L6904,L6907]',\n",
       " 'The intravenous, intramuscular, subcutaneous, intraosseous and endotracheal use of atropine is indicated for the temporary blockade of severe or life-threatening muscarinic effects.[L42815,L42835] The intramuscular use of atropine in the form of a pen injector is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having cholinesterase activity as well as organophosphorus or carbamate insecticides in adult and pediatric patients.[L42825] The ophthalmic use of atropine is indicated for mydriasis, cycloplegia, and penalization of the healthy eye in the treatment of amblyopia.[L42830] \\r\\n\\r\\nIn combination with difenoxin or diphenoxylate (tablets for oral use), atropine is indicated as adjunctive therapy in the management of acute nonspecific diarrhea.[L42840,L42865]',\n",
       " 'For relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain.',\n",
       " 'Fenfluramine is indicated for the treatment of seizures associated with Dravet syndrome and  Lennox-Gastaut syndrome in patients aged two years and older.[L14522]',\n",
       " 'Clonidine tablets and transdermal systems are indicated for the treatment of hypertension alone or in combination with other medications.[L7237,L7240] A clonidine injection is indicated for use with opiates in the treatment of severe cancer pain where opiates alone are insufficient.[L7243] An extended release tablet of clonidine is indicated for the treatment of ADHD either alone or in combination with other medications.[L7246]\\r\\n\\r\\nClonidine is also used for the diagnosis of pheochromocytoma,[A180565] treatment of nicotine dependance,[A180568] and opiate withdrawal.[A180571]',\n",
       " 'For the treatment of urinary tract infection',\n",
       " 'Valacyclovir is a nucleoside analog DNA polymerase inhibitor indicated for [FDA label]: \\r\\n\\r\\n**Adults**\\r\\n\\r\\n Cold Sores (Herpes Labialis)\\r\\n\\r\\n Genital Herpes\\r\\n\\r\\n Treatment of genital herpes lesions in immunocompetent patients (initial or recurrent episode)\\r\\n\\r\\n Suppression of genital herpes lesions in immunocompetent or HIV-infected patients\\r\\n\\r\\n Reduction of viral transmission\\r\\n\\r\\n Herpes Zoster\\r\\n\\r\\n**Pediatric Patients** \\r\\n\\r\\n Cold Sores (Herpes Labialis)\\r\\n\\r\\n Chickenpox \\r\\n\\r\\n\\r\\n\\r\\n**Limitations of use** [FDA label]\\r\\n\\r\\nThe efficacy and safety of valacyclovir have not been established in immunocompromised patients other than for the suppression of genital herpes in HIV-infected patients.\\r\\n',\n",
       " 'For the treatment of acute and chronic infections of the upper and lower urinary tract and in asymptomatic bacteriuria due to susceptible strains of bacteria.',\n",
       " 'Used in short-term (a few weeks) treatment of exogenous obesity in conjunction with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in patients with a body mass index of 30 kg of body weight per height in meters squared (kg/m<sup>2</sup>) or in patients with a body mass index of 27 kg/m<sup>2</sup> in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.',\n",
       " 'For the treatment of osteoarthritis and dysmenorrhoea',\n",
       " 'Lactulose is indicated for use as a laxative in the treatment of chronic constipation in adults and geriatric patients.[FDA Label,L6199,L6202]\\r\\n\\r\\nAdditionally, lactulose is also employed as an adjunct to protein restriction and supportive therapy for the prevention and treatment of portal-systemic encephalopathy (PSE), including both the hepatic pre-coma and coma variations.[FDA Label,L6199,L6202] In particular, lactulose solution has been effective at managing PSE resulting from surgical portacaval shunts or from chronic hepatic diseases like cirrhosis.[L6199]\\r\\n\\r\\nMoreover, there have also been studies demonstrating the capacity for lactulose to minimize the formation of gallstones and even some investigations regarding the experimental use of the agent in developing novel anticancer agents owing to its ability to bind galactin carbohydrates involved in various tumor progressions [L6202].',\n",
       " 'For the treatment of esophageal candidiasis, cadidemia, invasive pulmonary aspergillosis, and serious fungal infections caused by <i>Scedosporium apiospermum</i> and <i>Fusarium</i> spp.[L9821, L15571] ',\n",
       " 'For treatment of primary systemic carnitine deficiency, a genetic impairment of normal biosynthesis or utilization of levocarnitine from dietary sources, or for the treatment of secondary carnitine deficiency resulting from an inborn error of metabolism such as glutaric aciduria II, methyl malonic aciduria, propionic acidemia, and medium chain fatty acylCoA dehydrogenase deficiency. Used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. Parenteral levocarnitine is indicated for the prevention and treatment of carnitine deficiency in patients with end-stage renal disease.',\n",
       " 'Indicated for the management of essential or renovascular hypertension [L6586] as monotherapy or in combination with other antihypertensive agents, such as thiazide diuretics, for an additive effect.[label]\\r\\n\\r\\nIndicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis.[label]\\r\\n\\r\\nIndicated for the management of asymptomatic left ventricular dysfunction in patients with an ejection fraction of  to 35 percent to decrease the rate of development of overt heart failure and the incidence of hospitalization for heart failure.[label]',\n",
       " 'For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.',\n",
       " 'Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. It is often used in combination with [misoprostol] as a gastro-protective agent in patients with high risk of developing NSAID-induced ulcers.',\n",
       " 'For Protection against second- phase inflamation in exercise-induced bronchoconstriction and Asthma.',\n",
       " 'Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxis[FDA Label]as well as inflammatory and pruritic dermatoses[F4355]. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis[L8309,F4358].',\n",
       " \"For the management of Parkinson's Disease\",\n",
       " 'Doxazosin is indicated to treat the symptoms of benign prostatic hypertrophy, which may include urinary frequency, urgency, and nocturia, among other symptoms. In addition, doxazosin is indicated alone or in combination with various antihypertensive agents for the management of hypertension.[L7282] Off-label uses of doxazosin include the treatment of pediatric hypertension[A180634] and the treatment of ureteric calculi.[A180637]',\n",
       " 'Fluocinolone acetonide has been used extensively in different medical areas.\\r\\n\\r\\n-In dermatology, it is extensively used for the relief of inflammatory dermatosis, dermatitis, psoriasis, hypertrophic tissues, keloid tissues and atopic dermatitis.[F1955]\\r\\n\\r\\n-It has been used in shampoo products as a low to medium potency corticosteroid for the treatment of seborrheic dermatitis of the scalp.[L4682]\\r\\n\\r\\n-In ear drops, it is used as a low to medium potency corticosteroid for the treatment of chronic eczematous external otitis in adults and pediatric patients 2 years and older.[L4683]\\r\\n\\r\\n-As an intravitreal implant, it is indicated for the treatment of diabetic macular edema with patients that have been previously treated with a course of corticosteroids and no clinically significant rise in intraocular pressure.[L4684]\\r\\n\\r\\n-Fluocinolone acetonide was announced on October 15, 2018 to be FDA approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.[L4685]\\r\\n\\r\\n-Some reports have indicated the use of fluocinolone acetonide as a vasoprotective agent and for its use in the treatment of first-degree hemorrhoids.[A39532]',\n",
       " 'Used as alternative treatment for ascariasis caused by <i>Ascaris lumbricoides</i> (roundworm) and enterobiasis (oxyuriasis) caused by <i>Enterobius vermicularis</i> (pinworm). It is also used to treat partial intestinal obstruction by the common roundworm, a condition primarily occurring in children.',\n",
       " 'For the treatment of petit mal epilepsy.',\n",
       " 'For use as adjunctive treatment with thiazide diuretics or other kaliuretic-diuretic agents in congestive heart failure or hypertension.',\n",
       " 'Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including <i>Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae</i> (respiratory infections), and <i>Diplococcus pneumoniae</i>.',\n",
       " 'Ulobetasol cream and ointment are indicated in the treatment of inflammatory and pruritic corticosteroid responsive dermatoses.[L15047] Ulobetasol lotion is indicated in the treatment of plaque psoriasis.[L15052]',\n",
       " 'Gadoteridol is indicated for use with magnetic resonance imaging (MRI) in order to visualize lesions with disrupted blood-brain barrier and/or abnormal vascularity in the brain, spine, and associated tissues in adult and pediatric patients, including term neonates.[L49871] It is also indicated for visualization of lesions in the head and neck in adult patients.[L49871]',\n",
       " 'Labetalol injections are indicated to control blood pressure in severe hypertension.[L7727] Labetalol tablets are indicated alone or in combination with antihypertensives like thiazides and loop diuretics to manage hypertension.[L7730]',\n",
       " 'For use as the sole anesthetic agent for brief (15 minute) procedures, for induction of anesthesia prior to administration of other anesthetic agents, to supplement regional anesthesia, to provide hypnosis during balanced anesthesia with other agents for analgesia or muscle relaxation, for the control of convulsive states during or following inhalation anesthesia or local anesthesia, in neurosurgical patients with increased intracranial pressure, and for narcoanalysis and narcosynthesis in psychiatric disorders.',\n",
       " 'Used topically to treat the loss of skin color (vitiligo).',\n",
       " 'Linezolid is indicated in adults and children for the treatment of infections caused by susceptible Gram-positive bacteria, including nosocomial pneumonia, community-acquired pneumonia, skin and skin structure infections, and vancomycin-resistant _Enterococcus faecium_ infections.[L32965] Examples of susceptible bacteria include _Staphylococcus aureus_, _Streptococcus pneumoniae_, _Streptococcus pyogenes_, and _Streptococcus agalactiae_.[L32965]\\r\\n\\r\\nLinezolid is not indicated for the treatment of Gram-negative infections, nor has it been evaluated for use longer than 28 days.[L32965]',\n",
       " 'Administered topically, ivermectin cream is indicated for the treatment of inflammatory lesions associated with rosacea.[L36753] An over-the-counter ivermection lotion is commercially available and indicated for the topical treatment of head lice infestations in patients 6 months of age.[L36748]\\r\\n\\r\\nOrally administered ivermectin is indicated as a broad-spectrum anti-parasitic for the treatment of intestinal strongyloidiasis caused by _Strongyloides stercoralis_ and onchocerciasis caused by _Onchocerca volvulus_.[L31453] Systemic ivermectin therapy is used internationally for the treatment of various tropical diseases, including filariasis, cutaneous larva migrans, and _Loa loa_ infection, amongst others.[A238298]',\n",
       " 'Medroxyprogesterone acetate (MPA) oral tablets are indicated to treat secondary amenorrhea, reduce the incidence of endometrial hyperplasia in postmenopausal women, and to treat abnormal uterine bleeding due to hormonal imbalance, not organic pathology.[L8657] Oral tablets containing MPA and conjugated estrogens are indicated to prevent postmenopausal osteoporosis and to treat moderate to severe menopausal symptoms such as vasomotor symptoms, vulvar atrophy, and vaginal atrophy.[L8660] Subcutaneous MPA is indicated to prevent pregnancy and manage pain associated with endometriosis.[L8663] Intramuscular MPA is indicated to prevent pregnancy,[L8666] and at higher concentrations for palliative treatment of endometrial or renal carcinoma.[L8669]',\n",
       " 'For the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease.',\n",
       " 'For acute or long-term use in the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis), and acute gouty arthritis.',\n",
       " 'Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.',\n",
       " 'Indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. ',\n",
       " 'Chloroquine is indicated to treat infections of _P. vivax_, _P. malariae_, _P. ovale_, and susceptible strains of _P. falciparum_.[L12051] It is also used to treat extraintestinal amebiasis.[L12051]\\r\\n\\r\\nChloroquine is also used off label for the treatment of rheumatic diseases,[A191655] as well as treatment and prophylaxis of Zika virus.[A191649,A191652] Chloroquine is currently undergoing clinical trials for the treatment of COVID-19.[A191631]',\n",
       " 'For use in the treatment of pulmonary and extrapulmonary tuberculosis when other antitubercular drugs have failed.',\n",
       " 'For the treatment and prevention of hypotension due to hemorrhage, spinal anesthesia, and shock associated with brain damage',\n",
       " 'For the relief of moderate to severe pain.',\n",
       " 'Bisoprolol is indicated for the treatment of mild to moderate hypertension.[L7219] It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.[A180460,A180463]',\n",
       " 'For treatment of acute malarial attacks in non-immune subjects.',\n",
       " 'For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.',\n",
       " 'For the prevention of disseminated <i>Mycobacterium avium</i> complex (MAC) disease in patients with advanced HIV infection.',\n",
       " None,\n",
       " 'Used for the control of absence (petit mal) seizures that are refractory to treatment with other medications.',\n",
       " 'Used primarily to treat Lyme disease, acne, and bronchitis. Also indicated (but rarely used) to treat urinary tract infections, gum disease, malaria, and other bacterial infections such as gonorrhea and chlamydia. One of its other registered uses is the treatment of hyponatremia (low blood sodium concentration) due to the syndrome of inappropriate antidiuretic hormone (SIADH) where fluid restriction alone has been ineffective. ',\n",
       " 'Imatinib is indicated for the treatment of adult and pediatric chronic myeloid leukemia with Philadelphia chromosome mutation (Ph+) in blast crisis, accelerated phase, or chronic phase after IFN-alpha therapy failure.[L42080] Additionally, imatinib is also indicated to treat adult and pediatric Ph+ acute lymphoblastic leukemia, adult myelodysplastic/myeloproliferative diseases, adult aggressive systemic mastocytosis, adult hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), adult dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).[L42080]\\r\\n',\n",
       " 'Triamcinolone hexacetonide injections are indicated for intralesional administration in alopecia areata, discoid lupus erythematosus, keloids, and necrobiosis lipoidica diabeticorum.[L8246] This formulation can also be used for localized hypertrophic infiltrated inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus, and psoriatic plaques.[L8246]\\r\\n\\r\\nTriamcinolone acetonide spray and cream are indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.[L8249,L8258] A triamcinolone acetonide 10mg/mL or 40mg/mL injection is indicated intra-articularly for acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis.[L8252,L8255] The same 10mg/mL injection is indicated by the intralesional route for the treatment of alopecia areata, discoid lupus erythematosus, keloids, necrobiosis lipoidica diabeticorum, and tumors of an aponeurosis or tendon.[L8252] This formulation can also be used for localized hypertrophic infiltrated inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus, and psoriatic plaques.[L8252] The 40mg/mL injection is indicated intramuscularly for controlling severe allergic conditions such as asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity, perennial or seasonal allergic rhinitis, serum sickness, and transfusion reactions; treatment of bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, Stevens-Johnson syndrome, congenital adrenal hyperplasia, hypercalcemia in\\r\\ncancer, nonsuppurative thyroiditis, autoimmune hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, secondary thrombocytopenia, trichinosis, tuberculous meningitis, acute exacerbations of multiple sclerosis or cerebral edema, sympathetic ophthalmia, temporal arteritis, uveitis, ocular inflammation, berylliosis, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis, dermatomyositis, polymyositis, and systemic lupus erythematosus; adjunct treatment of adrenocortical insufficiency, regional enteritis, ulcerative colitis, fulminating or disseminated pulmonary tuberculosis, acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis; palliative management of leukemia and lymphoma; induction of diuresis or remission of proteinuria in idiopathic nephrotic syndrome or lupus erythematosus.[L8255] A triamcinolone intravitreal injection is indicated for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions.[L8261] The intravitreal injection is also used for visualization during vitrectomy.[L8261] An extended release suspension is indicated intra-articularly for management of pain in osteoarthritis of the knee.[L8264]\\r\\n\\r\\nA triamcinolone acetonide suspension for injection into the suprachoroidal space is indicated for the treatment of macular edema associated with uveitis.[L38963]',\n",
       " 'Use to promote weight gain after weight loss following extensive surgery.',\n",
       " 'Used for the management of patients with chronic stable angina and for the treatment of hypertension.',\n",
       " 'For management of manifestations of psychotic disorders.',\n",
       " 'Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]',\n",
       " 'For use in combination treatment of HIV infection (AIDS)',\n",
       " 'Bacitracin is indicated in topical formulations for acute and chronic localized skin infections.[A181997] Occasionally, it is also used intramuscularly for infantile streptococcal pneumonia and empyema.[A181997] Bacitracin is also formulated as an ointment with neomycin and polymyxin B for over the counter use.[A181997,L7769] A bacitracin ointment formulated with neomycin and polymyxin B along with hydrocortisone is indicated for the treatment of corticosteroid responsive dermatoses with secondary infection.[L7772]',\n",
       " 'Niacin is indicated to prevent vitamin deficiencies in pediatric and adult patients receiving parenteral nutrition as part of multivitamin intravenous injections.[L7550,L7553,L7556,L7559] Niacin oral tablets are indicated as a monotherapy or in combination with simvastatin or lovastatin to treat primary hyperlipidemia and mixed dyslipidemia.[L7562,L7565] It can also be used to reduce the risk of nonfatal myocardial infarctions in patients with a history of myocardial infarction and hyperlipidemia.[L7562,L7565] Niacin is also indicated with bile acid binding resins to treat atherosclerosis in patients with coronary artery disease and hyperlipidemia or to treat primary hyperlipidemia.[L7562,L7565] Finally niacin is indicated to treat severe hypertriglyceridemia.[L7562,L7565]',\n",
       " 'Clorazepate is indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. It is also used as adjunctive therapy in the management of partial seizures and for the symptomatic relief of acute alcohol withdrawal.[L44788]',\n",
       " 'For management of High blood pressure',\n",
       " \"Alendronic acid is indicated for the treatment and prevention of osteoporosis in men and postmenopausal women, treatment of glucocorticoid-induced osteoporosis, and Paget's disease of bone[FDA Label][A959,A176750]. However, alendronic acid is not indicated for use in pediatric populations or patients with a creatinine clearance <35mL/min[FDA Label].\",\n",
       " 'For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphocytic (lymphoblastic) leukemia after at least two prior regimens. It is designated as an orphan drug by the FDA for this use.',\n",
       " 'For the topical treatment of recurrent oral-facial herpes simplex episodes (cold sores or fever blisters).',\n",
       " 'Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures.[L41374] It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.[L41379]',\n",
       " 'For the treatment of bacterial vaginitis, keratitis, acute conjunctivitis, and blepharitis.',\n",
       " 'Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.[L10502]',\n",
       " 'For Primary Dysbetalipoproteinemia (Type III hyperlipidemia) that does not respond adequately to diet. This helps control high cholesterol and high triglyceride levels. ',\n",
       " 'Astemizole was indicated for use in the relieving allergy symptoms, particularly rhinitis and conjunctivitis. It has been withdrawn from the market however due to concerns of arrhythmias.',\n",
       " 'Historically used in an important medical test of renal function, specifically a measure of glomerular filtration rate. Sometimes used to help relieve symptoms of diabetes mellitus - a condition characterised by hyperglycemia and/or hyperinsulinemia.',\n",
       " 'For the local treatment of vulvovaginal candidiasis (infections caused by Candida)',\n",
       " 'Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy in patients unable to adequately exercise.[L31983] It is also indicated to convert sinus rhythm of paroxysmal supraventricular tachycardia.[L31998]',\n",
       " 'Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLC), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).[F4655, F4658]\\r\\n\\r\\nThis includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH).[F4655, F4658]\\r\\n\\r\\nSimvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease.[F4655, F4658]\\r\\n\\r\\nPrescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]',\n",
       " 'Pemetrexed is indicated for the treatment of the following conditions:\\r\\n\\r\\n**Non-squamous non-small cell lung cancer (NSCLC)**\\r\\n\\r\\n- in combination with [pembrolizumab] and platinum-based chemotherapy as initial treatment in metastatic disease where no EGFR or ALK genomic tumour aberrations exist [L40943]\\r\\n- in combination with [cisplatin] as initial treatment for locally advanced or metastatic disease [L40943,L44883]\\r\\n- as maintenance treatment for locally advanced or metastatic disease that has not progressed following four cycles of platinum-based chemotherapy [L40943,L44883]\\r\\n- recurrent metastatic disease following prior chemotherapy [L40943]\\r\\n- as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer [L44883]\\r\\n\\r\\n**Malignant pleural mesothelioma**\\r\\n\\r\\n- in combination with [cisplatin] for the initial treatment of patients with malignant pleural mesothelioma.[L40943,L44883] In the US, it is reserved for patients whose disease is unresectable or otherwise not candidates for curative surgery.[L40943]',\n",
       " 'For the treatment of <i>Enterobius vermicularis</i> (pinworm), <i>Trichuris trichiura</i> (whipworm), <i>Ascaris lumbricoides</i> (common roundworm), <i>Ancylostoma duodenale</i> (common hookworm), <i>Necator americanus</i> (American hookworm) in single or mixed infections.',\n",
       " 'For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.',\n",
       " 'Used to provide topical anesthesia of accessible mucous membranes prior to examination, endoscopy or instrumentation, or other procedures involving the esophagus, larynx, mouth, pharynx or throat, respiratory tract or trachea, urinary tract, or vagina. Also used to suppress the gag reflex and/or other laryngeal and esophageal reflexes to facilitate dental examination or procedures (including oral surgery), endoscopy, or intubation. Also used for relief of canker sores, cold sores or fever blister.',\n",
       " 'Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776]\\r\\n\\r\\nNystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].',\n",
       " 'For the relief of mild to moderate pain.',\n",
       " 'Mitotane is indicated for the treatment of inoperable, functional or nonfunctional, adrenocortical carcinoma.[L49570]',\n",
       " 'For the treatment of human immunovirus (HIV) infections.',\n",
       " 'For the treatment of osteosarcoma (after high dose methotrexate therapy). Used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists, and to treat megaloblastic anemias due to folic acid deficiency. Also used in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.',\n",
       " 'For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema.',\n",
       " 'For the relief of moderate to severe pain.',\n",
       " 'Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.',\n",
       " 'Latanoprost is indicated for the reduction of elevated intraocular pressure in patients who have been diagnosed with open-angle glaucoma or ocular hypertension.[L8357,L8402,L44401] It is available as monotherapy or in a combination product with [netarsudil] [L8369] or [timolol].[L15217]\\r\\n\\r\\nIn Canada, latanoprost is also indicated to treat elevated intraocular pressure due to angle-closure glaucoma that has been treated with peripheral iridotomy or laser iridoplasty.[L8402]',\n",
       " 'For management of perimenopausal and postmenopausal symptoms.',\n",
       " 'Trazodone is indicated for the treatment of major depressive disorder (MDD).[L3484] It has been used off-label for adjunct therapy in alcohol dependence, and off-label to treat anxiety and insomnia.[L3484] It may also be used off-label to treat symptoms of dementia, Alzheimers disease, schizophrenia, eating disorders, and fibromyalgia due to its effects on various neurotransmitter receptors.[A31634]',\n",
       " 'For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension',\n",
       " 'For the control of serum phosphorus in patients with Chronic Kidney Disease (CKD) on hemodialysis.',\n",
       " 'Acamprosate is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. It is also indicated for the maintenance of alcohol abstinence in patients who have undergone alcohol detoxification. This drug should be used with a psychosocial support program providing adequate support.[L31738]',\n",
       " 'For the treatment of painful peripheral musculoskeletal conditions and spasticity from upper motor neuron syndromes.',\n",
       " \"Verapamil is indicated in the treatment of vasopastic (i.e. Prinzmetal's) angina, unstable angina, and chronic stable angina. It is also indicated to treat hypertension, for the prophylaxis of repetitive paroxysmal supraventricular tachycardia, and in combination with digoxin to control ventricular rate in patients with atrial fibrillation or atrial flutter.[L8791] Given intravenously, it is indicated for the treatment of various supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm in patients with supraventricular tachycardia and for temporary control of ventricular rate in patients with atrial fibrillation or atrial flutter.[L10481]\\r\\n\\r\\nVerapamil is commonly used off-label for prophylaxis of cluster headaches.[A13983]\",\n",
       " 'For the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.',\n",
       " 'For the treatment of contact dermatitis, atopic dermatitis, exczema, psoriasis, diaper rash and other skin conditions',\n",
       " 'For the treatment of urinary tract infection and chronic bronchitis.',\n",
       " 'For use in combination with surgical castration for the treatment of metastatic prostate cancer involving distant lymph nodes, bone, or visceral organs (Stage D2).',\n",
       " 'For treatment of central precocious puberty (true precocious puberty, GnRH-dependent precocious precocity, complete isosexual precocity) in children of both sexes and for the treatment of endometriosis.',\n",
       " \"Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.[L41260]\\r\\n\\r\\nEpinephrine's cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes but is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock [F1247].\\r\\n\\r\\nEpinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics [F1247].\\r\\n\\r\\nIn addition to the above, epinephrine is used as an over the counter (OTC) agent for the intermittent symptoms of asthma, such as wheezing, tightness of chest and shortness of breath [F2131].  It is also used for the maintenance of mydriasis during intraocular surgery [L4825].\",\n",
       " 'A combination sumatriptan and [naproxen] tablet is indicated for the treatment of migraines with or without auras in patients 12 years of age and older.[L6793] Sumatriptan nasal powder, nasal spray, subcutaneous injection, and tablets are indicated to treat migraines with or without auras in adults.[L6796,L6799,L6805,L6808,L6811] One of the subcutaneous formulations of sumatriptan is also indicated to treat cluster headaches in adults[L6805], while the other subcutaneous formulation is not.[L6808]',\n",
       " 'For the treatment of peptic ulcer, gastric ulcer, and duodenal ulcer.',\n",
       " 'Cefixime is indicated for the treatment of uncomplicated urinary tract infections caused by _Escherichia coli_ and _Proteus mirabilis_, otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_, and _Streptococcus pyogenes_, pharyngitis and tonsillitis caused by _Streptococcus pyogenes_,  acute exacerbations of chronic bronchitis caused by _Streptococcus pneumoniae_ and _Haemophilus influenzae_, and uncomplicated gonorrhea (cervical/urethral) caused by _Neisseria gonorrhoeae_ (penicillinase-and non-penicillinase-producing isolates).[L49293]',\n",
       " 'For treatment of NIDDM in conjunction with diet and exercise. ',\n",
       " 'For the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including high-dose cisplatin (in combination with other antiemetic agents).',\n",
       " 'Galantamine is indicated for the treatment of mild to moderate dementia of the Alzheimers type.[L13571]',\n",
       " 'Tamoxifen is indicated to treat estrogen receptor positive metastatic breast cancer in adults, as an adjuvant in the treatment of early stage estrogen receptor positive breast cancer in adults, to reduce the risk of invasive breast cancer after surgery and radiation in adult women with ductal carcinoma in situ.[L7802]',\n",
       " 'Used to kill lice and the mites responsible for the skin condition scabies.',\n",
       " 'For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.',\n",
       " 'Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension.[L7423] Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).[L7426,L45663]',\n",
       " 'For the treatment of schizophrenia and generalized anxiety disorder.',\n",
       " 'Used to treat irregular heartbeats (arrhythmias) and maintain a normal heart rate.',\n",
       " 'Used to treat potentially life threatening fungal infections.',\n",
       " '**Indicated** for:[label,L6616]\\r\\n\\r\\n1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism.\\r\\n\\r\\n2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation.\\r\\n\\r\\n3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement.\\r\\n\\r\\n4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction.\\r\\n\\r\\n**Off-label** uses include:\\r\\n\\r\\n1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.[A179182]',\n",
       " 'Midazolam has different indications depending on its formulation by the FDA. \\r\\n\\r\\n**Nasal** \\r\\n\\r\\nFor the nasal spray formulation, midazolam is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 12 years of age and older.[L44773] \\r\\n\\r\\n**Intravenous** \\r\\n\\r\\nFor the intravenous injection formulation, midazolam is indicated as an agent for sedation/anxiolysis/amnesia and prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other CNS depressants.[L12981] The sedative, anxiolytic and amnestic use of midazolam can also be employed pre-operatively.[L12981] It can also be indicated for induction of general anesthesia, before administration of other anesthetic agents or as a component of intravenous supplementation of nitrous oxide and oxygen for a balanced anesthesia.[L12981] A relatively narrower dose range of midazolam and a shorter period of induction can be achieved if midazolam is combined with narcotic premedication.[L12981] Finally, midazolam can be indicated as a continous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a critical care setting.[L12981]\\r\\n\\r\\n**Intramuscular** \\r\\n\\r\\nFor the intramusuclar injection formulation, midazolam is indicated for preoperative sedation/anxiolysis/amnesia or for treatment of status epilepticus in adults.[L12981,L45048]\\r\\n\\r\\n**Oral**\\r\\n\\r\\nMidazolam syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. It is only approved in monitored settings only and not for chronic or home use.[L5092]\\r\\n\\r\\nIn Europe, a buccal formulation of midazolam is also approved for the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.[L45053]\\r\\n',\n",
       " 'Inhaled tobramycin is indicated for the management of cystic fibrosis patients with _Pseudomonas aeruginosa_, but is not recommended in patients under six years of age, those with forced expiratory volume in 1 second (FEV<sub>1</sub>) <25 or >80% predicted, or in those with _Burkholderia cepacia_.[L32739,L45364]\\r\\n\\r\\nTobramycin applied topically to the eyes is indicated for the treatment of external eye (and adjoining structure) infections by susceptible bacteria.[L32744] \\r\\n\\r\\nTobramycin injection is indicated in adult and pediatric patients for the treatment of serious bacterial infections, including septicemia (caused by _P. aeruginosa_, _Escherichia coli_, and _Klebsiella_ spp.), lower respiratory tract infections (caused by _P. aeruginosa_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp., _E. coli_, and _Staphylococcus aureus_, both penicillinase and non-penicillinase-producing strains), serious central-nervous-system infections (meningitis, caused by susceptible organisms), intra-abdominal infections including peritonitis (caused by _E. coli_, _Klebsiella_ spp., and _Enterobacter_ spp.), skin, bone, and skin structure infections (caused by _P. aeruginosa_, _Proteus_ spp., _E. coli_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp. and _S. aureus_), and complicated and recurrent urinary tract infections (caused by _P. aeruginosa_, _Proteus_ spp., _E. coli_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp., _S. aureus_, _Providencia_ spp., and _Citrobacter_ spp.).[L32749] Aminoglycosides, including tobramycin, should generally not be used in uncomplicated urinary tract infections or staphylococcal infections unless less toxic antibiotics cannot be used and the bacteria in question are known to be sensitive to aminoglycosides.[L32749,L45359]\\r\\n\\r\\nAs with all antibiotics, tobramycin use should be limited to cases where bacterial infections are known or strongly suspected to be caused by sensitive organisms, and the possible emergence of resistance should be monitored closely.[L32739,L32744,L32749]',\n",
       " 'For treatment of infections caused by susceptible strains of the designated microorganisms in uncomplicated urethral gonorrhea in males and endocervical and rectal gonorrhea in females caused by <i>Neisseria gonorrhoeae</i> as well as non gonoccocal urethritis and cervicitis due to <i>Chlamydia trachomatis</i>.',\n",
       " 'For the relief of bladder pain or discomfort associated with interstitial cystitis.',\n",
       " \"Fludrocortisone is indicated as partial replacement therapy for primary or secondary adrenocortical insufficiency in Addison's disease. It is also indicated for the treatment of salt-losing androgenital syndrome.[L8971]\",\n",
       " 'Mycophenolate mofetil is indicated in combination with other immunosuppressants to prevent the rejection of kidney, heart, or liver transplants in adult and pediatric patients 3 months old.[L42020] Mycophenolate mofetil may also be used off-label as a second-line treatment for autoimmune hepatitis that has not responded adequately to first-line therapy.[A180814] Other off-label uses of this drug include lupus-associated nephritis and dermatitis in children.[A180817]',\n",
       " 'For treatment of severe infections caused by susceptible bacteria.',\n",
       " 'For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits',\n",
       " 'For the treatment of hypertension.',\n",
       " 'When used intravenously or intramuscularly, phentolamine is used to prevent or control hypertensive episodes that may occur in a patient with pheochromocytoma due to stress or manipulation during preoperative preparation and surgical excision. It is also used to prevent or treat dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. It may be used to diagnose pheochromocytoma by the phentolamine-blocking test.[L48420]\\r\\n\\r\\nSubmucosal injection of phentolamine is indicated for the reversal of soft-tissue anesthesia (e.g. anesthesia of the lip and tongue) and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor in patients three years old and older.[L48415]\\r\\n\\r\\nPhentolamine ophthalmic solution is used to treat pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents.[L48390]',\n",
       " 'For diagnostic imaging. Primarily indicated in diagnostic fluorescein angiography or angioscopy of the fundus and of the iris vasculature.',\n",
       " 'For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.\\r\\n\\r\\nDaunorubicin is indicated in combination with [cytarabine] for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.[L32843]',\n",
       " 'Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.[L7958] \\r\\n\\r\\nOral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.[L9659]\\r\\n\\r\\nIntravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.[L7958]\\r\\n\\r\\nSubcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.[L43408]',\n",
       " 'For use as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called \"histaminic cephalalgia\".',\n",
       " 'Tizanidine is indicated for the relief of muscle spasticity, which can interfere with daily activities.  The general recommendation is to reserve tizanidine use for periods of time when there is a particular need for relief, as it has a short duration of action [FDA label, F4471]. ',\n",
       " 'Nitrofurantoin is indicated to treat acute uncomplicated urinary tract infections.[L6856,L6859,L6862]',\n",
       " 'For the treatment of senile dementia, migraines of vascular origin, transient ischemia, platelet hyper-aggregability, and macular degeneration.',\n",
       " 'For improvement of survival of stable patients with left ventricular systolic dysfunction (ejection fraction <40%) and clinical evidence of congestive heart failure after an acute myocardial infarction.',\n",
       " 'For the treatment of HIV-1 infection in combination with other antiretroviral agents.',\n",
       " 'Used for continuous ambulatory peritoneal dialysis (CAPD) of diabetic patients or automated peritoneal dialysis (APD) for the management of end-stage renal disease.',\n",
       " 'For treatment of chronic open-angle glaucoma and acute angle-closure glaucoma',\n",
       " 'Used as an adjunct to a medically supervised behaviour modification program in the maintenance of opiate cessation in individuals who were formerly physically dependent on opiates and who have successfully undergone detoxification. Also used for the management of alcohol dependence in conjunction with a behavioural modification program.',\n",
       " 'For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents when therapy is warranted',\n",
       " 'Tamsulosin is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.[Label]\\r\\n\\r\\nTamsulosin is also used off label for the treatment of ureteral stones, prostatitis, and female voiding dysfunction.[A178339,L6259]',\n",
       " 'Indicated in the treatment of esophageal cancer.',\n",
       " 'The indications for this drug are as follows:\\r\\n\\r\\n1. As an analgesic adjunct in the maintenance of balanced general anesthesia in patients who are intubated and ventilated.\\r\\n\\r\\n2. As a primary anesthetic agent for the induction and maintenance of anesthesia with 100% oxygen in patients undergoing major surgical procedures, in patients who are intubated and ventilated, such as cardiovascular surgery or neurosurgical procedures in the sitting position, to provide favorable myocardial and cerebral oxygen balance or when extended postoperative ventilation is anticipated.\\r\\n\\r\\n3. For epidural administration as an analgesic combined with low dose (usually 12.5 mg per administration) bupivacaine usually during labor and vaginal delivery \\r\\n\\r\\n4. The sublingual form is indicated for the management of acute pain in adults that is severe to warrant the use of an opioid analgesic in certified medically supervised healthcare settings, including hospitals, surgical centers, and emergency departments.\\r\\n\\r\\n[FDA label]',\n",
       " 'For the treatment of HIV infection and chronic hepatitis B (HBV).',\n",
       " 'For the treatment and prevention of osteoporosis in postmenopausal women.[L13805,L13808]',\n",
       " 'Used for the treatment of certain filarial diseases, including tropical pulmonary eosinophilia, loiasis, and lymphatic filariasis caused by infection with <i>Wuchereria bancrofti</i>, <i>Brugia malayi</i>, or <i>Brugia timori</i>.',\n",
       " 'Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis. ',\n",
       " 'Used in the treatment of resistant staphylococci infections.',\n",
       " \"Apomorphine is indicated to treat acute, intermittent treatment of hypomobility, off episodes associated with advanced Parkinson's disease.[L13919,L13922]\",\n",
       " 'Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder.[L3358] One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause.[L7703] Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).[A1093,A181754,A181904]',\n",
       " 'For the treatment of mild to moderate asthma',\n",
       " 'Norethisterone is indicated as an oral contraceptive when given as monotherapy[L9527] or in combination with an estrogen component, such as [ethinylestradiol] or [estradiol].[L10313,L10307] In combination with an estrogen component, oral norethisterone is also indicated as a hormone replacement therapy in the treatment of postmenopausal osteoporosis and moderate-to-severe vasomotor symptoms arising from menopause.[L10304] When applied via transdermal patch, the combination of norethisterone and estradiol is indicated for the treatment of hypoestrogenism, vulvovaginal atrophy, and moderate-severe vasomotor symptoms.[L10301]\\r\\n\\r\\nNorethisterone, taken in combination with intramuscular [leuprolide], is also indicated for the symptomatic treatment of endometriosis-related pain.[L10310]',\n",
       " 'Indicated for the treatment of chronic hepatitis B in adult patients with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease; this is based on histological, virological, biochemical, and serological responses in adult patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and in adult patients with clinical evidence of lamivudine-resistant hepatitis B virus with either compensated or decompensated liver function.',\n",
       " 'For the relief of the symptoms of upper respiratory mucosal congestion in perennial and allergic rhinitis, and for the relief of nasal congestion and eustachian t.b. congestion.',\n",
       " 'Clodronic acid is indicated as an adjunct in the management of osteolysis from bone metastases of malignant tumors and for management of hypercalcemia of malignancy.[L13910]',\n",
       " 'Used as a local anesthetic primarily in oral surgery',\n",
       " 'Lisinopril is indicated for the treatment of acute myocardial infarction, hypertension in patients 6 years, and as an adjunct therapy for heart failure.[L8384,L8387] A combination product with hydrochlorothiazide is indicated for the treatment of hypertension.[L8390]',\n",
       " 'Indicated for the treatment and management of hypotension.',\n",
       " 'For the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults. Also indicated for the treatment of external genital and perianal warts/condyloma acuminata in individuals 12 years old and above.',\n",
       " 'Used in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcers, gastric ulcers and duodenal ulcers, to reduce further gastric acid secretion and delay gastric emptying.',\n",
       " 'For the treatment of depression and depression accompanied by anxiety, agitation or sleep disturbance',\n",
       " 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]\\r\\n\\r\\nIntravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta ()-blockers; and for induction of intraoperative hypotension.[L7099] \\r\\n\\r\\nTopical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]',\n",
       " 'For inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.',\n",
       " 'For the treatment of strongyloidiasis (threadworm), cutaneous larva migrans (creeping eruption), visceral larva migrans, and trichinosis.',\n",
       " 'For the treatment of non-insulin dependent-diabetes mellitus in conjunction with diet and exercise.',\n",
       " 'For use, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.',\n",
       " 'For the treatment of poisoning due to those pesticides and chemicals of the organophosphate class which have anticholinesterase activity and in the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis.',\n",
       " 'Risperidone is indicated for the treatment of schizophrenia [L12885,L44692,L46297] and irritability associated with autistic disorder.[L12885] It is also indicated as monotherapy, or adjunctly with lithium or valproic acid, for the treatment of acute mania or mixed episodes associated with bipolar I disorder.[L12885,L44692]\\r\\n\\r\\nRisperidone is additionally indicated in Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches.[L12906]\\r\\n\\r\\nRisperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression.[A177226]',\n",
       " 'For the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, <i>Trichophyton tonsurans</i> and <i>Epidermophyton floccosum</i>.',\n",
       " 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ',\n",
       " 'Indicated for the symptomatic treatment of nausea, vomiting, and dizziness associated with motion sickness,[L6772] and management of vertigo due to various causes, including radiation sickness, Menieres syndrome, labyrinthitis and other vestibular disturbances.[L6766]',\n",
       " 'For the treatment of pneumonia due to <i>Pneumocystis carinii</i>.',\n",
       " 'Hetacillin is a beta-lactam antibiotic prodrug used to treat bacterial infections. In the body it gets converted to ampicillin.',\n",
       " \"For the treatment of amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease)\",\n",
       " 'Otic solutions are indicated for infections of the external auditory canal caused by susceptible organisms and with inflammation.[L10529,L10532] Hydrocortisone tablets are indicated for certain endocrine, rheumatic, collagen, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, and other conditions.[L10535] A hydrocortisone enema is indicated for ulcerative colitis,[L10538] a topical ointment with antibiotics is indicated for corticosteroid responsive dermatoses with infections,[L7772] and a topical cream with [acyclovir] is indicated to treat cold sores.[L7321] Oral granules of hydrocortisone are used as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age.[L16533]',\n",
       " 'Used for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.\\r\\n\\r\\nMannitol is also indicated as add-on maintenance therapy for improving pulmonary function in cystic fibrosis patients aged 18 and over who have passed the BRONCHITOL tolerance test (BTT). It is recommended that patients take an orally inhaled short-acting bronchodilator 5-15 minutes prior to every inhaled mannitol dose.[L20024]',\n",
       " 'Gadobenate dimeglumine is indicated for use in magnetic resonance imaging (MRI) of the central nervous system in adult and pediatric patients in order to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues.[L40888] It is also indicated for use in magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease.[L40888]',\n",
       " 'For the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.',\n",
       " 'To improve wakefulness in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.',\n",
       " 'Used to treat acute iron or aluminum toxicity (an excess of aluminum in the body) in certain patients. Also used in certain patients with anemia who must receive many blood transfusions.',\n",
       " 'Scopolamine is indicated in adult patients for the prevention of nausea and vomiting associated with motion sickness and for the prevention of postoperative nausea and vomiting (PONV) associated with anesthesia or opiate analgesia.[L31578]',\n",
       " 'For symptomatic relief of seasonal and perennial allergic rhinitis and vasomotor rhinitis, as well as allergic conjunctivitis caused by foods and inhaled allergens. Also for the relief of allergic reactions to blood or plasma, and the symptomatic management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema.',\n",
       " 'For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.',\n",
       " 'Used as a local anaesthetic and is often used in dentistry.',\n",
       " 'For the prevention of itching associated with allergic conjunctivitis.',\n",
       " 'For the treatment of major depressive episode without melancholia.',\n",
       " 'For induction and maintenance of general anesthesia.',\n",
       " 'For the control of tonic-clonic (grand mal) and complex partial (psychomotor) seizures.',\n",
       " 'Oral tretinoin is indicated for induction of remission in adults and pediatric patients one year of age and older with acute promyelocytic leukemia (APL), characterized by the presence of t(15;17) translocation or presence of PML/RAR gene expression and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated.[L45349]\\r\\n\\r\\nTopical tretinoin is also indicated alone [L45389] or in combination with [benzoyl peroxide] [L34869] or [clindamycin] [L45384] for the treatment of acne vulgaris. It is also used in prescription and over-the-counter for treating various skin conditions such as melasma,[L45394] hyperpigmentation,[A257474] and photoaging [A258180] alone or in combination with other drugs.',\n",
       " 'For use as a surgical scrub and a bacteriostatic skin cleanser. It may also be used to control an outbreak of gram-positive infection where other infection control procedures have been unsuccessful.',\n",
       " 'For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including initial and repeat courses of chemotherapy. Also used for the prevention of postoperative nausea and vomiting. This drug can be used intravenously for the treatment of postoperative nausea and vomiting.',\n",
       " 'Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,[L7213]',\n",
       " 'Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.',\n",
       " 'For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: <b>complicated skin and skin structure infections</b> due to <i>Staphylococcus aureus</i> (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), <i>Streptococcus pyogenes</i>, <i>Streptococcus agalactiae</i>, viridans group streptococci, <i>Enterococcus faecalis</i> (excluding vancomycin-resistant isolates), <i>Pseudomonas aeruginosa</i>, <i>Escherichia coli</i>, <i>Proteus mirabilis</i>, <i>Bacteroides fragilis</i> and <i>Peptostreptococcus</i> species; <b>complicated appendicitis and peritonitis</b> caused by viridans group streptococci, <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Bacteroides fragilis</i>, <i>B. thetaiotaomicron</i>, and <i>Peptostreptococcus</i> species. Also for use in the treatment of bacterial meningitis caused by <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i> (b-lactamase and non-b-lactamase-producing isolates), and <i>Neisseria meningitidis</i>.',\n",
       " 'For use as an electrolyte replenisher and in the treatment of hypokalemia.',\n",
       " 'For the treatment of metastatic colorectal cancer (first-line therapy when administered with 5-fluorouracil and leucovorin). Also used in combination with cisplatin for the treatment of extensive small cell lung cancer. Irinotecan is currently under investigation for the treatment of metastatic or recurrent cervical cancer. Also used in combination with fluorouracil and leucovorin for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. ',\n",
       " \"In the United States, methimazole is indicated for the treatment of hyperthyroidism in patients with Graves' disease or toxic multinodular goiter for whom thyroidectomy or radioactive iodine therapy are not appropriate treatment options. Methimazole is also indicated for the amelioration of hyperthyroid symptoms in preparation for thyroidectomy or radioactive iodine therapy.[L8336]\\r\\n\\r\\nIn Canada, methimazole carries the above indications and is also indicated for the medical treatment of hyperthyroidism regardless of other available treatment options.[L8339]\",\n",
       " 'The inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy. The nasal spray is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis.',\n",
       " 'For use in the treatment of patients with pheochromocytoma, for preoperative preparation of patients for surgery, management of patients when surgery is contraindicated, and chronic treatment of patients with malignant pheochromocytoma.',\n",
       " 'Clavulanic acid combined with other antibiotics is indicated to prevent the development of drug-resistant strains of bacteria and promotes their therapeutic antibacterial effects.[L7880,L7904]\\r\\n\\r\\nThe following conditions, when they produced beta-lactamases, have been treated with a combination of amoxicillin and clavulanic acid or ticarcillin and clavulanic acid[L7880,L7904]:\\r\\n\\r\\nAcute otitis media caused by  H. influenzae and M. catarrhalis\\r\\n\\r\\nSinusitis due to H. influenzae and M. catarrhalis\\r\\n\\r\\nLower respiratory tract infections due to Haemophilus influenzae, S.aureus, Klebsiella species, and Moraxella catarrhalis \\r\\n\\r\\nSkin and skin structure infections caused by Staphylococcus aureus, Escherichia coli, and Klebsiella species\\r\\n\\r\\nUrinary Tract Infections due to E. coli, Klebsiella species of bacteria, and Enterobacter species of bacteria, S.marcescens, or S.aureus\\r\\n\\r\\nGynecologic infections due to a variety of bacteria, including P.melaninogenicus, Enterobacter species, E.Coli species, Klebsiella species, S. aureus, S.epidermidis\\r\\n\\r\\nSepticemia due to a variety of bacteria, including Klebsiella species, E.Coli species, S.aureus, or Pseudomonas species\\r\\n\\r\\nBone and joint infections due to S.aureus\\r\\n\\r\\nIntraabdominal infections due to E.Coli, K.pnemoniae, or B.fragilis group\\r\\n\\r\\n**A note on susceptibility**\\r\\n\\r\\nIt should be noted that it is only to be administered in infections that are confirmed or highly likely to be caused by susceptible bacteria. Culture and susceptibility tests should be performed if possible and used in selecting whether this antibiotic is prescribed. When beta-lactamase enzyme production is not detected during microbiological testing, clavulanic acid should not be used. When these tests are not available patterns of local infection and susceptibility may be used to determine the appropriateness of using clavulanic acid.[L7880] Ticarcillin with clavulanate has shown particular efficacy in mixed infections in addition to empiric therapy before determining the susceptibility of causative organisms. The ticarcillin-clavulanic acid combination may prove to be an effective single-agent antibiotic therapy to treat infections where a regimen of several drugs may normally be used.[L7904]',\n",
       " 'Used to prevent and treat nausea and vomiting associated with anesthesia and surgery, administered intramuscularly or intravenously.',\n",
       " 'Olopatadine is indicated for the symptomatic treatment of ocular itching associated with allergic conjunctivitis as ophthalmic solution.[L6781]\\r\\n\\r\\nAs a nasal spray, as a monotherapy or in combination with [mometasone furoate], olopatadine is indicated for the symptomatic relief of seasonal allergic rhinitis in patients 12 years of age and older.[L6784,L39845]',\n",
       " 'Used topically as an antiinflammatory in the treatment of steroid-responsive dermatoses',\n",
       " 'Alprostadil is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival.[L45038] It is also indicated for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology,[L45028,L45033] and as an adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.[L45028]',\n",
       " 'For the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. In combination with chlordiazepoxide, clidinium is indicated to control emotional and somatic factors in gastrointestinal disorders, and is used as adjunctive therapy in the treatment of peptic ulcer, irritable bowel syndrome and acute enterocolitis.[L44893]',\n",
       " 'For patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.',\n",
       " 'For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme.',\n",
       " 'Used as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Also used in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension.',\n",
       " 'For treatment, in combination with heparin, of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy.',\n",
       " 'In the United States, oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.[L8627] \\r\\n\\r\\nIn Canada, oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in patients 6 years of age and older.[L8630]',\n",
       " 'Propiomazine is largely used for its antihistamininc sleep inducing effects in treating insomnia.',\n",
       " 'Used to treat respiratory tract, urinary and soft tissue infections.',\n",
       " 'For the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of <i>E. Coli</i>, <i>Enterobacter</i> species, <i>Klebsiella</i> species, and <i>Proteus</i> species.',\n",
       " 'Phenelzine is indicated for the treatment of nonendogenous, neurotic or atypical depression for patients that do not tolerate other forms of therapy.[L1356] \\r\\n\\r\\nAtypical depression has a high prevalence rate, starts in early life, tends to last longer, is more likely to occur in people with bipolar disorder, has a high comorbidity with anxiety disorder and carries more risk of suicidal behavior. It is important to specify the atypical feature to predict the clinical course of depression and hence generate the best treatment and service. The featuring symptoms of the atypical feature include mood reactivity, two or more of this symptoms: 1) increased appetite, 2) increased sleep, 3) leaden paralysis and 4) interpersonal rejection sensitivity and should not have melancholic or catatonic features of depression.[A31917]\\r\\n\\r\\nNeurotic depression is a depression of an emotionally unstable person. It is a secondary condition to major personality disorder, neuroses and drug use disorders. Likewise, a primary depression with a family history of depression spectrum disease would fit in this category.[A31922]\\r\\n\\r\\nA nonendogenous depression is characterized by a disturbance in mood and general outlook. The physical symptoms tend to be less severe and it often occurs in response to stressful life events that keep occurring over a large period of time generating a continuous stress in the daily living.[A31924]',\n",
       " 'For the treatment of enuresis. It has also been used for hyperhidrosis, and cramps or spasms of the stomach, intestines or bladder.',\n",
       " \"Estradiol is indicated in various preparations for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy due to menopause, for the treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure, and for the prevention of postmenopausal osteoporosis. It is also used for the treatment of breast cancer (only for palliation therapy) in certain men or women with metastatic disease, and for the treatment of androgen-dependent prostate cancer (only for palliation therapy).[L11485,L11494,L11497] It is also used in combination with other hormones as a component of oral contraceptive pills for preventing pregnancy (most commonly as [DB00977], a synthetic form of estradiol).\\r\\n\\r\\n**A note on duration of treatment**\\r\\n\\r\\nRecommendations for treatment of menopausal symptoms changed drastically following the release of results and early termination of the Women's Health Initiative (WHI) studies in 2002 as concerns were raised regarding estrogen use.[A31626] Specifically, the combined estrogenprogestin group was discontinued after about 5 years of follow up due to a statistically significant increase in invasive breast cancer and in cardiovascular events.[A31627] \\r\\n\\r\\nFollowing extensive critique of the WHI results, Hormone Replacement Therapy (HRT) is now recommended to be used only for a short period (for 3-5 years postmenopause) in low doses, and in women without a history of breast cancer or increased risk of cardiovascular or thromboembolic disease.[A31628] Estrogen for postmenopausal symptoms should always be given with a progestin component due to estrogen's stimulatory effects on the endometrium; in women with an intact uterus, unopposed estrogen has been shown to promote the growth of the endometrium which can lead to endometrial hyperplasia and possibly cancer over the long-term. \\r\\n\\r\\n\",\n",
       " 'For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.',\n",
       " 'For the treatment of hypertension.',\n",
       " 'For the treatment of various cancers',\n",
       " 'An acyclovir topical cream is indicated to treat recurrent herpes labialis in immunocompetent patients 12 years and older.[L7303] Acyclovir oral tablets, capsules, and suspensions are indicated to treat herpes zoster, genital herpes, and chickenpox.[L7315] An acyclovir topical ointment is indicated to treat initial genital herpes and limited non-life-threatening mucocutaneous herpes simplex in immunocompromised patients.[L7318] An acyclovir cream with hydrocortisone is indicated to treat recurrent herpes labialis, and shortening lesion healing time in patients 6 years and older.[L7321] An acyclovir buccal tablet is indicated for the treatment of recurrent herpes labialis.[L7324] An acyclovir ophthalmic ointment is indicated to treat acute herpetic keratitis.[L7327]',\n",
       " 'Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]',\n",
       " 'For use with magnetic resonance imaging (MRI) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues as well as lesions with abnormal vascularity in the head and neck. Also used to facilitate the visualization of lesions with abnormal vascularity in the body (excluding the heart).',\n",
       " 'For the treatment of mild to moderate essential hypertension, mild to moderate congestive heart failure, and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease. ',\n",
       " 'Used for its antineoplastic properties.',\n",
       " 'Used for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold.',\n",
       " \"Used to treat fungal (Tinea) skin infections such as athlete's foot, jock itch, ringworm, and tinea versicolor.\",\n",
       " 'Primidone is commonly indicated for the management of grand mal, psychomotor, and focal epileptic seizures.[L4645,L11112] In addition, it has also been studied and utilized as an effective management of essential tremor.[A39414,A39415,L4645]',\n",
       " \"In the US, sulfasalazine is indicated to treat mild to moderate ulcerative colitis and to prolong the remission period between acute attacks of ulcerative colitis.[L39065] Sulfasalazine is also indicated as an adjunct therapy in severe ulcerative colitis.[L39065]For the delayed-release tablet formulation, sulfasalazine is also indicated to treat rheumatoid arthritis in pediatric patients who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs or polyarticular-course juvenile rheumatoid arthritis with the same patients' characteristics.[L39065]\",\n",
       " 'May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Candesartan may be also used as a second line agent in the treatment of congestive heart failure, systolic dysfunction, myocardial infarction and coronary artery disease in those intolerant of ACE inhibitors.',\n",
       " 'For the treatment of pulmonary artery anomalies',\n",
       " None,\n",
       " 'Used to treat psoriasis, acne and sun damaged skin (photodamage).',\n",
       " 'For the in-hospital, short-term (up to 48 hours) management of severe hypertension when rapid, but quickly reversible, emergency reduction of blood pressure is clinically indicated, including malignant hypertension with deteriorating end-organ function.',\n",
       " 'Used to relieve anxiety, nervousness, and tension associated with anxiety disorders.',\n",
       " 'For the management of postoperative pain and the maintenance of general anesthesia.',\n",
       " 'For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly <i>Pseudomonas aeruginosa</i>.',\n",
       " 'Dicyclomine is indicated for the treatment of functional bowel disorder and irritable bowel syndrome.[L7967]',\n",
       " 'For the treatment of depression',\n",
       " 'Pentoxifylline is indicated for the treatment of intermittent claudication in patients with chronic occlusive arterial disease. Pentoxifylline may improve limb function and reduce symptoms but cannot replace other therapies such as surgical bypass or removal of vascular obstructions.[L30300]',\n",
       " 'Used as a local (ophthalmic) anesthetic.',\n",
       " 'Indapamide is a diuretic indicated for use as monotherapy or in combination with other blood pressure-lowering agents to treat hypertension.[L13982] It may also be used to treat fluid and salt retention associated with congestive heart failure.[L13982]\\r\\n',\n",
       " 'Tropicamide is indicated to induce mydriasis (dilation of the pupil) for diagnostic procedures and in conditions where short-term pupil dilation is desired, either as monotherapy [L32103] or in combination with [hydroxyamphetamine] [L32178] or [phenylephrine].[L46332] It provides clinically significant mydriasis with partial cycloplegia.[L32178]',\n",
       " 'For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.',\n",
       " 'Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates [A19644].\\r\\n\\r\\nThe addition of ribavirin in Technivie therapy indicated for treating HCV genotype 1a and 4 infections is recommended in patients with or without cirrhosis. \\r\\n\\r\\nResistance: viral genetic determinants resulting in variable response to ribavirin therapy has not been yet determined. ',\n",
       " 'For the treatment of backache and ankylosing spondylitis',\n",
       " 'Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia.[Label] These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia.[Label] Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.[Label]\\r\\n\\r\\nFentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.[L6598,L6601,L6604,L6607,L922,L6610]',\n",
       " 'Meloxicam is indicated for the symptomatic treatment of arthritis and osteoarthritis.  In addition, it is indicated for the pauciarticular and polyarticular course of Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years old or above.[L11398] Off-label uses include the treatment of dental or post-surgical pain. In addition to the above, meloxicam has also been studied in the treatment of neuropathic pain. [A190189]\\r\\n\\r\\nMeloxicam, in combination with [bupivacaine], is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.[L34100]',\n",
       " 'SLS is used as a surfactant in shampoos and toothpastes. SLS also has microbicidal activities against both enveloped (Herpes simplex viruses, HIV-1, Semliki Forest virus) and nonenveloped (papillomaviruses, reovirus, rotavirus and poliovirus) viruses, although it has not been approved for this use.',\n",
       " 'For the treatment of bronchospasm, chronic bronchitis, asthma, and emphysema.',\n",
       " 'For the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients.',\n",
       " 'Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus. ',\n",
       " 'For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma',\n",
       " 'Tadalafil is indicated for the treatment of erectile dysfunction (ED) and either alone or in combination with [finasteride] for the treatment of benign prostatic hypertrophy (BPH).[L39095,L39439] It is also indicated for the treatment of pulmonary arterial hypertension (PAH) both alone and in combination with [macitentan] or other endothelin-1 antagonists.[L39100,L39105]',\n",
       " 'For use as a pain reliever in the treatment of joint pain and post-surgical pain.',\n",
       " 'For the treatment and management of chronic alcoholism',\n",
       " 'For the prevention of pregnancy in women who elect to use this product as a method of contraception.',\n",
       " 'Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.',\n",
       " 'Used to treat occasional minor irritation, pain, sore mouth, and sore throat as well as cough associated with a cold or inhaled irritants.',\n",
       " 'For the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including <i>Fusarium solani</i> keratitis.',\n",
       " 'For the treatment of initial and recurrent urinary tract infections in adults caused by the following susceptible microorganisms: <i>Escherichia coli</i>, <i>Proteus mirabilis</i>, <i>Proteus vulgaris</i>, <i>Klebsiella</i> species (including <i>K. pneumoniae</i>), and <i>Enterobacter</i> species.',\n",
       " 'Fosfomycin is indicated for the treatment of uncomplicated cases of cystitis caused by susceptible strains of _Escherichia coli_ and _Enterococcus faecalis_.[L31818] Fosfomycin is not officially indicated for the treatment of pyelonephritis or perinephric abscess, although there have been reported cases of off-label usage in these situations.[L31818]',\n",
       " 'In general, diazepam is useful in the symptomatic management of mild to moderate degrees of anxiety in conditions dominated by tension, excitation, agitation, fear, or aggressiveness such as may occur in psychoneurosis, anxiety reactions due to stress conditions, and anxiety states with somatic expression.[F3160]\\r\\n\\r\\nMoreover, in acute alcoholic withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, and impending acute delirium tremens.[F3160]\\r\\n\\r\\nFurthermore, diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathologies, such as inflammation of the muscle and joints or secondary to trauma; spasticity caused by upper motor neuron disorders, such as cerebral palsy and paraplegia; athetosis and the rare \"stiff man syndrome\".[F3160]\\r\\n\\r\\nParticular label information from the United Kingdom also lists particular age-specific indications, including for adults: (1) The short-term relief (2-4 weeks) only, of anxiety which is severe, disabling, or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic or psychotic illness, (2) cerebral palsy, (3) muscle spasm, (4) as an adjunct to certain types of epilepsy (eg. myoclonus), (5) symptomatic treatment of acute alcohol withdrawal, (6) as oral premedication for the nervous dental patient, and (7) for premedication before surgery.[L5188]\\r\\n\\r\\nIn the same UK label information, diazepam is indicated in children for: (1) control of tension and irritability in cerebral spasticity in selected cases, (2) as an adjunct to the control of muscle spasm in tetanus, and for (3) oral premedication.[L5188]\\r\\n\\r\\nA diazepam nasal spray is indicated in patients 6 years and older to treat intermittent, stereotypic episodes of frequent seizure activity that are different than the patient\\'s usual seizure pattern.[L11247]',\n",
       " 'Used as an anorectic in the treatment of obesity.',\n",
       " 'For the treatment of anxiety disorders, depressive symptoms secondary to anxiety and agitation.',\n",
       " 'For the treatment of epilepsy.',\n",
       " 'For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.',\n",
       " \"For the medical termination of intrauterine pregnancy through 49 days' pregnancy. Also indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and are not candidates for surgery or have had unsuccessful surgery.\",\n",
       " 'For the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing.',\n",
       " 'Loperamide is indicated for the relief of diarrhea, including Travelers Diarrhea.[L42785] As an off-label use, it is often used to manage chemotherapy-related diarrhea.[A251610]',\n",
       " 'Indicated for the treatment of epilepsy.',\n",
       " 'For short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.',\n",
       " 'For use as an adjunct to diet to lower the blood glucose in patients with non-insulin dependent diabetes mellitus (Type II) whose hyperglycemia cannot be satisfactorily controlled by diet alone.',\n",
       " 'Used to relieve dryness and irritation caused by reduced tear flow that occurs in certain eye diseases (keratoconjunctivitis sicca), recurrent corneal erosions, decreased corneal sensitivity, exposure and neuroparalytic keratitis, and as a lubricant for artificial eyes.',\n",
       " 'Indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.',\n",
       " 'Oxazepam is indicated for the management of anxiety disorders and for the short-term relief of symptoms of anxiety.[L13895] It may also be used in the management of alcohol withdrawal symptoms.[L13895]',\n",
       " \"Donepezil, administered orally[L7916] or via transdermal delivery system,[L41125] is indicated for the treatment of dementia of the Alzheimer's type. It is also available as an extended-release capsule in combination with [memantine] for the treatment of moderate-to-severe dementia of the Alzheimer's type in patients previously stabilized on 10mg of donepezil hydrochloride once daily.[L7937] \\r\\n\\r\\nOff-label uses include the management of vascular dementia, Parkinson's Disease-associated dementia, and Lewy body dementia, amongst others.[A182333,T668]\",\n",
       " 'For the relief of moderate to severe pain.',\n",
       " 'Clofazimine is indicated for the treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.[L13802] To prevent the development of drug resistance, it should be used only in combination with other antimycobacterial leprosy treatments.',\n",
       " 'For relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions',\n",
       " 'The bitartrate salt of cysteamine is used for the oral treatment of nephropathic cystinosis and cystinuria in adults and children 6 years old.[L15616] The hydrochloride salt, used in eye drop preparations, is indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.[L15601,L15606]\\r\\n',\n",
       " \"For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.\",\n",
       " 'For the relief of anxiety, tension, and apprehension, also used as an anticonvulsant for the treatment of epilepsy.',\n",
       " 'For use in the management of the manifestations of psychotic disorders and for the control of severe nausea and vomiting in adults.',\n",
       " \"For the treatment of metastatic malignant melanoma. In addition, dacarbazine is also indicated for Hodgkin's disease as a secondary-line therapy when used in combination with other antineoplastic agents.\",\n",
       " 'Pseudoephedrine is a sympathomimetic amine used for its decongestant activity.[L11031,L11037,L11040,L11046,L11052,L11058,L11061]',\n",
       " 'Temozolomide is indicated in adult patients for the treatment of newly diagnosed glioblastoma concomitantly with radiotherapy and for use as maintenance treatment thereafter. It is also indicated for the treatment of refractory anaplastic astrocytoma in adult patients or adjuvant therapy for adults with newly diagnosed anaplastic astrocytoma.[L48265]',\n",
       " 'For the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate.',\n",
       " 'As a topical gel, aminolevulinic acid (ALA) is indicated for lesion-directed and field-directed treatment of actinic keratoses (AKs) of mild-to-moderate severity on the face and scalp in combination with photodynamic therapy (PDT) using BF-RhodoLED lamp, a narrowband, red light illumination source.[L40343] As a topical solution, ALA can also be used for the same indication mentioned previously in addition to AKs of the upper extremities, but in conjunction with blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator.[L40348] Finally, ALA is also available as an oral solution to be used as an adjunct for the visualization of glioma during surgery.[L40353]',\n",
       " 'Used, along with rest and physical therapy, to treat injuries and other painful muscular conditions. Investigated for use in trigeminal neuralgia (tic douloureux), a neuropathic disorder characterized by severe facial pain. Was investigated as a modulator of histamine release.',\n",
       " 'Terbinafine hydrochloride is indicated to treat fungal skin and nail infections caused by _Trichophyton_ species, _Microsporum canis_, _Epidermophyton floccosum_,[L9068] and _Tinea_ species.[L9065] Terbinafine hydrochloride also treats yeast infections of the skin caused by _Candida_ species and _Malassezia furfur_.[L9068]',\n",
       " None,\n",
       " \"For treatment of Wilson's disease, cystinuria and active rheumatoid arthritis.\",\n",
       " 'Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.[L9542]',\n",
       " 'For symptomatic treatment of mild to moderate pain accompanied by inflammation (e.g. musculoskeletal trauma, post-dental extraction, post-episiotomy), osteoarthritis, and rheumatoid arthritis.',\n",
       " 'Vardenafil is indicated for the treatment of erectile dysfunction.[L45563,L45568,L45573]',\n",
       " 'This drug is used alone or with concomitant antacids for the following conditions: short-term treatment of active duodenal ulcer, treating gastric acid hypersecretion due to Zollinger-Ellison syndrome, systemic mastocytosis, and other conditions that may pathologically raise gastric acid levels. It also used in the short term treatment of active benign gastric ulcers and maintenance therapy of gastric ulcers at a reduced dose. In addition to the above, ranitidine can be used for the treatment of GERD symptoms, treatment of erosive esophagitis (endoscopically diagnosed) and the maintenance of gastric or duodenal ulcer healing.[L10818,L10821]\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n\\r\\n',\n",
       " 'Immediate-release formulations of tacrolimus are indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants, in combination with other immunosuppressants.[L8162] Extended-release formulations of tacrolimus are indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving kidney transplants, in combination with other immunosuppressants,[L20034,L41005] and may be used in patients converted from immediate-release formulations.[L41005]\\r\\n\\r\\nTopical tacrolimus ointment is indicated as second-line therapy for short-term and non-continuous treatment of moderate-to-severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical treatments or for whom alternative treatments are not advisable.[L3935] Both available strengths are indicated in adult patients, while only the lower strength (0.03%) formulation is indicated in pediatric patients between 2 and 15 years of age.[L3935]',\n",
       " 'For the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction',\n",
       " 'For the treatment of hypertension, angina, and arrhythmia',\n",
       " 'For the treatment and prophylaxis of premature labour',\n",
       " 'Benzonatate is indicated for the symptomatic relief of cough.[L11193]',\n",
       " 'Dorzolamide is indicated for the management of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.[L11377] It can also be used in combination with [timolol] for the same indication in patients who are insufficiently responsive to ophthalmic beta-blockers.[L11380]\\r\\n\\r\\nIts pre-operative use was also investigated to prevent elevated intraocular pressure after neodynium yttrium aluminum garnet laser posterior capsulotomy.[A190183]',\n",
       " 'Used as eye drops to inhibit the miosis (pupil constriction) that may occur during ocular surgery.',\n",
       " 'Terbutaline is indicated for prevention and reversal of bronchospasm in patients at least 12 years old, with asthma and reversible bronchospasm associated with bronchitis and emphysema.[L32093,L32098]',\n",
       " 'For the treatment of euvolemic or hypervolemic hyponatremia (e.g. the syndrome of inappropriate secretion of antidiuretic hormone, or in the setting of hypothyroidism, adrenal insufficiency, pulmonary disorders, etc.) in hospitalized patients.',\n",
       " 'A number of prescription loteprednol etabonate ophthalmic products are specifically indicated for the treatment of post-operative inflammation and pain following ocular surgery [FDA Label]. ',\n",
       " 'Guaifenesin is an expectorant that is indicated for providing temporary symptomatic relief from congested chests and coughs which may be due to a cold, bronchitis, and/or other breathing illnesses [FDA Label, F4510, L6079].',\n",
       " 'Flupentixol is indicated for maintenance therapy of chronic schizophrenic patients whose main manifestations do not include excitement, agitation or hyperactivity.[L31808]\\r\\n\\r\\nIt is indicated for the management of depression in adult patients who may, or may not, also be showing signs of anxiety.[L31928]\\r\\n\\r\\nFlupentixol in combination with [melitracen] is indicated to manage symptoms of anxiety, depression, and asthenia in adults.[L31923]',\n",
       " 'For the management of hypertension alone or in combination with other classes of antihypertensive agents. Also used as a first-line agent in the treatment of diabetic nephropathy, as well as a second-line agent in the treatment of congestive heart failure (only in those intolerant of ACE inhibitors).',\n",
       " 'Sirolimus is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiving renal transplants. In patients at low-to moderate-immunologic risk, it is recommended that sirolimus be used initially in a regimen with [cyclosporine] and corticosteroids; cyclosporine should be withdrawn two to four months after transplantation. In patients at high-immunologic risk (defined as Black recipients and/or repeat renal transplant recipients who lost a previous allograft for immunologic reason and/or patients with high panel-reactive antibodies [PRA; peak PRA level > 80%]), it is recommended that sirolimus be used in combination with cyclosporine and corticosteroids for the first year following transplantation.[L19809]\\r\\n\\r\\nIt is also used to treat lymphangioleiomyomatosis.[L19809] \\r\\n\\r\\nIn the US, albumin-bound sirolimus for intravenous injection is indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumour (PEComa).[L39267]\\r\\n\\r\\nIn Europe, it is recommended that sirolimus for the prophylaxis of organ rejection in renal transplants is used in combination with cyclosporin microemulsion and corticosteroids for two to three months. Sirolimus may be continued as maintenance therapy with corticosteroids only if cyclosporin microemulsion can be progressively discontinued.[L7021]\\r\\n\\r\\nTopical sirolimus is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients six years of age and older.[L41489]',\n",
       " 'Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures.[L11518,L11521,L11527,L11533] Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis[L11512] and a slow-release \"chip\" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures.[L11536]',\n",
       " 'Emtricitabine is indicated in combination with other medications for the treatment of HIV-1 infections;[L9019,L9836,L44226] treatment of HIV-1 infections in pediatric patients 25-35kg, treatment of HIV-1 infections in adult patients 35kg, for pre exposure prophylaxis of HIV-1 in adolescent and adult patients excluding those who have receptive vaginal sex;[L4388,L9010] treatment of HIV-1 infections in pediatric and adult patients 17kg, pre exposure prophylaxis in adolescents and adults 35kg;[L9833] treatment of HIV-1 in patients 12 years and 35kg;[L9587] treatment of HIV-1 in patients weighing 35kg;[L9839,L9842] treatment of HIV-1 in patients weighing 25kg;[L9647,L9845] and treatment of HIV-1 in patients weighing 40kg.[L9848]',\n",
       " 'Chlorothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.',\n",
       " 'Quinapril is indicated for the treatment of hypertension and as an adjunct therapy in the treatment of heart failure.[L8420] Quinapril in combination with hydrochlorothiazide is indicated for the treatment of hypertension.[L8423]',\n",
       " 'Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation. ',\n",
       " 'For the prevention of angina pectoris due to coronary artery disease.',\n",
       " \"Risedronic acid is indicated for the treatment of osteoperosis in men, treatment of Paget's disease, treatment and prevention of osteoperosis in postmenopausal women, and treatment and prevention of glucocorticoid-induced osteoperosis[FDA Label].\",\n",
       " 'For the prevention of itching of the eyes caused by allergies such as hay fever, and allergic conjunctivitis',\n",
       " 'For the treatment of hypertension.',\n",
       " 'For the treatment of edema associated with congestive heart failure, hepatic and renal disease including the nephrotic syndrome.',\n",
       " \"For the palliative treatment of Hodgkin's disease (Stages III and IV), lymphosarcoma, chronic myelocytic or chronic lymphocytic leukemia, polycythemia vera, mycosis fungoides, and bronchogenic carcinoma. Also for the palliative treatment of metastatic carcinoma resulting in effusion.\",\n",
       " 'For the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy (including high dose cisplatin), postoperation, and radiation (including total body irradiation and daily fractionated abdominal radiation).',\n",
       " 'For use in the treatment of atrophic vaginitis and kraurosis vulvae.',\n",
       " 'For the treatment of dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosum',\n",
       " 'Used to temporarily numb the front surface of the eye so that the eye pressure can be measured or a foreign body removed.',\n",
       " 'For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.',\n",
       " 'For palliative treatment of advanced breast cancer in postmenopausal women.',\n",
       " 'For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G).',\n",
       " 'For the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uveitis.',\n",
       " 'For the short-term treatment of insomnia.',\n",
       " 'For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.',\n",
       " 'For use during the induction and maintenance of general anesthesia.',\n",
       " 'For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection in adults.',\n",
       " 'Used to dilate air passages in the lungs that have become narrowed as a result of disease or inflammation. It is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).',\n",
       " 'Used for the symptomatic relief of hypersensitivity reactions and particularly for the control of pruritic skin disorders',\n",
       " 'For the treatment of high blood pressure and edema caused by diseases like congestive heart failure, liver failure, and kidney failure.',\n",
       " 'In the adult patient population:\\r\\ni) orally administered ondansetron tablets and orally disintegrating tablets (ODT) are indicated for:\\r\\n- the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including high dose (ie. greater than or equal to 50 mg/m2) cisplatin therapy, and radiotherapy, and\\r\\n- the prevention and treatment of postoperative nausea and vomiting\\r\\n\\r\\nii) intravenously administered ondansetron injection formulations are indicated for:\\r\\n- the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including high dose (ie. greater than or equal to 50 mg/m2) cisplatin therapy, and\\r\\n- the prevention and treatment of postoperative nausea and vomiting\\r\\n\\r\\nIn the pediatric (4-18 years of age) patient population:\\r\\ni) ondansetron was effective and well tolerated when given to children 4-12 years of age for the treatment of post-chemotherapy induced nausea and vomiting,\\r\\nii) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for the treatment of children 3 years of age or younger,\\r\\niii) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for use in any age group of the pediatric population for the treatment of post-radiotherapy induced nausea and vomiting, and\\r\\niV) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for use in any age group of the pediatric population for the treatment of postoperative nausea and vomiting\\r\\n\\r\\nIn the geriatric (>65 years of age) patient population:\\r\\ni) efficacy and tolerance of ondansetron were similar to that observed in younger adults for the treatment of post-chemotherapy and radiotherapy-induced nausea and vomiting, and\\r\\nii) clinical experience in the use of ondansetron in the prevention and treatment of postoperative nausea and vomiting is limited and is not indicated for use in the geriatric patient population ',\n",
       " 'Bimatoprost is used for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.\\r\\nThese patients must be intolerant to other intraocular pressure lowering medications or inadequately responsive to other treatments.[L6877]\\r\\n\\r\\nBimatoprost is also indicated to treat eyelash hypotrichosis.[L6910]',\n",
       " 'For the treatment of partial seizures',\n",
       " 'For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.',\n",
       " 'Quinidine is indicated for the management and prophylactic therapy of atrial fibrillation/flutter, as well as the suppression of recurrent documented ventricular arrhythmias.[L42420,L3719] It is also used in the treatment of Brugada syndrome, short QT syndrome and idiopathic ventricular fibrillation.[A250050,A250055].',\n",
       " 'Zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.[L42530] Zonisamide oral suspension is indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years of age and older.[L42535]',\n",
       " 'For treatment of secondary hyperparathyroidism associated with chronic kidney disease (CKD) Stage 3 and 4',\n",
       " 'For the treatment of trichomoniasis caused by <i>T. vaginalis</i> in both female and male patients. Also for the treatment of giardiasis caused by <i>G. duodenalis</i> in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by <i>E. histolytica</i> in both adults and pediatric patients older than three years of age.',\n",
       " 'As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ',\n",
       " 'For treatment and management of pain (systemic) and for use as an anesthesia adjunct.',\n",
       " 'For the reatment of type II diabetes mellitus.',\n",
       " 'For the chemoprophylaxis, prophylaxis, and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Also for the treatment of parkinsonism and drug-induced extrapyramidal reactions.',\n",
       " \"Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis,[L7432, L49811] certain types of amebiasis, and various anaerobic infections.[A181057, L49811] The above anaerobic infections may occur on the skin and skin structures, the abdomen, the heart, reproductive organs, central nervous system, and the respiratory system. Some may also be present in the bloodstream in cases of septicemia. Common infections treated by metronidazole are Bacteroides species infections, Clostridium infections, and Fusobacterium infections, as well as Peptococcus and Peptostreptococcus infections.[L3754] Topical formulations of metronidazole are indicated for the treatment of inflammatory lesions of rosacea.[L45166]\\r\\n\\r\\nIt is also used off-label in the treatment of Crohn's disease, as a prophylactic agent after surgery[A181039], and in the treatment of Helicobacter pylori infection.[A181045] It has also been studied in the prevention of preterm births and to treat periodontal disease.[A1391,A181078]\",\n",
       " 'For the termination of pregnancy during the second trimester (from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period), as well as for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period. Also used in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole). Other indications include improving the cervical inducibility (cervical \"ripening\") in pregnant women at or near term with a medical or obstetrical need for labor induction, and the management of postpartum hemorrhage.',\n",
       " 'For the treatment of acute migraine headache in adults',\n",
       " 'For use in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of <i>Neisseria gonorrhoeae</i>.',\n",
       " 'Administered orally, ketotifen is indicated as an add-on medication in the chronic treatment of mild atopic asthma in children.[L32283] It is also available as an over-the-counter ophthalmic solution which is indicated for the temporary prevention of itching of the eye due to allergic conjunctivitis.[L32278]',\n",
       " 'Buprenorphine is available in different formulations, such as sublingual tablets, buccal films, transdermal films, and injections, alone or in combination with [naloxone].\\r\\n\\r\\nThe buccal film, intramuscular or intravenous injection, and transdermal formulation are indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.[L46566, L46576, L46581]\\r\\n\\r\\nThe extended-release subcutaneous injections of buprenorphine are indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. Injections are part of a complete treatment plan that includes counselling and psychosocial support.[L46561]\\r\\n\\r\\nSublingual tablets and buccal films, in combination with naloxone, are indicated for the maintenance treatment of opioid dependence as part of a complete treatment plan that includes counselling and psychosocial support.[L42285, L46571]',\n",
       " 'For short term treatment of acutely decompensated severe chronic heart failure (CHF). Also being investigated for use/treatment in heart disease.',\n",
       " 'For the treatment of infections caused by susceptible organisms.',\n",
       " 'Cyclobenzaprine is indicated as a short-term (2-3 weeks) adjunct therapy, along with rest and physical therapy, for relief of muscle spasm associated with acute, painful musculoskeletal conditions. It has not been found effective in the treatment of spasticity originating from cerebral or spinal cord disease, or spasticity in children with cerebral palsy.[L8408,L8411] Cyclobenzaprine is also occasionally used off-label for reducing pain and sleep disturbances in patients with fibromyalgia.[A184946]',\n",
       " 'For the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension.',\n",
       " 'For the treatment of severe psoriasis in adults.',\n",
       " 'Famotidine is indicated in pediatric and adult patients (with the bodyweight of 40 kg and above) for the management of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD, diagnosed by biopsy.[L11139]\\r\\n\\r\\nIt is also indicated in adult patients for the treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine neoplasias) and reduction of the risk of DU recurrence.[L11139]\\r\\n\\r\\nThe intravenous formulation of famotidine is available for some hospitalized patients with pathological hypersecretory conditions or intractable ulcers or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication.[L11142]\\r\\n\\r\\nOver-the-counter famotidine is used for the management and prevention of heartburn caused by gastroesophageal reflux in children and adults. Off-label uses of famotidine include the reduction of NSAIDs-associated gastrointestinal effects, treatment of refractory urticarial, prevention of stress ulcer in critically-ill patients, and symptomatic relief of gastritis.[L11166,L11172]',\n",
       " 'Azacitidine (for subcutaneous or intravenous use) is indicated for the treatment of adult patients with the following French-American-British (FAB) myelodysplastic syndrome (MDS) subtypes: refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL). Azacitidine is also indicated for the treatment of pediatric patients aged 1 month and older with newly diagnosed Juvenile Myelomonocytic Leukemia (JMML).[L41910,L46861]\\r\\n\\r\\nAzacitidine (for oral use) is indicated for continued treatment of adult patients with acute myeloid leukemia (AML) who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative therapy.[L35335]',\n",
       " 'Misoprostol is indicated as a tablet to reduce the risk of NSAID induced gastric ulcers but not duodenal ulcers in high risk patients.[L7616] Misoprostol is also formulated in combination with diclofenac to treat symptoms of osteoarthritis or rheumatoid arthritis in patients with a high risk of developing gastric ulcers.[L7619] Misoprostol is used off label for the management of miscarriages, prevention of post partum hemorrhage, and is also used alone or in combination with mifepristone in other countries for first trimester abortions.[A181589,A181583,A181697]',\n",
       " 'For use, alone or in combination with an HMG-CoA reductase inhibitor, as adjunctive therapy to diet and exercise for the reduction of elevated LDL cholesterol in patients with primary hypercholesterolemia (Fredrickson Type IIa).',\n",
       " 'For the treatment of acute bacterial exacerbations of chronic bronchitis',\n",
       " 'For combination antiretroviral treatment of HIV-1 infected adult patients with evidence of viral replication, who are highly treatment-experienced or have HIV-1 strains resistant to multiple protease inhibitors.',\n",
       " 'Used in the treatment of schizophrenia, organic brain disorders, alcoholism and psychoneuroses.',\n",
       " 'For treatment of depression, including the depressed phase of bipolar depression, psychotic depression, and involutional melancholia, and may also be helpful in treating certain patients suffering severe depressive neurosis.',\n",
       " 'Oxymetazoline is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.[L15062]\\r\\n\\r\\nOphthalmic oxymetazoline is indicated for the treatment of acquired blepharoptosis in adults.[L15067]\\r\\n\\r\\nWhen used in combination with tetracaine intranasally, oxymetazoline is indicated for regional anesthesia when performing a restorative procedure on Teeth 4-13 and A-J in adults and children who weigh 40 kg or more.[L15057]\\r\\n\\r\\nOxymetazoline can be found in over-the-counter nasal products as a nasal decongestant.[L15092]\\r\\n\\r\\nFor off-label uses, oxymetazoline has been used during nasal intubation and during ear, nose, and throat surgery to improve visualization of the airway and to minimize post-operative bleeding.[A215542]',\n",
       " 'Key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts.',\n",
       " 'Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.',\n",
       " 'Salmeterol is indicated in the treatment of asthma with an inhaled corticosteroid, prevention of exercise induced bronchospasm, and the maintenance of airflow obstruction and prevention of exacerbations of chronic obstructive pulmonary disease.[L11545,L11548,L11551,L11554,L11557]',\n",
       " 'For the relief of mild to moderate pain, for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis.',\n",
       " 'For the treatment of peptic ulcer disease, irritable bowel syndrome, pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, and reflex neurogenic bladder in children.',\n",
       " 'Used as an adjunct with succinylcholine (or suxamethonium chloride) to prolong muscle relaxation and to prevent succinylcholine-induced muscle fasciculations.',\n",
       " \"For treatment and management of Parkinson's disease.\",\n",
       " 'For the treatment of Human immunovirus (HIV) infections in conjunction with other antivirals.',\n",
       " 'For the topical treatment of chronic open-angle glaucoma.',\n",
       " '**Pain, fever, and inflammation**\\r\\n\\r\\nAcetylsalicylic acid (ASA), in the regular tablet form (immediate-release), is indicated to relieve pain, fever, and inflammation associated with many conditions, including the flu, the common cold, neck and back pain, dysmenorrhea, headache, tooth pain, sprains, fractures, myositis, neuralgia, synovitis, arthritis, bursitis, burns, and various injuries. It is also used for symptomatic pain relief after surgical and dental procedures [FDA label]. \\r\\n\\r\\nThe _extra strength_ formulation of acetylsalicylic acid is also indicated for the management migraine pain with photophobia (sensitivity to light) and phonophobia (sensitivity to sound)[FDA label].\\r\\n\\r\\n**Other indications**\\r\\n\\r\\nASA is also indicated for various other purposes, due to its ability to inhibit platelet aggregation. These include: \\r\\n\\r\\nReducing the risk of cardiovascular death in suspected cases of myocardial infarction (MI) [FDA label]. \\r\\n\\r\\nReducing the risk of a first non-fatal myocardial infarction in patients, and for reducing the risk of morbidity and mortality in cases of unstable angina and in those who have had a prior myocardial infarction [FDA label].\\r\\n\\r\\nFor reducing the risk of transient ischemic attacks (TIA) and to prevent atherothrombotic cerebral infarction (in conjunction with other treatments) [FDA label].\\r\\n\\r\\nFor the prevention of thromboembolism after hip replacement surgery [FDA label]. \\r\\n\\r\\nFor decreasing platelet to platelet adhesion following carotid endarterectomy, aiding in the prevention of transient ischemic attacks (TIA) [FDA label].\\r\\n\\r\\nUsed for patients undergoing hemodialysis with a silicone rubber arteriovenous cannula inserted to prevent thrombosis at the insertion site [FDA Label]. \\r\\n\\r\\n**Important note regarding use of the extended-release formulation [F4405]**\\r\\n\\r\\nIn the setting of acute myocardial infarction, or before percutaneous interventions, the extended-release form of acetylsalicylic acid should not be used. Use immediate-release formulations in scenarios requiring rapid onset of action [Label, F4405]. The extended-release form is taken to decrease the incidence of mortality and myocardial infarction (MI) for individuals diagnosed with chronic coronary artery disease (CAD), including patients with previous myocardial infarction (MI) or unstable angina or with chronic stable angina. Additionally, the extended-release form is used to decrease the risk of death and recurrent episodes of stroke in patients with a history of stroke or TIA [F4405].\\r\\n\\r\\n\\r\\n ',\n",
       " 'Used for the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).',\n",
       " 'For the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy, as monotherapy or in combination with other antineoplastic agents.',\n",
       " 'Used to treat serious gram&ndash;negative infections of the lungs, urinary tract, and skin.',\n",
       " 'For use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use.',\n",
       " 'In the United States, fexofenadine is indicated for the symptomatic treatment of allergic rhinitis in patients 2 years old and chronic idiopathic urticaria in patients 6 months old.[L4269] In Canada, fexofenadine carries the same indications but is approved only for patients 12 years old.[L10779] Fexofenadine is also available in combination with [pseudoephedrine] for the symptomatic treatment of season allergic rhinitis in patients 12 years old.[L10800]',\n",
       " 'Isoniazid is used for the treatment of all forms of tuberculosis in which organisms are susceptible. It is also used in combination with rifampin and pyrazinamide.[L45369]',\n",
       " 'For the acute treatment of migraine attacks with or without aura in adults.',\n",
       " 'Rizatriptan is indicated for the acute treatment of diagnosed migraine with or without aura.[L46018, L46023, L46038, L46043] Rizatriptan is not indicated for the prophylactic therapy of migraine nor the treatment of cluster headache.[L46018]\\r\\n\\r\\nIn Canada, rizatriptan is approved in adults.[L46038, L46043] In the US, the oral tablet formulations are used in patients six years of age and older [L46018] and the oral film formation is approved for patients 12 years of age and older weighing 40 kg or more.[L46023] ',\n",
       " 'For the treatment of the following mild-to-moderate infections caused by susceptible strains of microorganisms: acute bacterial exacerbations of chronic bronchitis, secondary bacterial infection of acute bronchitis, community-acquired pneumonia, pharyngitis/tonsilitis, and uncomplicated skin and skin structure infections.',\n",
       " 'For the treatment of bacteremia, septicaemia, respiratory tract infections, skin and soft-tissue infection, burns, wounds, and peri-operative infections caused by susceptible strains.',\n",
       " 'Hydrocodone is indicated for the management of acute pain, sometimes in combination with [acetaminophen] or [ibuprofen], as well as the symptomatic treatment of the common cold and allergic rhinitis in combination with decongestants, antihistamines, and expectorants.[label,L7991]',\n",
       " 'Norgestimate is formulated with [ethinylestradiol] as a combined oral contraceptive.[L11845,L11848] It can also be given with low dose ethinylestradiol for contraception as well as the treatment of moderate acne vulgaris in women 15 years old.[L11848]',\n",
       " 'Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma.[L32253] Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.[L32253]',\n",
       " 'Oral and intramuscular methylprednisolone are indicated for a number of endocrine,  rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, nervous system, and other disorders.[L10785,L10788] Intra-articular and soft tissue injections are indicated for short term treatment of acute gouty arthritis, acute and subactute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis.[L10788] Intralesional injections are indicated for alopecia areata, discoid lupus erythematosus, keloids, lichen planus, lichen simplex chronicus and psoriatic plaques, necrobiosis lipoidica diabeticorum, and localized hypertrophic infiltrated inflammatory lesions of granuloma annulare.[L10788]',\n",
       " 'Pindolol is indicated in the management of hypertension.[L32353] In Canada, it is also indicated in the prophylaxis of angina.[L32388]',\n",
       " 'For production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks.',\n",
       " 'For the treatment of short-term treatment of insomnia in adults.',\n",
       " 'For the treatment of postoperative inflammation in patients who have undergone cataract extraction.',\n",
       " 'For prevention or reduction of intraoperative and postoperative increases in intraocular pressure (IOP) before and after ocular laser surgery when used prophylactically. Also used as a short-term adjunctive therapy in patients with open-angle glaucoma who are on maximally tolerated medical therapy requiring additional IOP reduction.',\n",
       " 'For use as a radio-opaque medium for hysterosalpingography and lymphography, and as an antineoplastic agent when part of the iodine is 131-I. It is also used in follow-up imaging for chemoembolization.',\n",
       " 'Used alone or in combination with other classes of antihypertensives for the treatment of hypertension.[L44652] Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).[A255892]',\n",
       " 'For the relief of symptoms of seasonal allergic rhinitis, perennial (non-seasonal) allergic rhinitis. Desloratidine is also used for the sympomatic treatment of pruritus and urticaria (hives) associated with chronic idiopathic urticaria.',\n",
       " 'Methyldopa is indicated for the management of hypertension as monotherapy [L32614] or in combination with hydrochlorothiazide.[L32619] Methyldopa injection is used to manage hypertensive crises.[L32624]',\n",
       " 'Only for the treatment of symptoms of severe diarrhea-predominant irritable bowel syndrome (IBS) in women with chronic symptoms (generally lasting greater than 6 months) who does not present with anatomic or biochemical GI abnormalities and have not responded to conventional therapy.',\n",
       " \"For the treatment of Wilms' tumor, childhood rhabdomyosarcoma, Ewing's sarcoma and metastatic, nonseminomatous testicular cancer as part of a combination chemotherapy and/or multi-modality treatment regimen\",\n",
       " 'For treatment of tinea versicolor, tinea capitis, dandruff and seborrheic dermatitis of the scalp.',\n",
       " 'Intranasal azelastine is indicated for the symptomatic treatment of seasonal allergic rhinitis in patients 5 years and older and for the symptomatic treatment of vasomotor rhinitis in patients 12 years and older.[L8240] Ophthalmic azelastine solution is indicated for the treatment of itchy eyes associated with allergic conjunctivitis.[L8270]\\r\\n\\r\\nAs a 0.15% nasal spray, azelastine hydrochloride is also indicated for over-the-counter treatment of allergies in patients aged six years and older.[L34640]',\n",
       " 'Ezetimibe is indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor (statin).[L11347,L11401,L11404] It is also indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with mixed hyperlipidemia in combination with fenofibrate, and to reduce elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH), in combination with atorvastatin or simvastatin.[L11347] Ezetimibe may also be used to reduce elevated sitosterol and campesterol in patients with homozygous sitosterolemia (phytosterolemia).[L11347]',\n",
       " 'For the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults.',\n",
       " 'For as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina.',\n",
       " 'For the treatment of <i>Pneumococcal</i> infection, acute sinusitis, acute bacterial tonsillitis, acute bronchitis and bronchiolitis, lower respiratory tract infection and lobar (pneumococcal) pneumonia.',\n",
       " 'Ethinylestradiol is combined with other drugs for use as a contraceptive, premenstrual dysphoric disorder, moderate acne, moderate to severe vasomotor symptoms of menopause, prevention of postmenopausal osteoporosis.[L11944,L11965,L11947,L11950,L11845,L9806,L11953,L10304,L11956,L11959,L11962]',\n",
       " 'For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: <i>S.pneumoniae</i>, <i>H.influenzae</i>, <i>S.aureus</i>, <i>P.aeruginosa</i>, <i>E. cloacae</i>, <i>P. mirabilis</i>, <i>C. civersus</i>, <i>S. asprphyticus</i>, <i>E.coli</i>, and <i>K.pneumoniae</i>.',\n",
       " 'Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.',\n",
       " 'For the treatment of insomnia characterized by difficulty with sleep onset.',\n",
       " 'For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.',\n",
       " 'Isotretinoin is indicated to treat severe recalcitrant nodular acne and patients 12 years enrolled in the iPLEDGE program.[Label,L6579]',\n",
       " 'Formoterol is indicated in various formulations for the treatment of asthma and COPD. For the treatment of COPD, formoterol is available as a single-entity inhalation solution,[L10986] in combination with the long-acting muscarinic antagonists (LAMAs) [aclidinium][L10992] and [glycopyrronium],[L10989] and in combination with the corticosteroid [budesonide].[L10619] For the treatment of asthma, formoterol is available in combination with [mometasone furoate] for patients 5 years and older[L10995] and with budesonide for patients 6 years and older.[L10619] Formoterol may also be used on an as-needed basis for prophylaxis against exercise-induced bronchospasm.[L10998]',\n",
       " \"For the treatment of refractory deficient red cell production anemias, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner's syndrome. It is also indicated in the prophylaxis of hereditary angioedema.\",\n",
       " 'Dimenhydrinate is indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness.[L32980,L32985]',\n",
       " 'Glycopyrronium formulated as a topical cloth is indicated to treat primary axillary hyperhidrosis in patients 9 years,[L4755] and an inhalational solution is indicated for long term maintenance of airflow obstruction in COPD.[L33105] A glycopyrronium intravenous and intramuscular injection is indicated in adults and pediatric patients to reduce the volume and acidity of gastric secretions, reduce airway secretions, and block cardiac inhibitory reflexes during the induction of anesthesia and intubation; to treat surgically-induced, drug-induced, or vagal reflex associated arrhythmias intraoperatively; and to prevent peripheral muscarinic effects of cholinergic drugs.[L33120] The same injection is indicated in adults as an adjunct therapy in the treatment of peptic ulcers, as is an orally disintegrating tablet formulation.[L33120,L39615] An oral solution is indicated to treat excessive drooling associated with neurologic conditions in patients aged 3-16 years.[L33140] Glycopyrronium and [budesonide][L33145] can be formulated with [formoterol] fumarate for the maintenance of COPD.[L33150]',\n",
       " 'For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.\\r\\n\\r\\nCytarabine is indicated in combination with [daunorubicin] for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.[L32843]',\n",
       " 'For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure',\n",
       " \"For the treatment of mild to moderate dementia associated with Parkinson's disease or of the Alzheimer's type.\",\n",
       " 'For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.',\n",
       " 'Used to relieve the inflammation, swelling, stiffness, and joint pain associated with rheumatoid arthritis and osteoarthritis.',\n",
       " 'For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).',\n",
       " 'Azathioprine is indicated to treat rheumatoid arthritis and prevent renal transplant rejection.[L11214]',\n",
       " 'Oral neomycin sulfate is indicated as an adjunctive therapy in hepatic coma (portal-system encephalopathy) by reducing ammonia-forming bacteria in the intestinal tract. It is strongly recommended that oral neomycin is only used in infections that are proven or strongly suspected to be caused by susceptible bacteria to reduce the risk of the development of drug-resistant bacteria.[L11979]\\r\\n\\r\\nNeomycin, in combination with polymyxin B sulfates and hydrocortisone in otic suspensions, is used in the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the antibiotics. This otic formulation is also used in the treatment of infections of mastoidectomy and fenestration cavities caused by organisms susceptible to the antibiotics.[L10532]\\r\\n\\r\\nThe ophthalmic solution containing neomycin in combination with polymyxin B sulfates and dexamethasone is used to treat steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists.[L10716]',\n",
       " 'Used in the treatment of active, progressive or destructive forms of inflammatory arthritis, such as adult rheumatoid arthritis.',\n",
       " 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]',\n",
       " \"Doxorubicin is indicated for the treatment of neoplastic conditions like acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin and non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms tumor, metastatic neuroblastoma, metastatic soft tissue and bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, and metastatic bronchogenic carcinoma.[L45231] Doxorubicin is also indicated for use as a component of adjuvant therapy in women with evidence of axillary lymph node involvement following resection of primary breast cancer.[L45231] For the liposomal formulation, doxorubicin is indicated for the treatment of ovarian cancer that has progressed or recurred after platinum-based chemotherapy, AIDS-Related Kaposi's Sarcoma after the failure of prior systemic chemotherapy or intolerance to such therapy, and multiple myeloma in combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.[L45226]\",\n",
       " 'For the acute treatment of migraine attacks with or without aura in adults.',\n",
       " 'Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.[L8447,L8450] Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.[A185138,L8447,L8450,L45663]',\n",
       " 'For the treatment of bacterial infections caused by susceptible organisms.',\n",
       " 'Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known to induce bronchospasm.[Label,F3265,F3268]',\n",
       " 'For the production of local or regional anesthesia for surgery and obstetrics, and for post-operative pain management',\n",
       " 'For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.',\n",
       " 'For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients.',\n",
       " 'Hydroxyurea is indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in adult and pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises.[L41150]',\n",
       " 'Letrozole is indicated to treat postmenopausal women with hormone receptor (HR) positive early breast cancer, postmenopausal women with early breast cancer who have periviously been treated with tamoxifen, and postmenopausal women with HR+ or unknown advanced breast cancer.[L11623] Letrozole, given with ribociclib, is indicated to treat pre, peri, and postmenopausal women with HR+ and human epidermal growth factor 2 (HER2) negative advanced or metastatic breast cancer.[L11626]',\n",
       " 'For the local treatment of vulvovaginal candidiasis (moniliasis).',\n",
       " 'For use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous  (myeloid, myelocytic, granulocytic) leukemia (FDA has designated busulfan as an orphan drug for this use). It is also used as a component of pretransplant conditioning regimens in patients undergoing bone marrow transplantation for acute myeloid leukemia and nonmalignant diseases.',\n",
       " 'For symptomatic treatment of acute and chronic rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, primary dysmenorrhea and mild to moderate pain associated with musculotendinous trauma (sprains and strains), postoperative (including dental surgery) or postpartum pain.',\n",
       " 'For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.',\n",
       " \"Used as a diagnostic drug for testing hypothalamic-pituitary ACTH function. Occasionally used in Cushing's syndrome.\",\n",
       " 'For the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease who are on hemodialysis or peritoneal dialysis. Also for the treatment of hypercalcemia in patients with parathyroid carcinoma.',\n",
       " 'Clobetasol propionate is indicated to treat moderate to severe plaque psoriasis[L11818,L11821,L11824] as well as inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.[L11815,L11827]',\n",
       " 'For the treatment of mildly to moderately active ulcerative colitis.',\n",
       " \"Sulfamethoxazole is indicated in combination with trimethoprim, in various formulations, for the following infections caused by bacteria with documented susceptibility: urinary tract infections, acute otitis media in pediatric patients (when clinically indicated), acute exacerbations of chronic bronchitis in adults, enteritis caused by susceptible _Shigella_, prophylaxis and treatment of _Pneumocystis jiroveci_ pneumonia, and travelers' diarrhea caused by enterotoxigenic _E. coli_.[L11830,L11863]\\r\\n\\r\\nIn Canada, additional indications include the adjunctive treatment of cholera, treatment of bacillary dysentery, nocardiosis, and second-line treatment of brucellosis in combination with [gentamicin] or [rifampicin].[L11851]\",\n",
       " 'Glyburide is indicated alone or as part of combination product with metformin, as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus.[L8120,L8123]',\n",
       " 'Oral and topical minocycline are indicated to treat inflammatory lesions of acne vulgaris.[L11701,L11704,L11719] Subgingival microspheres are indicated as an adjunct treatment in the reduction of pocket depth in adults with periodontitis.[L11716] Oral and intravenous formulations are indicated to treat infections of susceptible microorganisms.[L11707,L11710,L11713] These include rickettsiae, _Mycoplasma pneumoniae_, _Chlamydia trachomatis_, _Chlamydophila psittaci_, _Chlamydia trachomatis_, _Ureaplasma urealyticum_, _Borrelia recurrentis_, _Haemophilus ducreyi_, _Yersinia pestis_, _Francisella tularensis_, _Vibrio cholerae_, _Campylobacter fetus_, _Brucella_ species, _Bartonella bacilliformis_, _Klebsiella granulomatis_, _Escherichia coli_, _Enterobacter aerogenes_, _Shigella_ species, _Acinetobacter_ species, _Haemophilus influenzae_, and _Kelbsiella_ species.[L11710]',\n",
       " ...]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drugbank['indication'].to_list()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = bindingDB_all.dropna(subset=['DrugBank ID of Ligand'])\n",
    "df = df.drop_duplicates(subset = 'DrugBank ID of Ligand')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "def drugbank_therapeutic_area(drugbank_id):\n",
    "    indications = drugbank[drugbank['drugbank-id'] == drugbank_id]['indication'] \n",
    "    if indications.empty:\n",
    "        return None\n",
    "    else:\n",
    "        return indications.iloc[0]\n",
    "\n",
    "df['Therapeutic Area'] = df['DrugBank ID of Ligand'].apply(drugbank_therapeutic_area)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8814984709480123\n"
     ]
    }
   ],
   "source": [
    "m=0\n",
    "for j in df['Therapeutic Area']:\n",
    "    if j == None:\n",
    "        m = m+1\n",
    "print(m/len(df['Therapeutic Area']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Ellagic acid is being investigated for use in follicular lymphoma, brain injury in intrauterine growth restricted babies, obese adolescents, and solar lentigines.',\n",
       " 'Bosutinib is indicated for the treatment of adult and pediatric patients 1 year of age and older with chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy. It is also indicated for the treatment of adult patients with accelerated or blast phase Philadelphia chromosome-positive chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy.[L48355]',\n",
       " 'Vandetanib is currently approved as an alternative to local therapies for both unresectable and disseminated disease. Because Vandetanib can prolong the Q-T interval, it is contraindicated for use in patients with serious cardiac complications such as congenital long QT syndrome and uncompensated heart failure. ',\n",
       " 'For the treatment of HIV-1 infection in combination with other antiretroviral agents.',\n",
       " 'Investigated for use/treatment in breast cancer and lung cancer.',\n",
       " 'Used in combination with first- and second-line chemotherapy for the treatment of metastatic colorectal cancer and non-small cell lung cancer (NSCLC).',\n",
       " 'Palbociclib is indicated in combination with [letrozole] as initial endocrine-based therapy for the treatment of human epidermal growth factor receptor type 2 (HER2)-negative and hormone receptor(HR)-positive tumors in adult patients with advanced/metastatic breast cancer. It is as well approved in combination with [fulvestrant] in patients with disease progression with prior endocrine therapy.[A176783]\\r\\n\\r\\nIn the official labeling, the use of palbociclib should be accompanied with either an aromatase inhibition, no restricted to letrozole, as initial endocrine-based therapy in postmenopausal women or in man.[L48076]\\r\\n\\r\\nThe breast cancer starts as a group of cancer cells that grow into and destroy the nearby breast tissue. This growth can spread into other parts of the body which is called metastasis. According to the location of the cancer cells, it can be categorized in ductal carcinoma and lobular carcinoma. However, other types of breast cancer include inflammatory breast cancer, Paget disease of the breast, triple negative breast cancer non-Hodgkin lymphoma and soft tissue sarcoma.[L5870] In males, breast cancer is usually treated as the cases of postmenopausal women and almost all the cases are ductal carcinoma.[L5873]',\n",
       " 'Histamine phosphate is indicated as a diagnostic aid for the evaluation of gastric acid secretory function.',\n",
       " 'Rivaroxaban is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips replacements and total knee replacement surgery; prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); to reduce risk of recurrent DVT and/or PE. Rivaroxaban is also indicated, in combination with aspirin, for reducing the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease. Its use is also not recommended in those with severe renal impairment (<30mL/min).[L12819]\\r\\n\\r\\nRivaroxaban is also indicated for the treatment and prevention of VTE in pediatric patients (from birth to 18 years of age) and for thromboprophylaxis in pediatric patients 2 years old with congenital heart disease following the Fontan procedure.[L12819]\\r\\n',\n",
       " 'Triclosan is used in a variety of common household products, including soaps, mouthwashes, dish detergents, toothpastes, deodorants, and hand sanitizers.  It is also used in health care settings in surgical scrubs and personnel hand washes.',\n",
       " 'Indicated for use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds.[label]',\n",
       " \"For the treatment of Alzheimer's disease (AD).\",\n",
       " 'For the treatment of tapeworm and intestinal fluke infections: Taenia saginata (Beef Tapeworm), Taenia solium (Pork Tapeworm), Diphyllobothrium latum (Fish Tapeworm), Fasciolopsis buski (large intestinal fluke). Niclosamide is also used as a molluscicide in the control of schistosomiasis.',\n",
       " 'Investigated for use/treatment in viral infection.',\n",
       " 'Treatment of type 2 diabetes mellitus to improve glycemic control in combination with other agents or as monotherapy. ',\n",
       " 'Vildagliptin is indicated in the treatment of type II diabetes mellitus in adults. As monotherapy, vildagliptin is indicated in adults inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance.[L32803] It is also indicated as dual therapy in combination with metformin, a sulphonylurea, or a thiazolidinedione in adults patients with insufficient glycemic control despite maximal tolerated dose of monotherapy.[L32803] \\r\\n\\r\\nVildagliptin is also marketed in a combination product with [metformin] for the treatment of adults with type II diabetes mellitus who inadequately respond to either monotherapy of vildagliptin or metformin. This fixed-dose formulation can be used in combination with a sulphonylurea or insulin (i.e., triple therapy) as an adjunct to diet and exercise in adults who do not achieve adequate glycemic control with monotherapy or dual therapy.[L32813]',\n",
       " 'Boceprevir, when used in combination with [DB00811], [DB00008], and [DB00022] is indicated for use in the treatment of chronic HCV genotype 1 infection in adults [FDA Label].',\n",
       " 'Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, as well as adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib, and adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy. Dasatinib is also indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase or newly diagnosed Ph+ ALL in combination with chemotherapy.[L45171]',\n",
       " 'Investigated for use/treatment in leukemia (myeloid).',\n",
       " 'Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ',\n",
       " 'For use as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.',\n",
       " 'For the treatment and prevention of osteoporosis.',\n",
       " 'The capsaicin 8% patch is indicated in the treatment of neuropathic pain associated with post-herpetic neuralgia. There are multiple topical capsaicin formulations available, including creams and solutions, indicated for temporary analgesia in muscle and join pain as well as neuropathic pain. ',\n",
       " 'Dapagliflozin is indicated as an adjunct treatment to improve glycemic control in adult patients with type 2 diabetes mellitus along with diet and exercise.[L46372,A6757,A6758]For patients with chronic kidney disease at risk of progression, dapagliflozin in used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure.[L46372] Dapagliflozin is also indicated to either reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors.[L46372] Combination products with dapagliflozin also exist, either as a dapagliflozin-saxagliptin or dapagliflozin-metformin hydrochloride formulation.[L38724,L38729] Both are used as an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes.[L38724,L38729]',\n",
       " 'As the product Kinevac (FDA), sincalide is used for the following indications: 1) to stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; (2) to stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; (3) to accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract.[L48541]',\n",
       " 'For use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m<sup>2</sup>, or patients wih a BMI greater than 27 kg/m<sup>2</sup> with associated risk factors, such as type 2 diabetes or dyslipidaemia.',\n",
       " 'For the treatment of bronchial asthma, keloid and hypertrophic scar, and allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.',\n",
       " 'Chenodiol is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. Chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones.',\n",
       " 'Indicated for the treatment of allergic conditions, symptomatic relief of hypersensitivity reaction, and treatment of pruritic skin disorders.',\n",
       " 'Abiraterone is indicated for the treatment of **metastatic castration-resistant prostate cancer (mCRPC)** in combination with [methylprednisolone] [L40968] or [prednisone].[L40193, L47740, L47745] \\r\\n\\r\\nIn Europe and Canada, it is also used in patients with mCRPC who are asymptomatic or mildly symptomatic after the failure of androgen deprivation therapy for whom chemotherapy is not yet clinically indicated.[L47740, L47745] In Europe, it is used in patients whose disease has progressed on or after a docetaxel-based chemotherapy regimen.[L47740] In Canada, it is used in patients who have received prior chemotherapy containing [docetaxel] after the failure of androgen deprivation therapy.[L47745]\\r\\n\\r\\nAbiraterone is indicated in combination with [prednisone] for the treatment of **metastatic high-risk castration-sensitive prostate cancer (CSPC)**.[L40193] In Europe and Canada, it may also be used in combination with [prednisolone] and androgen deprivation therapy in newly diagnosed patients.[L47740, L47745]\\r\\n\\r\\nIn Canada and the US, abiraterone is also available in a combination product with [niraparib], which is indicated with [prednisone] for the treatment of adults with deleterious or suspected deleterious BRCA-mutated (BRCAm) mCRPC.[L46896, L47755] In Canada, this combination product is also used with [prednisolone] and is reserved for patients who are asymptomatic or mildly symptomatic, and in whom chemotherapy is not clinically indicated.[L46896]',\n",
       " 'Used in the emergency treatment of cardiac arrhythmias.',\n",
       " 'Used to manage hypertension and tachycardia. Also used to treat glaucoma.',\n",
       " 'Used to treat hypertension.',\n",
       " 'Investigated for use/treatment in solid tumors.',\n",
       " 'Treatment of advanced renal cell cancer and advanced soft tissue sarcoma (in patients previously treated with chemotherapy) ',\n",
       " 'Used for the treatment of schizophrenia.',\n",
       " 'Sodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturateprotein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.',\n",
       " 'For relief of heartburn and acid indigestion. May also be used as a nutritional supplement or to treat hypocalcemia. ',\n",
       " 'For sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning that is judged to be life-threatening [FDA Label].',\n",
       " 'Used as a bronchodilator in the treatment of asthma patients. ',\n",
       " 'For the treatment of depression (originally intended to treat tuberculosis).',\n",
       " 'Xylometazoline is indicated for the temporary relief of nasal congestion due to cold, hay fever or other respiratory allergies.[L31598]',\n",
       " 'Investigated for use/treatment in infectious and parasitic disease (unspecified) and pediatric indications.',\n",
       " 'Used as a topical antifungal treatment.',\n",
       " 'Used in the treatment of congestive heart failure.',\n",
       " 'Zotepine, like other atypical antipsychotics, is considered as the first-line treatment in newly diagnosed schizophrenia. It is usually thought to be an option of choice for managing acute schizophrenic episodes when discussion with the patient is not possible. Zotepine, as an atypical antipsychotic, is used in patients who are suffering unacceptable side effects from conventional antipsychotics or in relapse patients that were inadequately controlled.[T108] \\r\\n\\r\\nIt is important to consider that the indications stated above are related to atypical antipsychotics, that zotepine is not currently FDA, Canada or EMA approved and that studies have not shown any additional benefit when compared with other approved atypical antipsychotics.[A31857]\\r\\n\\r\\nSchizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels and behaves. It is usually marked for a loose reality perspective delineated by hallucinations, delusions and thought and movement disorders.[L1320]',\n",
       " 'In the information for tolfenamic acid, it is stated that this drug, being an NSAID, is effective in treating the pain associated with the acute attack of migraines in adults.[L1293]',\n",
       " 'Tofacitinib is indicated for the treatment of adult patients with moderately-to-severely active rheumatoid arthritis (RA), active psoriatic arthritis, active ankylosing spondylitis, or moderately-to-severely active ulcerative colitis who have had an inadequate response or intolerance to one or more TNF blockers.[L30395] It is also indicated as an oral solution in patients 2 years of age for the treatment of polyarticular course juvenile idiopathic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.[L30395]\\r\\n\\r\\nTofacitinib is not recommended to be used in combination with other biologic disease-modifying anti-rheumatic drugs (DMARDs) or potent immunosuppressive agents such as azathioprine or cyclosporine.[L30395]',\n",
       " 'Used to relieve cramps or spasms of the stomach and intestines. It is also useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also be used to help relieve period pain. Alverine citrate is also under investigation to increase the cytotoxic effects of the proteasome inhibitor MG132 on breast cancer cells. ',\n",
       " 'Used for over a century as a laxative.',\n",
       " 'For the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.',\n",
       " 'Investigated for the treatment of cancer.',\n",
       " 'Methacholine is indicated in adult and pediatric patients aged five years and older without clinically apparent asthma for the diagnosis of bronchial airway hyperactivity via the methacholine challenge test.[L31763]',\n",
       " 'Indicated as a sympatholytic and mydriatic. Impotence has been successfully treated with yohimbine in male patients with vascular or diabetic origins and psychogenic origins.',\n",
       " 'Ursodeoxycholic acid is indicated for the treatment of patients with primary biliary cholangitis.[L44627] \\r\\n\\r\\nIt is used for the short-term treatment of radiolucent, noncalcified gallbladder stones in patients selected for elective cholecystectomy. It is also used to prevent gallstone formation in obese patients experiencing rapid weight loss.[L44793]',\n",
       " 'For more information, refer to [ibuprofen].',\n",
       " 'Used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.',\n",
       " 'Bisacodyl is indicated to relieve occasional constipation and irregularity.[L13362]',\n",
       " 'Used in the treatment of amoebiasis.',\n",
       " 'Nitroxoline is an antibiotic agent.',\n",
       " 'For the treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.',\n",
       " 'Hydroxyprogesterone caproate was previously indicated in the US for the prevention of spontaneous preterm births in singleton pregnancies in women with a history of spontaneous preterm birth. This indication was revoked by the FDA in April 2023.[L46113]\\r\\n\\r\\nHydroxyprogesterone caproate remains indicated in other jurisdictions for the management of primary and secondary amenorrhea, corpus luteum insufficiency, and for the prevention of preterm birth.[L46123,L46128]',\n",
       " 'Diloxanide is used alone as a primary agent in the treatment of asymptomatic (cyst passers) intestinal amebiasis caused by Entamoeba histolytica. Diloxanide may also be used concurrently, or sequentially, with other agents such as the nitroimidazoles (eg. metronidazole) in the treatment of invasive or extraintestinal forms of amebiasis.\\r\\n',\n",
       " 'For the palliative treatment of patients with advanced prostatic carcinoma.',\n",
       " 'Formerly widely used as an antipyretic and analgesic in rheumatism, neuritis, and common colds. Currently used to measure total body water.',\n",
       " 'For the management of schizophrenia.',\n",
       " 'For the treatment of angina and high blood pressure.',\n",
       " 'Trimetazidine is indicated for the symptomatic treatment of stable angina pectoris in patients inadequately controlled or intolerant to first line therapies.[L33015]',\n",
       " 'For prophylaxis and treatment of bacterial infections.',\n",
       " \"Used for the treatment of various topical fungal infections, including athlete's foot (tinea pedis).\",\n",
       " 'Naphazoline is indicated for use as OTC eyedrops for ocular vasoconstriction or as a nasal preparation for nasal congestion[A176558,L5804,L5807].',\n",
       " 'Indicated as symptomatic treatment of allergic reactions: urticaria, allergies of the upper respiratory tract such as hey fever and perennial rhinitis, food and drug allergies; pruritus of various origins, except pruritus due to cholestasis; insect bites. Dimethindene is also indicated for pruritus in eruptive skin diseases such as chicken-pox. Dimethindene can also be used as an adjuvant in eczema and other pruriginous dermatoses of allergic origin. ',\n",
       " 'Hydralazine is indicated alone or adjunct to standard therapy to treat essential hypertension.[L8782] A combination product with isosorbide dinitrate is indicated as an adjunct therapy in the treatment of heart failure.[L8785]',\n",
       " 'Used to maintain blood pressure in hypotensive states.',\n",
       " 'For the treatment of moderate to severe hypertension.',\n",
       " 'Tetryzoline is indicated for the temporary relief of discomfort and redness of the eye due to minor eye irritations as monotherapy [L32579] or in combination with other eye lubricants and anti-irritants.[L32584, L32589, L32594]\\r\\n\\r\\nTetryzoline is also indicated for decongestion of nasal and nasopharyngeal mucosa.[L32599]',\n",
       " 'Used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.',\n",
       " 'For short-term treatment of severe insomnias, that are not responsive to other hypnotics.',\n",
       " 'Used to treat sneezing, runny nose, itching, watery eyes, hives, rashes, itching, and other symptoms of allergies and the common cold.',\n",
       " 'Molindone is used for the management of the manifestations of psychotic disorders.',\n",
       " 'Treatment of chronic psychoses and states of aggressiveness of various origins [L1515].',\n",
       " 'For the treatment of schizophrenia, sleep, disorders, agitation and mentally confused states [L1317, L1319, L1322].  ',\n",
       " 'Intravenous amisulpride is indicated in adults for the prevention of postoperative nausea and vomiting, either alone or in combination with an antiemetic of a different class. It is also indicated for the treatment of postoperative nausea and vomiting in patients who have received anti-emetic prophylaxis with an agent of a different class or have not received prophylaxis.[L32759]\\r\\n\\r\\nOral amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, characterized by positive symptoms with delusions, hallucinations, thought disorders, hostility and suspicious behavior; or primarily negative symptoms (deficit syndrome) with blunted affect, emotional and social withdrawal. Amisulpride also controls secondary negative symptoms in productive conditions as well as affective disorders such as depressive mood or retardation.[L32764]',\n",
       " 'For the maintenance treatment of chronic non-agitated schizophrenic patients.',\n",
       " 'For the treatment of all types of acute and chronic schizophrenia, including those which did not respond to the usual neuroleptics; manic syndromes.',\n",
       " \"For use/treatment in neurologic disorders and parkinson's disease as well as moderate-to-severe primary Restless Legs Syndrome.\",\n",
       " 'Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder.[L3358] One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause.[L7703] Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).[A1093,A181754,A181904]',\n",
       " 'Artinolol was introduced to be used as an antihypertensive agent since 1986.[T88] It has been studied for other functions like tremor control for patients with Parkinson disease and it is currently in clinical trials for its use in the control of blood pressure and heart rate.[L1168]',\n",
       " 'Used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.',\n",
       " 'Brotizolam is indicated for 2-4 weeks in the treatment of severe or debilitating insomnia. ',\n",
       " 'Diprenorphine is indicated to reverse the effects of powerful opioids including etorphine and carfentanil, often used for tranquilizing large animals. This drug is not approved for use in humans.',\n",
       " 'Some people use this compound as a psychedelic inducing agent.',\n",
       " 'Investigated for use/treatment in sleep disorders and insomnia.',\n",
       " 'theobromine is used as a vasodilator, a diuretic, and heart stimulant. And similar to caffeine, it may be useful in management of fatigue and orthostatic hypotension.',\n",
       " 'For the treatment of a wide range of gastrointestinal disorders, including such conditions as peptic ulcer, gastritis, hyperchlorhydria, functional diarrhea, irritable or spastic colon, pyloroduodenal irritability, pylorospasm, acute nonspecific gastroenteritis, biliary dyskinesia and chronic cholelithiasis, duodenitis, gastrointestinal spasm; it may also be used to treat genitourinary spasm.',\n",
       " 'Used to treat short-term sleeping problems (insomnia), such as difficulty falling asleep, frequent awakenings during the night, and early-morning awakening.',\n",
       " 'For the potential treatment of various leukemias, including chronic myeloid leukemia (CML).',\n",
       " 'As an oral extended-release tablet and a once-monthly extended-release suspension for intramuscular injection, paliperidone is indicated for the treatment of adults and adolescents with schizophrenia and in the treatment of schizoaffective disorder in combination with antidepressants or mood stabilizers.[L16168,L37744] Paliperidone is also available in both an every-three-month and twice-yearly extended-release suspension for intramuscular injection for the treatment of schizophrenia.[L4137,L37749]',\n",
       " 'Used mainly in the treatment of narcotic dependence.',\n",
       " 'Agomelatine is indicated to treat major depressive episodes in adults.',\n",
       " 'For the treatment of pancreatic cancer and appetite disorders.',\n",
       " 'Intended for the treatment of anxiety disorders.',\n",
       " 'For use as adjunctive medication in some psychotic patients. Propericiazine (Pericyazine)is used for the control of residual prevailing hostility, impulsiveness and aggressiveness. ',\n",
       " 'Etoperidone has been studied for the treatment of depression[T47], tremors in Parkinson, extrapyramidal symptoms[L1041] and male impotence[L1042]. It is not certain if it was ever approved and marketed but its current status is withdrawn.',\n",
       " 'Fenoterol is used for the treatment of asthma.',\n",
       " 'Used for the treatment of schizophrenia [L1097].',\n",
       " 'Indicated for symptomatic treatment of irritable bowel syndrome (IBS) and treatment of postoperative paralytic ileus following abdominal surgery. ',\n",
       " 'Arformoterol is indicated in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.[L43732]',\n",
       " 'For use in combination treatment of HIV infection (AIDS).',\n",
       " 'Investigated for use/treatment in fibromyalgia.',\n",
       " 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]',\n",
       " 'Tetraethylammonium is an experimental drug with no approved indication.',\n",
       " 'Used for treatment in psychosis, schizophrenia and schizoaffective disorders, manic disorders, and bipolar disorders as monotherapy or in combination.',\n",
       " 'For the treatment of atrial fibrillation and irritable bowel syndrome (IBS).',\n",
       " 'Used in the treatment of schizophrenia.',\n",
       " 'Treatment of acute schizophrenia. ',\n",
       " 'Desvenlafaxine is indicated for the treatment of major depressive disorder in adults.[L47936] It has also been used off-label to treat hot flashes in menopausal women.[A261166]',\n",
       " 'Viloxazine is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older.[L41685]',\n",
       " 'Lurasidone is indicated for the treatment of schizophrenia in patients 13 years old.[L16103] It is also indicated as a monotherapy for the treatment of bipolar depression in patients 10 years old, or in combination with lithium or valproate for the treatment of bipolar depression in adults.[L16103]',\n",
       " 'For the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old.',\n",
       " 'For relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorders.',\n",
       " 'Choline magnesium trisalicylate is used to reduce pain and inflammation caused by conditions such as arthritis. This medication is also used to treat fever in adults.',\n",
       " 'Zomepirac was indicated for the management of mild to severe pain.',\n",
       " 'Prucalopride is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.[L4882]\\r\\n\\r\\nCIC is one of the most common chronic functional gastrointestinal disorders worldwide. The diagnosis of this agent is very hard and it can be confirmed if the patient experience at least two of the following:\\r\\n\\r\\n-Straining during more than 25% of the bowel movements.\\r\\n\\r\\n-Lumpy or hard stools in 25% of the bowel movements.\\r\\n\\r\\n-Sensation of incomplete evacuation in more than 25% of all bowel movements.\\r\\n\\r\\n-Sensation of anorectal blockage or obstruction in more than 25% of the bowel movements.\\r\\n\\r\\n-Manual maneuvers required in more than 25% of the bowel movements.\\r\\n\\r\\n-Fewer than 3 bowel movements per week.[L4883]',\n",
       " 'Used as an appetite suppressant.',\n",
       " 'Clinical trials are now testing the therapeutic potential of MDMA for post-traumatic stress disorder (PTSD) and anxiety associated with terminal cancer. MDMA is one of the four most widely used illicit drugs in the U.S.',\n",
       " 'Pheniramine is commonly used in over-the-counter products to treat seasonal allergies or cold and flu symptoms.[L7649,L7652]',\n",
       " \"Investigated for use/treatment in peripheral vascular disease and raynaud's disease.\",\n",
       " 'Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment[A177187,Label].',\n",
       " 'Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the management of fibromyalgia in patients that are 18 years old or above [F3925]. \\r\\n\\r\\nWhile milnacipran may be used for the treatment of major depressive disorder (MDD), it is only recommended in adult patients who are 18 years old or above [F3922] due to an increased risk for suicidal ideation, thinking, and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders. Some regional prescribing information notes that the use of the medication is specifically for the short-term symptomatic relief of MDD [F3919]. Nevertheless, it is important to note that the regulatory approval of and/or indications listed here for milnacipran may or may not exist and/or vary greatly between regions and nations [F3928, F3934].',\n",
       " 'There is no approved indication for guvacine.',\n",
       " 'For the treatment of mucosal (caused by Leishmania braziliensis), cutaneous (caused by L. braziliensis, L. guyanensis, and L. panamensis), and visceral leishmaniasis (caused by L. donovani). In comparing Leishmania drug susceptibility, it has been found that L. donovani is the most susceptible to miltefosine while L. major is the least susceptible.  Off-label use includes treatment of free-living amebae (FLA) infections (unlabeled use; CDC, 2013). ',\n",
       " 'Neostigmine is used for the symptomatic treatment of myasthenia gravis by improving muscle tone.',\n",
       " 'Sulfathiazole is effective against a wide range of gram positive and gram negative pathogenic microorganisms. Although no longer used in humans, it is used in cattle.',\n",
       " 'Decitabine is indicated for the treatment of patients with myelodysplastic syndromes (MDS) including all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia), as well as for MDS scored as belonging to the intermediate-1, intermediate-2, or high-risk group in the International Prognostic Scoring System.[L14962]',\n",
       " \"Betahistine is indicated for the reduction of recurrent vertigo episodes associated with Mnire's disease in patients 18 years old and above.[L16388]\",\n",
       " 'Investigated for use/treatment in solid tumors and cancer/tumors (unspecified).',\n",
       " 'For treatment of human sleeping sickness, onchocerciasis and other diseases caused by trypanosomes and worms.',\n",
       " 'Carfilzomib is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy in combination with lenalidomide and dexamethasone; or dexamethasone; or daratumumab and dexamethasone; or daratumumab and hyaluronidase-fihj and dexamethasone; or isatuximab and dexamethasone. It is also indicated as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.[L39392,L42350]',\n",
       " 'Investigated for use/treatment in breast cancer.',\n",
       " 'Indicated for following conditions alone or in combination with conjugated estrogens in women with a uterus:\\r\\n\\r\\n- Treatment of moderate to severe vasomotor symptoms associated with menopause\\r\\n\\r\\n- Prevention of postmenopausal osteoporosis',\n",
       " 'Crizotinib is a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test.[L42460] Crizotinib is also indicated for the treatment of relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive in pediatric patients 1 year of age and older and young adults. The safety and efficacy of crizotinib have not been established in older adults with relapsed or refractory, systemic ALK-positive ALCL.[L42460] Additionally, crizotinib is indicated for the treatment of adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory inflammatory myofibroblastic tumor (IMT) that is ALK-positive.[L42460]',\n",
       " 'Pimavanserin is indicated for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis.[L32883] ',\n",
       " 'Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in patients aged 10 years and older with type 2 diabetes. It is used either alone or in combination with [metformin] or [linagliptin].[L13679, L13673, L13688, L49449] It is also indicated to reduce the risk of cardiovascular death in adult patients with both type 2 diabetes mellitus and established cardiovascular disease, either alone or as a combination product with metformin.[L13688, L40778]\\r\\n\\r\\nAn extended-release combination product containing empagliflozin, metformin, and linagliptin was approved by the FDA in January 2020 for the improvement of glycemic control in adults with type 2 diabetes mellitus when used adjunctively with diet and exercise.[L11479]\\r\\n\\r\\nEmpagliflozin is also approved to reduce the risk of cardiovascular mortality and hospitalization due to heart failure in adult patients with heart failure, either alone or in combination with metformin.[L13688, L45578] It is also indicated in adults to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression.[L40778, L48255]\\r\\n\\r\\nEmpagliflozin is not approved for use in patients with type 1 diabetes.',\n",
       " 'Idelalisib is indicated in the treatment of chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL). For the treatment of relapsed CLL, it is currently indicated as a second-line agent in combination with rituximab in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities, while in the treatment of FL and SLL it is intended to be used in patients who have received at least two prior systemic therapies.',\n",
       " 'Drospirenone, in combination with ethinyl estradiol or estetrol, is indicated as an oral contraceptive for the prevention of pregnancy.[L7973,L33174] In addition to its use for contraceptive effects, this combination is used to treat moderate acne vulgaris and the symptoms of premenstrual dysphoric disorder.[L7973,L7976]  The drug has approved indications for combination with estrogens for the treatment of menopause-associated symptoms, such as vasomotor symptoms and vulvovaginal atrophy. Drospirenone combined with estrogen may also may aid in the prevention of osteoporosis in women who have been post-menopausal for at least a year and are not candidates for other therapies.[L7997,L8075]   It can sometimes be found in preparations containing estrogen and folic acid for folic acid replenishment during oral contraception.[L8078]\\r\\n\\r\\nWhen used for the treatment of acne vulgaris, drospirenone-containing contraceptives should only be used in women 14 years of age who have experienced menarche, desire oral contraception, and do not have any contraindications to oral contraceptives.[L7976] Off-label uses for this drug include the treatment of menstrual irregularities, dysmenorrhea, hirsutism, and endometriosis.[A2439,A182576]',\n",
       " 'Sulbactam is used in combination with other antibacterial agents. With [ampicillin], it is used to treat skin and skin structure infections, intra-abdominal infections, and gynecological infections caused by susceptible bacteria.[L50131]\\r\\n\\r\\nIn combination with [durlobactam], sulbactam is indicated in adults for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of _Acinetobacter baumannii-calcoaceticus_ complex.[L47336]',\n",
       " 'Diosmin is used over-the-counter alone or with ingredients such as [hesperidin] and [diosmetin] to support vein and capillary function.[L32823,L32848]',\n",
       " 'Investigated for use/treatment in cancer/tumors (unspecified), gastric cancer, and pancreatic cancer.',\n",
       " \"Ibrutinib is indicated for the treatment of the following conditions. \\r\\n\\r\\n**Chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)**\\r\\n\\r\\n- In the US, it is used in adult patients with or without 17p deletion.[L42980, L45884] \\r\\n- In Europe and Canada, it is used as a single agent or combined with [rituximab], [obinutuzumab], or [venetoclax] in previously untreated CLL patients. In patients who have received at least one prior therapy, it is used as a single agent or in combination with [bendamustine] and [rituximab].[L45884, L45889]\\r\\n\\r\\n**Waldenstrm's macroglobulinemia**\\r\\n\\r\\n- It is used alone [L42980, L45884, L45889] or with [rituximab].[L45884, L45889]\\r\\n- In Europe, it is approved for patients who have received at least one prior therapy or in first-line treatment for patients unsuitable for chemoimmunotherapy.[L45884]\\r\\n\\r\\n**Chronic graft-versus-host disease (cGVHD)**\\r\\n\\r\\n- In the US, it is approved in patients aged one year and older after the prior failure of one or more lines of systemic therapy.[L42980]\\r\\n- In Canada, it is approved in adults with steroid-dependent or refractory cGVHD.[L45889]\\r\\n\\r\\n**Mantle cell lymphoma (MCL)**\\r\\n\\r\\n- In Europe and Canada, ibrutinib is also indicated to treat relapsed or refractory MCL in adults.[L45884, L45889]\\r\\n\\r\\n**Marginal zone lymphoma (MZL)**\\r\\n\\r\\n- In Canada, it is approved for adults who require systemic therapy and have received at least one prior anti-CD20-based therapy.[L45889]\",\n",
       " 'Etravirine is indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in treatment-experienced patients 2 years of age.[L9320]',\n",
       " 'Linagliptin is indicated for the treatment of type II diabetes in addition to diet and exercise[L9557]. It should not be used to treat type I diabetes or in diabetic ketoacidosis.[L9557] An extended-release combination product containing empagliflozin, linagliptin, and metformin was approved by the FDA in January 2020 for the improvement of glycemic control in adults with type 2 diabetes mellitus when used adjunctively with diet and exercise.[L11479]',\n",
       " 'For the treatment bacterial infections.',\n",
       " 'Investigated for use/treatment in prostate cancer.',\n",
       " 'Used to lower LDL and HDL cholesterol.',\n",
       " 'Plerixafor is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma or multiple myeloma.[L45678]',\n",
       " 'Brexpiprazole is indicated as adjunctive therapy to antidepressants for the treatment of major depressive disorder in adults.[L39568] It is also indicated for the treatment of schizophrenia in patients 13 years of age and older.[L39568]\\r\\n\\r\\nBrexpiprazole is also indicated for the treatment of agitation associated with dementia due to Alzheimers disease; however, it is not indicated as an as-needed (prn) treatment for this condition.[L46417]',\n",
       " 'Regorafenib is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy. Regorafenib is also indicated for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumour (GIST) who have been previously treated with imatinib mesylate and sunitinib malate. Regorafenib is also indicated for the treatment of patients with hepatocellular carcinoma (HCC) previously treated with sorafenib.[L16835]',\n",
       " 'For prophylaxis of invasive <em>Aspergillus</em> and <em>Candida</em> infections in patients, 13 years of age and older, who are at high risk of developing these infections due to being severely immunocompromised as a result of procedures such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD), or due to hematologic malignancies with prolonged neutropenia from chemotherapy. Also for the treatment of oropharyngeal candidiasis, including oropharyngeal candidiasis refractory to itraconazole and/or fluconazole. Posaconazole is used as an alternative treatment for invasive aspergillosis, <em>Fusarium</em> infections, and zygomycosis in patients who are intolerant of, or whose disease is refractory to, other antifungals.',\n",
       " \"Treatment of hyperkinetic movement disorders like chorea in Huntington's disease, hemiballismus, senile chorea, Tourette syndrome and other tic disorders, and tardive dyskinesia \",\n",
       " 'Estropipate is used for the treatment of moderate to severe vasomotor symptoms associated with the monopause, and moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause. It is also used to treat hypoestrogenism due to hypogonadism, castration or primary ovarian failure, and prevent postmenopausal osteoporosis.',\n",
       " 'For improvement in appearance of moderate to severe fullness associated with submental fat in adults. ',\n",
       " 'Used primarily as an anti-anxiety agent. Typically used short term, and may be given as a single dose of up to 100mcg/kg to reduce anxiety and tension experienced prior to surgery. ',\n",
       " 'For use as an aid in smoking cessation.\\r\\n\\r\\nVarenicline as a nasal spray is indicated for the symptomatic treatment of dry eye disease.[L38954]',\n",
       " 'Tiaprofenic acid is used to treat pain, especially arthritic pain.',\n",
       " 'For the treatment of estrogen-receptor positive breast cancer in post-menopausal women.',\n",
       " 'Aclidinium bromide inhalation powder is indicated for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.',\n",
       " 'Eugenol is not currently available in any FDA-approved drug products. There are a number of unapproved OTC products that advertise it for the use of toothache.  Eugenol is is also commonly used in combination with zinc oxide in dental procedures for the cementation of temporary prostheses and the temporary restoration of teeth and cavities.',\n",
       " \"Afatinib is a kinase inhibitor indicated as monotherapy [L2937] for the first-line [FDA Label] treatment of (a) Epidermal Growth Factor Receptor (EGFR) TKI (tyrosine kinase inhibitor)-naive adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have non-resistant EGFR mutations as detected by an FDA-approved test [FDA Label], and (b) adult patients with locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy [FDA Label, L2937].\\r\\n\\r\\nRecently, as of January 2018, the US FDA approved a supplemental New Drug Application for Boehringer Ingelheim's Gilotrif (afatinib) for the first line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test [L2939]. The new label includes data on three additional EGFR mutations: L861Q, G719X and S768I [L2939].\",\n",
       " 'Cetizoxime was previously indicated for the treatment of infections due to susceptible strains of bacteria.',\n",
       " \"Bifeprunox is being evaluated for the treatment of schizophrenia, psychosis, and Parkinson's disease.\",\n",
       " 'For use as an alkalinizing agent.',\n",
       " \"Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and have demonstrated disease progression on or within 60 days of completion of the last therapy. It is also indicated for the treatment of Kaposi's sarcoma (KS) in AIDS patients who have failed highly active antiretroviral therapy (HAART) and for the treatment of KS in HIV-negative patients.[L40918]\",\n",
       " 'Osimertinib is indicated as adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations (as detected by an FDA-approved test), and as the first-line treatment of adult patients with metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations (as detected by an FDA-approved test). Osimertinib is also indicated for the treatment of adult patients with metastatic EGFR T790M mutation-positive NSCLC, as detected by an FDA-approved test, whose disease has progressed on or after EGFR TKI therapy.[L43453]',\n",
       " 'For use as an adjunct to percutaneous coronary intervention (PCI) for reducing the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients in who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor.',\n",
       " 'For the treatment of psychosis, particular those of schizophrenia, and manic phases of bipolar disorder.',\n",
       " 'Dronedarone is indicated for the management of atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmal or persistent AF to reduce the risk of hospitalization.[L8699]',\n",
       " 'This drug is used in conjunction with diet and exercise to increase glycemic control in adults diagnosed with type 2 diabetes mellitus [FDA label].\\r\\n\\r\\nAnother indication for canagliflozin is the prevention of major cardiovascular events (myocardial infarction, stroke, or death due to a cardiovascular cause) in patients with type 2 diabetes, as well as hospitalization for heart failure in patients with type 2 diabetes[L5897,[L8917].\\r\\n\\r\\nIn addition to the above, canagliflozin can be used to lower the risk of end-stage kidney disease and major increases in serum creatinine and cardiovascular death for patients with a combination of type 2 diabetes mellitus, diabetic nephropathy, and albuminuria.[L8917]\\r\\n\\r\\nIt is important to note that this drug is **not** indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis [FDA label]. ',\n",
       " 'Telaprevir, when used in combination with [DB00811], [DB00008], and [DB00022] is indicated for use in the treatment of chronic HCV genotype 1 infection in adults [FDA Label].',\n",
       " 'Investigated for use/treatment in HIV infection.',\n",
       " 'For the treatment of solid tumors.',\n",
       " 'For the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.',\n",
       " 'Carfentanil is similar (but more potent) to the opioid analgesic fentanyl. It is used as a tranquilizer for large animals.',\n",
       " 'Investigated for use/treatment in irritable bowel syndrome (IBS).',\n",
       " 'Used for the treatment of pain inflammation and fever in horses and dogs.',\n",
       " 'Investigated for use/treatment in HIV infection.',\n",
       " 'Diagnostic agent for radionuclide myocardial perfusion imaging (MPI) ',\n",
       " 'Administered intravenously, biricodar dicitrate is to be used in combination with cancer chemotherapy agents.',\n",
       " 'Investigated for use/treatment in ulcerative colitis.',\n",
       " 'Loxoprofen is non-steroidal anti-inflammatory medication (NSAID) indicated for pain and inflammation related to musculoskeletal and joint disorders.[L1226] In addition to its effects on pain, it is an antipyretic and anti-inflammatory medication.[L1227]',\n",
       " 'Indicated for use in smoking cessation. ',\n",
       " 'Dextroamphetamine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).[Label]',\n",
       " 'Dihydromorphine is an opioid analgesic used for moderate to severe pain relief.',\n",
       " 'For the treatment of congestive heart failure.',\n",
       " 'Prior to its withdrawal, aminopterin was initially used in the treatment of childhood leukemia; specifically to induce remissions. Later, aminopterin was used off-label in the United States to treat psoriasis, yielding dramatic lesion clearing. Aminopterin was later supplanted by methotrexate for treating cancer because of its better therapeutic index. Aminopterin (as well as methotrexate) has also been explored for use as an abortifacient. However, their association with severe congenital malformations and teratogenic effects have become known as fetal aminopterin syndrome. ',\n",
       " \"Investigated for use/treatment in cancer/tumors (unspecified), eye disorders/infections, psoriasis and psoriatic disorders, and rheumatoid arthritis.\\r\\nCan-Fite BioPharma has reported that by targeting the adenosine A3-receptor, CF101 may also be used to treat Crohn's disease, a serious gastrointestinal disorder.\",\n",
       " 'Eflornithine is indicated to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma (HRNB) who have demonstrated at least a partial response to prior multiagent, multimodality therapy including anti-GD2 immunotherapy.[L49288]  It was also previously indicated for the treatment of female hirsutism and African trypanosomiasis but has since been discontinued.[L49318]',\n",
       " 'Potential therapy for schizophrenia, depression and visceral pain.',\n",
       " 'Investigated for use/treatment in pulmonary hypertension, connective tissue diseases, hypertension, and congestive heart failure.',\n",
       " \"Investigated for use/treatment in Alzheimer's disease, Attention Deficit/Hyperactivity Disorder (ADHD), and Schizophrenia and schizoaffective disorders.\",\n",
       " 'Cortisone acetate is indicated to treat a wide variety of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders.[A226300,L13203]',\n",
       " 'For the treatment of dementia in subjects with Alzheimers disease.',\n",
       " 'Because of its high affinity for the phencyclidine binding site on the NMDA receptor, the 3H radiolabelled form of tenocyclidine is widely used in research into NMDA receptors.',\n",
       " 'For the management of osteoarthritis.',\n",
       " 'Umeclidinium is approved by the FDA and Health Canada for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).[L44466,L46931] Additionally, umeclidinium also exists as combination products with [vilanterol] or [vilanterol] and [fluticasone furoate].[L44461,L44456,L46961,L46966] Both products were indicated for the maintenance treatment of COPD, but only the umeclidinium/[vilanterol]/[fluticasone furoate] product was approved  for the maintenance treatment of asthma in patients aged 18 years and older.[L44461,L44456,L46961,L46966]',\n",
       " 'For the long term, once-daily-dosing maintenance of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.\\r\\n',\n",
       " \"Investigated for use/treatment in alzheimer's disease and schizophrenia and schizoaffective disorders.\",\n",
       " 'Nonoxynol 9 is a surfactant spermicide used for contraception in spermicidal creams, jellies, foams, gel, and lubricants. It is also used in conjuction with other methods of contraception, including condoms, cervical caps and diaphragms.',\n",
       " 'Pirfenidone is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).[L26801,L26816,L42555] In Canada and Europe, it is approved in adults only.[L26816,L42555]',\n",
       " 'Technetium Tc 99m Medronate is indicated for use as a bone imaging agent to delineate areas of altered osteogenesis.',\n",
       " 'Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) in adults.[L47946]',\n",
       " 'Investigated for use/treatment in bacterial infection, infectious and parasitic disease (unspecified), and tuberculosis.',\n",
       " 'Suvorexant is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.',\n",
       " 'Vismodegib is indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation.[L45803]',\n",
       " 'Afamelanotide is indicated for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).[L9086]',\n",
       " 'Tedizolid is indicated for the treatment of acute bacterial infections of the skin and skin structure (ABSSSI). To prevent drug resistance, tedizolid should only be used for infections that are caused by susceptible bacteria.[L11232]',\n",
       " 'For the treatment of major depressive disorder. ',\n",
       " 'Fingolimod is indicated for the treatment of patients aged 10 and above with relapsing forms of multiple sclerosis, which may include clinically isolated syndrome, relapsing-remitting disease, as well as active secondary progressive disease.[L12651,L44346]',\n",
       " 'Cariprazine is indicated for the treatment of **schizophrenia** in adults to manage both positive and negative symptoms. It is also indicated to monotherapy for acute management of manic or mixed episodes associated with bipolar I disorder (**bipolar mania**) in adults, and acute management of depressive episodes associated with bipolar I disorder (**bipolar depression**) in adults.[L43307,L40198]',\n",
       " 'For use as adjunctive therapy in the treatment of peptic ulcer. It has not been \\r\\nshown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications.\\r\\n',\n",
       " 'For short-term treatment of mild to moderate pain, including dysmenorrhoea, musculoskeletal pain and toothache [L1302]. ',\n",
       " 'Investigated for use/treatment in depression.',\n",
       " 'For the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults.',\n",
       " 'For the treatment of hypertension.',\n",
       " 'Investigated for use/treatment in diabetic kidney disease.',\n",
       " 'Ophthalmic tetracaine is indicated for the for procedures requiring a rapid and short- acting topical ophthalmic anesthetic.\\r\\n\\r\\nThe combination lidocaine and tetracaine patch is indicated for local dermal analgesia for superficial dermatological procedures and superficial venous access.  The combination lidocaine and tetracaine cream is intended to provide topical local analgesia for superficial dermatological procedures.',\n",
       " 'Used in homozygous familial hypercholesterolemia (HoFH) patients to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C).',\n",
       " 'For the treatment of congestive heart failure and hypertension.',\n",
       " 'For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.',\n",
       " 'Treatment of opioids induced constipation in palliative patients that are inadequately responding to laxative therapy. ',\n",
       " 'Investigated for use/treatment in nocturia (frequent nighttime urination) and urinary incontinence.',\n",
       " 'Investigated for use/treatment in atherosclerosis, coronary artery disease, diabetes mellitus type 2, and in-stent restenosis.',\n",
       " 'Currently being tested as a treatment of severe intoxications with hepatotoxic substances, such as death cap (Amanita phalloides) poisoning.',\n",
       " 'ThioTEPA is used a as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients. Also, when high dose chemotherapy with HPCT support it is appropriate for the treatment of solid tumours in adult and paediatric patients.',\n",
       " 'Lofexidine is indicated for mitigation of symptoms associated with acute withdrawal from opioids and for facilitation of the completion of opioid discontinuation treatment. It is the first non-opioid medication for the symptomatic management of opioid discontinuation.[L2801]\\r\\n\\r\\nOpioid withdrawal syndrome is a debilitating manifestation of opioid dependence.[A33085] This condition is extremely unpleasant lasting several days with some of the main features being abdominal pain, nausea, diarrhea, mydriasis, lacrimation, and piloerection. These symptoms are often observed after abrupt reductions in the opioid dose and can be resolved by re-administration of the opioid.[A33088]',\n",
       " 'For the treatment of hepatitis C virus (HCV) infection.',\n",
       " \"Developed in the 1960's for use as an antidepressant before market withdrawal in 1962. \\r\\n\",\n",
       " 'Intended for use as a radiation sensitizer in the treatment of brain cancer.',\n",
       " 'Avanafil is indicated for the treatment of erectile dysfunction.[L32058]',\n",
       " 'Adjuvant treatment of partial-onset seizures. ',\n",
       " 'Used to control postpartum hemorrhage and bleeding after giving birth.',\n",
       " 'For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications.',\n",
       " 'Vilazodone is approved for treatment of major depressive disorder.[Label,A38477,A177622]',\n",
       " 'Silodosin is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). It is not indicated for the treatment of hypertension.[L32368]',\n",
       " 'Dolutegravir is indicated in combination with other antiretroviral agents for the treatment of patients with HIV-1 infection that comply with the characteristics of being adults or children aged 12 years and older and present at least a weight of 40 kg.[A7520] The FDA combination therapy approval of dolutegravir and [rilpivirine] is indicated for adults with HIV-1 infections whose virus is currently suppressed (< 50 copies/ml) on a stable regimen for at least six months, without history of treatment failure and no known substitutions associated to resistance to any of the two components of the therapy.[L1031]\\r\\n\\r\\nDolutegravir is also available in combination with [lamivudine] and [abacavir] for the treatment of adult and pediatric patients with HIV-1 who weigh 10kg.[L41365]',\n",
       " 'Bedaquiline is indicated as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB). Reserve SIRTURO for use when an effective treatment regimen cannot otherwise be provided.[L48506]\\r\\n\\r\\nThis indication is approved under FDA accelerated approval based on time to sputum culture conversion. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.[L48506]',\n",
       " 'Investigated for use/treatment in addictions.',\n",
       " 'Netupitant is an antiemitic drug approved by the FDA in October 2014 for use in combination with palonosetron for the prevention of acute and delayed vomiting and nausea associated with cancer chemotherapy including highly emetogenic chemotherapy.',\n",
       " 'Used to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. Also investigated for use in the treatment of pain (acute or chronic).',\n",
       " 'In the US and Europe, lacosamide is indicated for the treatment of partial-onset seizures in children and adults.[L49191, L49196, L49201] In Canada, it is reserved for use in adults.[L49206]\\r\\n\\r\\nIt is also used as an adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients four years of age and older.[L49191, L49201]\\r\\n\\r\\nThe extended-release capsules of lacosamide are indicated for the treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg.[L49196]',\n",
       " 'For the treatment of chronic hepatitis B in adult and adolescent patients 16 years of age with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.',\n",
       " 'Cilnidipine is indicated for the management of hypertension for end-organ protection.[L1436] It is reported to be useful in elderly patients and in those with diabetes and albuminuria. Cilnidipine has been increasingly used in patients with chronic kidney disease \\r\\n\\r\\nHypertension is the term used to describe the presence of high blood pressure. The blood pressure is generated by the force of the blood pumped from the heart against the blood vessels. Thus hypertension is caused when there is too much pressure on the blood vessels and this effect can damage the blood vessel.[L1438]',\n",
       " 'For the reduction of blood pressure when when oral antihypertensive therapy is not feasible or not desirable.',\n",
       " 'Indicated for the treatment of mild to moderate essential hypertension and management of chronic stable angina.',\n",
       " 'For the treatment of arsenic, gold and mercury poisoning. Indicated in acute lead poisoning when used concomitantly with edetate calcium disodium (DB00974).',\n",
       " \"Investigated for use/treatment in lymphoma (non-hodgkin's) and solid tumors.\",\n",
       " 'For the treatment of rheumatoid arthritis (RA).',\n",
       " 'For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity.',\n",
       " 'As monotherapy, dabrafenib is indicated to treat unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.[L41955] \\r\\n\\r\\nIn combination with [trametinib], dabrafenib is indicated to treat for:\\r\\n\\r\\n- the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test.[L41955]\\r\\n- the adjuvant treatment of melanoma with BRAF V600E or V600K mutations and involvement of lymph node(s), following complete resection.[L41955]\\r\\n- the treatment of metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation.[L41955]\\r\\n- the treatment of locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment options.[L41955]\\r\\n- treatment of adult and pediatric patients six years and older with unresectable or metastatic solid tumours with BRAF V600E mutation who have progressed following prior treatment and have no satisfactory alternative treatment options. This indication is approved under accelerated approval based on the overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).[L45548]\\r\\n- the treatment of pediatric patients one year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy.[L45548]\\r\\n\\r\\nDabrafenib has limitations of use: it is neither indicated for treating patients with colorectal cancer because of known intrinsic resistance to BRAF inhibition nor wild-type BRAF solid tumours.[L45548]',\n",
       " 'Pinaverium is indicated for the symptomatic treatment of irritable bowel syndrome (IBS) and functional disorders of the biliary tract.',\n",
       " 'Betaine is indicated for the treatment of homocystinuria in pediatric and adult patients to decrease elevated homocysteine blood levels.[L43105] Included within the category of homocystinuria are deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylenetetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (cbl).[L43105]',\n",
       " 'Cobimetinib is indicated in combination with [vemurafenib] for the treatment of unresectable or metastatic melanoma with a BRAF V600E or V600K mutation. As a single agent, cobimetinib is also indicated for the treatment of adult patients with histiocytic neoplasms.[L43717]',\n",
       " 'For the treatment of bacterial infections.',\n",
       " 'Used to treat infections caused by susceptible Gram-positive bacteria, particularly beta-lactamase-producing organisms such as <i>Staphylococcus aureus</i> that would otherwise be resistant to most penicillins.',\n",
       " 'For the treatment of endometriosis and fibrocystic breast disease (in patients unresponsive to simple measures). Also used for the prophylactic treatment of all types of hereditary angioedema in males and females.',\n",
       " 'Available predominantly as a liquid mouthwash, oromucosal spray, or topical cream, benzydamine is most frequently employed as a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions. \\r\\n\\r\\nWhen formulated as a mouthwash or spray, benzydamine may be used to treat traumatic conditions like pharyngitis following tonsillectomy or the use of a naso-gastric tube, inflammatory conditions like pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy, dentistry operations and procedures, or more general conditions like sore throat, sore tongue, sore gums, mouth ulcers, or discomfort caused by dentures. [L1121] \\r\\n\\r\\nWhen used as a topical cream, benzydamine may be employed to relieve symptoms associated with painful inflammatory conditions of the muscolo-skeletal system including acute inflammatory disorders such as myalgia and bursitis or traumatic conditions like sprains, strains, bruises, sore muscles, stiff joints, or even the after-effects of fractures. [ L1123]',\n",
       " 'For the treatment of bacterial infection.',\n",
       " 'For the management of vasospastic angina, chronic stable angina and hypertension.',\n",
       " 'Used as an ingredient in sunscreen and other cosmetics.',\n",
       " 'For the treatment of asthma and chronic obstructive pulmonary disease (COPD).',\n",
       " 'Dabigatran etexilate is available in both oral pellet and capsule form. Dabigatran etexilate pellets are indicated for the treatment of venous thromboembolic events (VTE) in pediatric patients between three months and 12 years of age who have been treated with a parenteral anticoagulant for at least 5 days. They are also indicated in the same age group to reduce the risk of recurrence of VTE in patients who have been previously treated.[L34675]\\r\\n\\r\\nIn capsule form, dabigatran etexilate is indicated in adults to reduce the risk of stroke and systemic embolism associated with non-valvular atrial fibrillation and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for 5-10 days. It is also indicated in adults to reduce the risk of recurrence of DVT and PE in patients who have been previously treated and for the prophylaxis of DVT and PE in patients who have undergone hip replacement surgery. Lastly, it is indicated in pediatric patients between eight and 18 years of age for the treatment of venous thromboembolic events (VTE) in patients who have been treated with a parenteral anticoagulant for at least 5 days and to reduce the risk of recurrence of VTE in patients who have been previously treated.[L34680]\\r\\n\\r\\nDabigatran etexilate is also approved by the EMA to prevent VTE in adult patients. For pediatric patients, Dabigatran etexilate is used to treat TVE and prevent recurrent TVE for patients from birth to less than 18 years of age.[L46856]',\n",
       " 'For the treatment of disorders of the upper gastro-intestinal region that are due to an excess of hydrochloric acid in the gastric juice, i.e. duodenal ulcers, benign gastric ulcers. Also for prophylaxis of recurrent gastric and duodenal ulcers',\n",
       " 'Triethylenetetramine is a copper chelator indicated for the treatment of adult patients with stable Wilsons disease who are de-coppered and tolerant to [penicillamine].[L41730]',\n",
       " 'Ivabradine is indicated by the FDA to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction 35%, who are in sinus rhythm with resting heart rate 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use. It is also indicated for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy for pediatric patients 6 months of age or more[FDA Label].',\n",
       " 'For the treatment of renal cell carcinoma (RCC). Also investigated for use/treatment in breast cancer, lymphoma (unspecified), rheumatoid arthritis, and multiple myeloma.',\n",
       " 'Fluticasone furoate is indicated for once-daily maintenance (i.e. prophylactic) treatment of asthma in patients 5 years old.[L40838] Fluticasone furoate is available in two combination medications - one in combination with [vilanterol] and one in combination with both vilanterol and [umeclidinium]- which are both indicated for the management of chronic obstructive pulmonary disease (COPD) and for the treatment of asthma in patients 18 years old for the vilanterol-umeclidinium-fluticasone product and 5 years old for the vilanterol-fluticasone product.[L44456,L46481] \\r\\n\\r\\nFluticasone furoate is available over the counter as a nasal spray for the symptomatic treatment of hay fever and other upper respiratory allergies in patients 2 years old.[L40843]',\n",
       " 'Pretomanid is indicated, as part of a combination regimen with bedaquiline and linezolid, for the treatment of adults with pulmonary tuberculosis (TB) that is resistant to isoniazid, rifamycins, a fluoroquinolone and a second-line injectable antibacterial drug or adults with pulmonary TB resistant to isoniazid and rifampin, who are treatment-intolerant or non-responsive to standard therapy.[L44707]',\n",
       " 'Used for the treatment of hypertension and heart failure [A20319].',\n",
       " 'Spirapril is an ACE inhibitor class drug used to treat hypertension.',\n",
       " 'Acepromazine was first used in humans in the 1950s as an antipsychotic agent. It is now rarely used in humans. Acepromazine is frequently used in animals as a sedative and antiemetic. Its principal value is in quietening and calming anxious animals.',\n",
       " 'Vecuronium is a muscle relaxing agent and is used as an adjunct in general anesthesia.',\n",
       " 'Intended for the treatment of various forms of cancer.',\n",
       " 'Investigated for use/treatment in colorectal cancer, leukemia (myeloid), pancreatic cancer, and solid tumors.',\n",
       " 'Investigated for use/treatment in breast cancer, ovarian cancer, and prostate cancer.',\n",
       " 'Indicated for the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.',\n",
       " 'Mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. May be used for surgical prophylaxis; if required metronidazole may be added to cover B. fragilis.',\n",
       " 'For the treatment of serious infections caused by susceptible strains of  microorganisms.',\n",
       " 'Cefepime is indicated for the treatment of pneumonia caused by susceptible bacteria, and for empiric therapy for febrile neutropenic patients. Cefepime is also indicated for the treatment of uncomplicated and complicated urinary tract infections (cUTI) including pyelonephritis, uncomplicated skin and skin structure infections, and complicated intra-abdominal infections (used in combination with [metronidazole]) in adults caused by susceptible bacteria.[L42095,L42100]\\r\\n\\r\\nCefepime is also used in combination with [enmetazobactam] to treat cUTI.[L50117]',\n",
       " 'Latamoxef is an oxacephem antibiotic usually grouped with the cephalosporins. It is used to treat bacterial infections. Latamoxef  is primarily indicated in conditions like Bone and joint infection, GI infections, Gynecological infections, Meningitis, Respiratory tract infections, Septicaemia, Skin infections, Soft tissue infections, UTI. ',\n",
       " 'Indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms.',\n",
       " 'Investigated for use/treatment in atopic dermatitis.',\n",
       " 'As the product Ella (available in Canada and the US), ulipristal is indicated for use as emergency contraception after unprotected intercourse or possible contraceptive failure when administered within 120 hours (5 days) after unprotected intercourse or a known or suspected contraceptive failure. As the product Fibristal (available in Canada), ulipristal is indicated for treatment of the signs and symptoms of uterine fibroids in adult women.',\n",
       " 'Investigated for use/treatment in asthma and burns and burn infections.',\n",
       " 'Edoxaban is indicated for reducing the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF). However, it should not be used in patients with creatinine clearance (CrCL) > 95 mL/min because of increased risk of ischemic stroke compared to warfarin at the highest dose studied (60 mg). It is also indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5-10 days of initial therapy with a parenteral anticoagulant.',\n",
       " 'Tapentadol is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Due to the risks of addiction, drug abuse, and drug misuse, tapentadol is reserved for patients for whom alternative treatment options are unavailable.[L47286, L47516, L47521]\\r\\n\\r\\nThe immediate-release tapentadol oral tablets are approved for use in patients six years and older with a body weight of at least 40 kg.[L47286] Tapentadol oral solution is used in patients aged six years and older with a body weight of at least 16 kg.[L47521] These formulations are not intended for long-term use unless the pain remains severe enough to require an opioid analgesic, for which alternative treatment options remain inadequate.\\r\\n\\r\\nThe extended-release tablets of tapentadol are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. They are also indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. This formulation is not indicated as an as-needed (prn) analgesic.[L47516]',\n",
       " 'Investigated for use/treatment in cystic fibrosis, HIV infection, hepatitis (viral, B), and malaria.',\n",
       " 'Used to treat postpartum haemorrhage and postabortion haemorrhage in patients with uterine atony. ',\n",
       " 'Sonidegib is approved for use in the US and EU for treatment of adults with locally advanced basal cell carcinoma (BCC) that has recurred post surgery or radiation therapy.  It is also approved for adult patients with BCC who are not eligible for surgery or radiation therapy. (2)',\n",
       " 'Macitentan is indicated for the treatment of WHO group 1 pulmonary arterial hypertension (PAH) both alone and in combination with tadalafil.[L35890, L39105]',\n",
       " 'Investigated for use/treatment in neurologic disorders.',\n",
       " 'Used to decrease appetite.',\n",
       " 'Mainly used as an anti-anxiety agent. Studies have found delorazepam to be more effective in the first 4 weeks of use than antidepressants; however, after 4 weeks, antidepressants showed superior anti-anxiety effects. Anti-anxiety effects also appear to be weaker in elderly patients. \\r\\n\\r\\nEffectiveness has also been observed in the treatment of alcohol withdrawal. Delorazapam was reported to be a manageable drug in that it did not exhibit severe side effects and did not require further therapies to control symptoms of withdrawal.',\n",
       " 'Methyltestosterone is an anabolic steroid hormone used to treat men with a testosterone deficiency. It is also used in women to treat breast cancer, breast pain, swelling due to pregnancy, and with the addition of estrogen it can treat symptoms of menopause.',\n",
       " 'For the treatment of pain.',\n",
       " 'Intended for the treatment of various forms of cancer.',\n",
       " 'Phenazopyridine hydrochloride is indicated to relieve uncomfortable symptoms that occur as a consequence of mucosal irritation of the lower urinary tract in adults.  The irritation may be a result of trauma, surgery, endoscopic procedures, infection, or the insertion of instruments or urinary catheters.[L7826] Phenazopyridine may be used in combination with antimicrobial therapy but is not used as an antimicrobial agent. It contributes to the relief of discomfort and pain before antimicrobial therapy begins to take effect.  It is important to note that the duration of treatment with this drug should last a maximum of 2 days.[L7826] Phenazopyridine is available in many countries as an over the counter drug.[A182147]',\n",
       " 'Eslicarbazepine acetate is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.[L4565]',\n",
       " 'Cobicistat is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection. It is not interchangeable with ritonavir to increase systemic exposure of darunavir 600 mg twice daily, fosamprenavir, saquinavir, or tipranavir due to lack of exposure data. The use of cobicistat is not recommended with darunavir 600 mg twice daily, fosamprenavir, saquinavir or tipranavir. Complex or unknown mechanisms of drug interactions preclude extrapolation of ritonavir drug interactions to certain cobicistat interactions. Cobicistat and ritonavir when administered with either atazanavir or darunavir may result in different drug interactions when used with concomitant medications.',\n",
       " 'Ulesfia (benzyl alcohol) lotion is indicated for the topical treatment of head lice infestation in patients 6 months of age and older. Ulesfia Lotion does not have ovicidal activity.',\n",
       " 'By the WHO, moxisylyte is indicated for the symptomatic management of sequelae of cerebral infarction or hemorrhage.[T91] The cerebral infarction is characterized by the blockage of the artery either by the formation of a thrombus or an embolus.[A31644] \\r\\n\\r\\nOn the other hand, the FDA classified moxisylyte for the reversal of phenylephrine-induced mydriasis in patients who have narrow anterior angles and are at risk of developing an acute attack of angle-closure glaucoma.[L1172]  Closed-angle glaucoma is caused by the contact between the iris and the trabecular meshwork. This contact will damage the aqueous outflow by the meshwork thus, increasing eye pressure and producing the symptoms of glaucoma.[A31645] Mydriasis is referred to the dilatation of the pupils and this standard body function is known to be a trigger factor for the development of acute closed-angle glaucoma.This risk is explained by the generation of a pupillary block, which is the contact between the pupillary margins and the lens, thus preventing flow from the aqueous humor to the anterior chamber and followed by an increased pressure gradient.[L1173] \\r\\n\\r\\nMoxisylyte is also approved in France as the first drug for the treatment of impotence.[A31647]']"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "diseases_list = df['Therapeutic Area'].to_list()\n",
    "diseases_list = [x for x in diseases_list if x is not None]\n",
    "diseases_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "# plt.figure(figsize=(30,20))\n",
    "# sns.barplot(data=disease_count_df, x='Count', y='Disease', palette='viridis')\n",
    "# plt.title('Disease Counts')\n",
    "# plt.xlabel('Count')\n",
    "# plt.ylabel('Disease')\n",
    "# plt.tight_layout()\n",
    "# plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/65/r52mz7k10_l6lkp_jfvvl2mr0000gn/T/ipykernel_88647/1419649343.py:3: FutureWarning: \n",
      "\n",
      "Passing `palette` without assigning `hue` is deprecated and will be removed in v0.14.0. Assign the `x` variable to `hue` and set `legend=False` for the same effect.\n",
      "\n",
      "  sns.barplot(x=organisms.index, y=organisms.values, palette=\"viridis\")\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2400x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "organisms = bindingDB['Target Source Organism According to Curator or DataSource'].value_counts()\n",
    "plt.figure(figsize=(24,6))\n",
    "sns.barplot(x=organisms.index, y=organisms.values, palette=\"viridis\")\n",
    "plt.xticks(rotation = 90)\n",
    "plt.yscale('log')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [],
   "source": [
    "df2 = bindingDB.dropna(subset=['Article DOI']).sample(10000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "df2 = add_location(df2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [],
   "source": [
    "df2.loc[df2['Affiliated Location'] != \"No affiliation found\", 'country'] = df2['Affiliated Location'].apply(fct_extract_country)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [],
   "source": [
    "pivot_df2 = df2.pivot_table(\n",
    "    index='Target Source Organism According to Curator or DataSource', \n",
    "    columns='country', \n",
    "    aggfunc='size', \n",
    "    fill_value=0\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2000x1000 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(20, 10))\n",
    "cmap = plt.get_cmap('viridis_r')\n",
    "cmap.set_under('white')\n",
    "sns.heatmap(pivot_df2, annot=True, cmap=cmap, vmin=0.01)\n",
    "plt.title(\"Studies Distribution by Organism and Country\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "coloraxis": "coloraxis",
         "geo": "geo",
         "hovertemplate": "<b>%{hovertext}</b><br><br>country=%{location}<br>Count=%{z}<extra></extra>",
         "hovertext": [
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Human immunodeficiency virus 1",
          "Homo sapiens",
          "Homo sapiens",
          "Oryctolagus cuniculus",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Human immunodeficiency virus 1",
          "Homo sapiens",
          "Homo sapiens",
          "Human immunodeficiency virus 1",
          "Rattus norvegicus",
          "Homo sapiens",
          "Homo sapiens",
          "Marthasterias glacialis",
          "Electrophorus electricus",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Marthasterias glacialis",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Glycine max",
          "Rattus norvegicus",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Human immunodeficiency virus 1",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Human immunodeficiency virus 1",
          "Homo sapiens",
          "Homo sapiens",
          "Rattus norvegicus",
          "Homo sapiens",
          "Cavia porcellus",
          "Mycobacterium tuberculosis",
          "Canavalia ensiformis",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Bos taurus",
          "Homo sapiens",
          "Homo sapiens",
          "Homo sapiens",
          "Plasmodium vivax",
          "Homo sapiens",
          "Homo sapiens",
          "Pseudomonas aeruginosa",
          "Homo sapiens",
          "Homo sapiens",
          "Trypanosoma brucei brucei"
         ],
         "locationmode": "country names",
         "locations": [
          "Afghanistan",
          "Albania",
          "American Samoa",
          "Anguilla",
          "Antigua and Barbuda",
          "Argentina",
          "Armenia",
          "Aruba",
          "Australia",
          "Austria",
          "Bahamas",
          "Bangladesh",
          "Belgium",
          "Benin",
          "Bermuda",
          "Bolivia, Plurinational State of",
          "Bonaire, Sint Eustatius and Saba",
          "Canada",
          "Central African Republic",
          "Chile",
          "China",
          "Cocos (Keeling) Islands",
          "Colombia",
          "Congo, The Democratic Republic of the",
          "Costa Rica",
          "Croatia",
          "Czechia",
          "Denmark",
          "Dominica",
          "Egypt",
          "Eritrea",
          "Ethiopia",
          "Finland",
          "France",
          "Germany",
          "Greece",
          "Hungary",
          "India",
          "Iran, Islamic Republic of",
          "Ireland",
          "Isle of Man",
          "Israel",
          "Italy",
          "Japan",
          "Jordan",
          "Malaysia",
          "Malta",
          "Micronesia, Federated States of",
          "Moldova, Republic of",
          "Montenegro",
          "Morocco",
          "Netherlands",
          "New Zealand",
          "Pakistan",
          "Panama",
          "Poland",
          "Portugal",
          "Puerto Rico",
          "Qatar",
          "Russian Federation",
          "Sao Tome and Principe",
          "Saudi Arabia",
          "Singapore",
          "Slovakia",
          "Spain",
          "Sweden",
          "Switzerland",
          "Thailand",
          "Tunisia",
          "United Kingdom",
          "United States",
          "United States of America",
          "Virgin Islands, U.S.",
          "Western Sahara"
         ],
         "name": "",
         "type": "choropleth",
         "z": [
          2,
          2,
          14,
          1,
          18,
          26,
          11,
          6,
          12,
          8,
          9,
          5,
          29,
          5,
          21,
          4,
          7,
          46,
          3,
          1,
          97,
          5,
          7,
          2,
          24,
          2,
          6,
          4,
          6,
          3,
          4,
          2,
          5,
          69,
          136,
          4,
          10,
          19,
          1,
          3,
          4,
          5,
          179,
          26,
          2,
          7,
          5,
          4,
          2,
          5,
          5,
          7,
          1,
          4,
          2,
          11,
          1,
          6,
          7,
          7,
          3,
          3,
          1,
          4,
          14,
          5,
          20,
          4,
          3,
          45,
          9,
          1301,
          1,
          2
         ]
        }
       ],
       "layout": {
        "coloraxis": {
         "colorbar": {
          "title": {
           "text": "Count"
          }
         },
         "colorscale": [
          [
           0,
           "#0d0887"
          ],
          [
           0.1111111111111111,
           "#46039f"
          ],
          [
           0.2222222222222222,
           "#7201a8"
          ],
          [
           0.3333333333333333,
           "#9c179e"
          ],
          [
           0.4444444444444444,
           "#bd3786"
          ],
          [
           0.5555555555555556,
           "#d8576b"
          ],
          [
           0.6666666666666666,
           "#ed7953"
          ],
          [
           0.7777777777777778,
           "#fb9f3a"
          ],
          [
           0.8888888888888888,
           "#fdca26"
          ],
          [
           1,
           "#f0f921"
          ]
         ]
        },
        "geo": {
         "center": {},
         "domain": {
          "x": [
           0,
           1
          ],
          "y": [
           0,
           1
          ]
         }
        },
        "legend": {
         "tracegroupgap": 0
        },
        "margin": {
         "t": 60
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import plotly.express as px\n",
    "\n",
    "country_counts = df2.groupby(['country', 'Target Source Organism According to Curator or DataSource']).size().reset_index(name='Count')\n",
    "max_organism_countries = country_counts.loc[country_counts.groupby('country')['Count'].idxmax()]\n",
    "\n",
    "fig = px.choropleth(\n",
    "    max_organism_countries,\n",
    "    locations=\"country\",\n",
    "    locationmode='country names',\n",
    "    color=\"Count\",\n",
    "    hover_name=\"Target Source Organism According to Curator or DataSource\"\n",
    ")\n",
    "fig.show()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ada",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
